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ABSTRACT
The physiological mechanisms for achieving fecal continence and the results
of the surgical methods to correct incontinence are reviewed. The devices hitherto
designed to attempt to achieve continence artificially are discussed and an analysis of
4130 reported complications of a successful device for the control of urinary
incontinence (the AMS 800) are presented. Based on these reviews, the need to
design and evaluate a prosthetic anal sphincter is identified and such a device is
presented in this thesis.
The effect of circumferential occlusive pressure on the blood flow of porcine
colon was assessed by a Laser Doppler flow meter. It was demonstrated that distal
blood flow is reduced by 50% at 52 mmHg. The occlusion pressure required to
achieve continence to semi-solids was shown to be reduced by the introduction of
angulation both in a theoretical model and experimentally, using a specifically
designed fecal substitute.
The Neosphincter was, therefore, designed to simulate the normal physiology
of the anorectum by closing and angulating the bowel without causing crenation and
ischaemia.
The design parameters of the device were evaluated in an in-vitro model and
its placement assessed in a series of acute animal experiments in a porcine model.
The effects of the prosthesis set at an operating occlusion pressure of 33-45 mmHg
were then evaluated in survival animal experiments by implantation in Yucatan mini-
pigs for up to 20 weeks. The device produced fecal continence in 85% of the
activation times without causing ischaemic injury. Mechanical complications
associated with the control pump were encountered and design faults were identified.
A new pump was designed by the author.
The effect of Neosphincter function on blood flow distribution in the human
colon was studied during colectomy using a prototype Laser Doppler flow scanner.
Blood flow remained greater than 50% at 60 mmHg occlusion pressure.
The data presented show that the Neosphincter achieves continence in the
mini-pig model and further suggest that continence would be achieved in the human
without producing intestinal ischaemia. Ethical approval has been obtained to
proceed to trials in human patients.
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Outline and organization of this Thesis
The first part of this thesis is a collection of review chapters on the subjects of
faecal continence, incontinence and attempts to achieve continence artificially. The
complications of a device generally accepted as an option for the treatment of urinary
incontinence are reviewed both from the literature, and the reports to the Federal
Drug Agency (FDA) in the USA of over 4000 complications.
The first section describes the design of the device and its in-vitro evaluation.
Some of the engineering parameters assessed both in-vivo and in-vitro are also
presented in this section.
The second section describes the acute and long term animal experiments and
results, while in the third section the results of acute experiments on the effects of the
device on the blood flow distribution in human colon are presented.
The main thesis concludes with some thoughts on future experiments and
technological developments.
A series of six appendixes follows in the last section. These can be read
independently and summarize mainly pure and applied mathematical models of fluid
flow and rheological evaluation experiments, engineering considerations on the
design of this device and reviews of previously patented devices. Most of the
experimental data appear in Appendix 4. Appendix 5 presents all the survival
clinical and system engineering data for each animal: the clinical data are analyzed in
Chapter 6 and the engineering data of the assessment of the device is presented in
Chapter 3. In two cases (AMS complication review and sphincter assessment data in
Chapter 3) the raw data would occupy several hundred pages. These data are
included on 3.5" computer discs appropriately labeled. It should be noted, however,
that this cannot protect the files from unauthorized access or tampering and the
author has kept appropriately backed up files.
An outline of the contents of the thesis is presented in a short table of




A Review of the Physiological Faecal Continence
Mechanisms
Is conventional surgery satisfactory for the correction of
faecal incontinence?
Attempts to achieve continence artificially: A Review
A successful continence device? Review of 4000
complications associated with the AMS 800 Artificial Urinary
Sphincter
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Wife: Did not the God approach you?*
Carion: Not till later. And then I did a thing that will make you laugh. For as he
neared me, by some dire mishap my wind exploded like a thunder-clap.
Wife: I guess the God was awfully disgusted.
Carion: No, but Iaso blushed a rosy red and Panaceia turned away her head
holding her nose: my wind's not frankincense**.
Aristophanes Plutus (lines 696-703).
*: The God was Asclepius.
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There is no generally acceptable definition of anal continence that can be
applied to all ages and all patients; also, what is considered normal may vary.
Absolute control of rectal contents is not present in all normal individuals. The
incidence of minor deficits in a control population without anorectal complaints was
found to be approximately 10% '. The usual clinical definition of continence is
based on the absence of faecal soiling, but this may be difficult to establish depending
on the degree of cleanliness of the subject being questioned. A score of faecal
incontinence was reported by Miller et al2, which relates to both the frequency and
consistency of the stool (Table 1). Control of flatus in some societies may not be
socially necessary. Anal incontinence is not a life threatening disease (in fact it is not
a diagnosis, it is a symptom) but it is a socially devastating condition. Many patients
do not seek medical advice and thus suffer social alienation and serious psychiatric
isolation. As a consequence, reliable epidemiological data on incontinence is
unavailable and its incidence is, therefore, underestimated1'3,4.
Flatus Fluid Solid
Incontinence less than once a month 1 4 7
Incontinence between once a month and once a week 2 5 8
Incontinence more than once a week 3 6 9
Table 1: Faecal incontinence score2.
Faecal continence in the human depends upon the coordinated action of the
anal sphincters which produce circumferential occlusion, and the pelvic floor
musculature (especially the puborectalis) which produce angulation between the
rectum and anal canal. Other factors which are important in maintaining continence
24
include: the consistency of the stool5"7, the capacity of the rectum8"11, normal recto¬
sigmoid motility12'13, the preservation of a normal sampling reflex14"16, normal
14 j- 21 22 23anorectal sensation ' " , normal resting anal tone ' ' , preservation of anorectal
angulation (see Chapter 1) and resistance to opening of the anal canal24. The normal
• • 25
anorectal function parameters are summarized in Table 2 (methodology of
26 25
measurements summarized by Corman and Keighley and Williams ).
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Incontinent Normal
Maximum resting anal pressure, cmH20 (mmHg) 58 (42.6) 87 (64)
Maximum squeeze anal pressure, cmH20 (mmHg) 120 (82.2) 193 (142)
Rectoanal inhibitory reflex present (%) 31 100
Anocutaneous reflex present (%) 47 100
Threshold rectal sensation (ml) 42 29
Maximum volume retained (ml) 268 >400
Basal sigmoid pressure, cmH20 (mmHg) 44 (32.3) 27(19.8)
Motility index 680 320
Transit markers passed in 5 days (%) 76 75
Resting anorectal angle (°) 123 88
Pelvic floor descent at rest (cm) +2.2 -0.4
Pelvic floor descent during straining (cm) +0.6 -4.3
Anal sensation threshold: midzone (mA) 13.7 5.3
Rectal emptying: % passed in 1 minute 75 75
Saline infusion: volume of first leak (ml) 180 960
Pudendal nerve terminal motor latency (ms) 2.4 2.0
Fiber density in puborectalis 1.7 1.4




Our present knowledge of the pelvic floor is based largely on the meticulous
28 29
dissections and observations of Thompson (1899) , Milligan and Morgan (1934) ,
Golligher et al (1955)30, Parks (1956)31 and Kerremans (1969)32, based on cadaveric
31
dissections and intraoperative observations .
The anorectal region is of dual embryological origin: the visceral inner tube
comprises mucosa, submucosa, circular and longitudinal muscle, the latter being
29
thickened caudally to form the internal anal sphincter (Milligan and Morgan 1934 ).
The outer tube consists of the skeletal muscle comprising the funnel like levator ani
muscles and, more caudally, the external anal sphincter (Parks 197533).
The anal canal
The anal canal commences at the anorectal angle and ends at the anal verge.
It is 3-4 cm long. The lower canal and transition zone are richly innervated with
27 i r» •
sensory nerve endings and surrounded by a complex of sphincters (external and
internal). The two concentric cylinders which form the anal canal are shown in
Figure 1. The anal canal appears to have a slit-like anteroposterior cross section
radiologically34. This may be explained by the anteroposterior attachments of the
middle part of the external sphincter (perineal body and coccyx respectively).
32 35Kerremans and Duthie report that the caudal part of the sphincter is attached to
the coccyx as well, and Shafik36"41 reports a triple sling arrangement (Figure 2): This
involves a three-loop system with two U-shaped loops directed anteriorly and one
posteriorly. The top loop arises and inserts on the pubis and is made up of the deep
external sphincter and puborectalis. The middle loop attaches to the coccyx
(superficial anal sphincter). The lower loop inserts in the anterior perianal skin. His
anatomical (gross and microscopic) descriptions are based on post-mortem
dissections of a small number of subjects reported in the above series of papers. He
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Figure 2: The triple loop system of Shafik36"41. Reproduced from Corman26.
While it is an interesting concept, this theory serves more to obfuscate than to
clarify the issues of pelvic floor anatomy and muscle control. In addition, Shafiks'
findings have not been confirmed by other investigators42.
The external anal sphincter
The external sphincter is part of a composite striated muscle encircling the
anal canal that enables voluntary control of continence. It is arbitrarily divided into
three parts: subcutaneous, superficial and deep (Figure 1). This distinction is of little
practical importance as none of these parts is recognizable surgically.
29
It is recommended that it be ....
... relegated to the junkyard of anatomic trivia where it may languish for the sake of the
historical anatomist or the rare individual who spends time carving out the most meticulous
dissections. (Dalley, from Corman 199326).
32
Kerremans suggested that the different interpretations of the anatomy of this
muscle may be due to the variability of the fibrous sheaths which appear to subdivide
it. Posteriorly, the upper fibers of the external sphincter merge with the inner fibers
of the puborectalis.
The internal anal sphincter
The internal sphincter is the continuation of the distal portion of the circular
27 35
muscle of the rectum which is thickened to «2 mm at that level ' . It is 2 to 4 cm
long 35. In the descriptions of Milligan and Morgan29 the internal anal sphincter does
not reach the anal canal. This has been disputed by Eisenhammer43 and this later
confirmed by other workers30'44.
The levator ani
This muscle was first described by Vesalius45, as "Duo musculi intestinum
post egestionem sursum trahentes" (Figure 3). It arises from the bony pelvis and the
obturator fascia and spreads out in a funnel like manner to form a thin muscular
pelvic floor(Figure 4). For practical purposes, each levator ani may be regarded as
consisting of two main parts: the pubococcygeus with its specialized portion the
puborectalis and the iliococcygeus (Figure 4, A and B). The pubococcygeus and
puborectalis arise from the posterior aspect of the pubis and from the white line as far
back as the obturator canal. The pubococcygeus fuses with its fellow posteriorly to
form part of the anococcygeal raphe. Its inner portion is thickened and forms the
puborectalis which arises from the symphysis pubis. These fibers surround the
prostate (or vagina) and the anorectum, meeting fibers from the opposite side in a
loop or U-shaped girdle (Figure 4). Apart from the external sphincter, the
puborectalis blends with the longitudinal muscle and the adjacent part of the internal
30
sphincter (Figure 1). The iliococcygeus is a thin muscle which supports the pelvic
outlet.
Contraction of the levator ani and the puborectalis sling pulls the anorectal
junction upward and forwards, elongating the anal canal and increasing angulation
13 •between the anal canal and the rectum . This, along with contraction of the external
and/or internal anal sphincters results in effective closure of the anal canal.
Figure 3: The Anal Sphincters (Special Muscles of the Rectum), reproduced
from: The Illustrations from the Works of Andreas Vesalius46, plate 55:4.
31
A.





Inferior fascia of urogenital diaphragm cut
Deep transverse perineal muscle
Superficial transverse perineal muscle cut
Visceral extensions from levator ani to
conjoined longitudinal muscle
Ischial tuberosity
Deep external sphincter cut
Conjoined longitudinal muscle
Internal anal sphincter f _ .
Pubococcygeus




Gluteus maximus muscle cut
Coccyx
Figure 4: Anatomy of the male perineal musculature:
A. Inferior view with the skin and subcutaneous tissues removed.
B. Exposure at the level of the midanal canal (from Corman 1993).
Buck's fascia over corpora cavernosa.
Gracilis muscle
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Somatic and visceral innervation of the pelvicfloor:
Figure 5: Sagittal section of the female pelvis to show the innervation of the anal
sphincters and puborectalis (reproduced from Keighley and Williams 199342)
Somatic innervation
The striated muscles of the pelvic floor are innervated by the S2, S3, S4
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motor nerve roots . The external anal sphincter, as well as the peripheral part of the
levator ani, is supplied by the pudendal nerve (Figure 5). It also carries afferent
nerves from the anal canal and perianal skin. The puborectalis is supplied by the
perineal branch of S4, which also carries afferent fibers from the anal canal and
perianal skin. The levator ani, therefore, has dual nerve supply: it is supplied by the
pudendal nerve (peripheral part) and perineal branches of S3 and S4 (the branch of
S4 supplies the puborectalis).
33
Percy et al (1981 )47, demonstrated the functional innervation in-vivo in 20
patients. In their experiments, the direct branch of the sacral nerves S3 and S4 was
identified on the visceral surface of the levator ani and puborectalis during the
operation of postanal perineorrhaphy. These branches were electrically stimulated
and the evoked responses recorded using a concentric needle electromyography
(EMG) electrode placed in each component of the pelvic floor musculature
(pubococcygeus, puborectalis, and the upper and lower parts of the external anal
sphincter). Stimulation evoked action potentials from the pubococcygeus in all 20
cases and the puborectalis in 19. No evoked EMG activity was detected from the
external sphincter muscle on either side.
The response to stimulation of the pudendal nerves was studied in addition in
three patients. Evoked activity was recorded in the ipsilateral external sphincter but
not in the components of the levator ani. Moreover in these three patients there was
no overlap in the parts of the pelvic floor supplied by the pudendal nerve and the
direct branches of S3 and S4. Their results suggest that the pudendal nerve does not
normally innervate puborectalis and document that this muscle is predominantly
innervated by the direct branches of S3 and S4.
Afferent somatic innervation is abundant and varied from about 10-15 mm
above the anal valves, down to the boundary with hairy skin. Somatic sensation
(touch, pin-prick, heat and cold) was demonstrated to be perceived in the anal canal
48
to a level 2.5-15 mm above the anal valves . This was suggested to be important in
the discrimination between solid, liquid and gaseous contents14.
Visceral innervation
Parasympathetic innervation to the rectum/internal sphincter (visceral inner
tube) is supplied by the nervi erigentes (S2-4) via the presacral nerves, and
sympathetic from the hypogastric plexus along the inferior rectal artery27'42.
Nociceptive pathways travel in both parasympathetic and sympathetic systems via
the inferior and superior hypogastric plexus to the ganglions at LI and L2. The
34
sensation of rectal distention travels with the pelvic splanchnic nerves to S2 and S3.
It appears that this may be mediated by receptors found both in the rectal wall and
pelvic floor fascia / musculature, as this sensation is not completely abolished by
rectal resection and coloanal anastomosis49.
Physiological considerations
In this section, the function of the anal canal, the sphincter mechanisms and
the pelvic floor muscles will be described.
The physiological mechanism of the pelvic floor is designed to accomplish
the following two tasks:
• To convert a potential perineal colostomy into an automatically functioning
sphincter controlled anus.
• To resist intra-abdominal pressure forces which, if unopposed would tend to
33
produce herniation of the perineum .
The anal canal is anatomically 3-4 cm in length and is normally closed at rest
and during sleep50. A high pressure zone is present in the anal canal (Table 2), and
35this is maximal at about 2 cm from the anal verge . This high pressure zone is
present in both term and pre-term infants and its length is 14.7 ±2.9 mm and 10.3 ±2
mm respectively51. There have been recent reports of attempts to plot the spatial
distribution of the pressures inside the anal canal by using a multi-channel water
perfused pressure measuring station pullthrough setup and presenting the results as a
52
vector diagram (Figure 6). The area of the polygon is a reflection of the net
35
pressure at a specific level in the anal canal. The pressure vector volume at a specific
level is the area multiplied by the distance between stations.
The results shown in Figure 6 do not represent true pressure distributions in the
authors' opinion for the following reasons:
- It is impossible according to engineering laws for a system in equilibrium to have
a heterogeneous pressure distribution along any axis. If the pressure was indeed
greater posteriorly than anteriorly, the posterior rectal wall would move towards
the area of lower pressure until the pressures equalize and at this point the
movement would cease.
- The presence of the thick perfused catheter upsets the basal pressure
52characteristics of the anal canal and, due to the tube's low compliance and lack
of compressibility, does not allow effective pressure transmission to the anterior
rectal wall.
- The path of the pulled-through catheter is not straight but follows the curve of the
anorectal junction. It is well known that pressure measuring catheters are
unreliable in directional measurements under these circumstances as the
application and relative sealing of the pressure measuring area of the catheter
against the mucosa would lead to an artificially high reading.
What this method probably demonstrates is the direction from which active pressure
is being applied (e.g. posteriorly by the puborectalis or caudally and anteriorly when
the anterior part of the catheter abuts on the area of the pubis) and also the fact that
36
part of this exerted pressure is being dissipated by the catheter so that only a fraction
is transmitted to and measured at the other side.
37
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Figure 6: Vector diagram of anal pressures . Reproduced from Keighley and
Williams25.
(a) The eight port perfused catheter. A, anterior; P, posterior; L, left; R, right.
(b) The station pullthrough anal manometry probe placed in the rectum.
(c) An eight quadratic wedge of the pressure vectogram.
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Mechanicalproperties ofthe anal canal
In a theoretical evaluation to describe the mechanical properties of the anal
53canal region, Gibbons et al modeled the anal sphincter complex by a two tube
model, with a luminal diameter = d. The outside cylinder represents the external anal
sphincter and the inside the internal sphincter and mucosa. The basic assumptions
made are that when the "anal cylinder" layer is lax, tension is zero and that sphincter
pressure solely depends on the outside layer. Tension versus diameter were predicted
52 53
to vary linearly and this was confirmed experimentally ' . The situation at the
limits (i.e. d=0) may not be completely accounted for by the initial assumptions made
by the model: The anal canal pressure was measured with probes of different
52diameters and the anal sphincter tension estimated . The measurements were
performed at rest, maximal pelvic floor contraction and rectal distention. Estimated
tension was plotted and found to increase linearly with probe diameter (i.e. anal
distention). When all three lines were extrapolated to the origin, zero tension was
predicted at approximately 1.5 mm of internal anal diameter for all three (rest,
maximal pelvic floor contraction and rectal distention).
In the above theoretical model53, the luminal pressure is predicted to fall to
zero before the diameter is zero. The "autoregulatory thickness adjustment" was thus
proposed, which allows for the diameter to fall to zero passively. It was, therefore,
proposed that this function of passively occluding the diameter of the anal canal at
52 53
rest is achieved by the passive engorgement of the anal canal cushions ' . The anal
canal would subsequently resist passive opening24'53.
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The muscles ofthe anal canal:
Internal anal sphincter
13 32
The internal sphincter (IAS) is in a continuously tonic state ' , and provides
the most important component of resting anal pressure when the anal canal is
closed22'23. This contribution is reported to be between 50%22 and 85%23 at rest.
Shafik54 suggests that the IAS is not at maximal contractility at rest, especially since
its contractility is reportedly improved by biofeedback55"57; this is probably true but
cannot be surmised from the method of stimulation he described54, as the EAS may
also have been stimulated at the same time.
The IAS muscle exhibits continuous activity which is both under autonomic
control and locally mediated by an intermyenteric plexus (since circular rectal
25 58 59
myotomy abolishes activity ). Myogenic activity has also been reported in-vitro '
58and was indistinguishable from that of more proximal rectal muscle . Electrical
activity consists of slow (16 per minute) and ultra slow waves (1.6 per minute), but
32this does not correlate directly with pressure activity . The activity of the smooth
muscle component is completely inhibited by rectal distention: the rectoanal
1213* • • *51
inhibitory reflex ' . This reflex is present in both term and pre-term infants .
Resting anal pressure is decreased when 0.2% solution of glyceryl trinitrate was
applied locally60. This supports the hypothesis that nitric oxide is the final mediator
61 62in IAS relaxation suggested by animal in-vitro experiments , animal in-vivo and
63 • ...human studies . Direct demonstration of a descending nitrergic rectoanal pathway
was described recently64. The in-vitro responses of the smooth muscle components




















Present Stimulation Stimulation Relaxation
Internal anal
sphincter
Present Relaxation Stimulation Relaxation
Table 3: In-vitro response of human rectal and anal muscle to cholinergic and
59
adrenergic neurotransmitters (summarised from O'Kelly et aV ).
The internal anal sphincter is also important as a means for allowing rectal
contents to come into contact with the sensitive anal mucosa during the sampling
reflex14"16. This reflex is deficient in faecal incontinence15. The function of the
internal anal sphincter deteriorates with advancing age8,65'66.
External anal sphincter
Voluntary control of continence is provided by the external anal sphincter and
the puborectalis sling. Voluntary contraction is accompanied by rapid recruitment
and high pressures are achieved in normal subjects (see Table 2). External sphincter
function cannot be sustained and there is rapid fatigue, hence it usually merely
provides a final control mechanism if fecal material enters the upper anal canal. Age
• • 67 •
causes increased fiber density in the EAS , probably as a result of denervation, with
a concomitant decrease in its ability to generate occlusive pressure. The external anal
sphincter was originally thought to be quiescent at rest and activated only by reflex
41
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mechanisms . This hypothesis was subsequently disproved and it is now known that
this muscle (and the other striated muscles of the pelvic floor) are electrically
13 32
continually active even at rest ' . Their electrical activity varies with the posture
13 •and activity of the subject . The resting EMG activity of the external anal sphincter
13
is normal after transection of the spinal cord above the third lumbar segment .
During coughing, there was greatly increased EMG activity in the external sphincter
which coincided with the rise in intra-abdominal pressure. This suggests that the
cough response is part of a reflex mechanism. Cutaneous perianal stimulation excites
68
a reflex response from the external anal sphincter . This response can be elicited in
paraplegic patients indicating that cortical control is not involved and that it is a
spinal reflex.
A burst of EMG activity preceding the inhibition of the internal anal sphincter
17
is recorded in the external anal sphincter after rectal distention . This activity
persists throughout the duration of rectal distention in normal subjects but not in
23
patients who suffered cord transection above the lumbar segments . This
32
phenomenon has been termed constant relaxation .
32
Upon straining, different EMG responses of the EAS are observed in
different subjects:
13
1. Sudden abolition of all electrical activity (also reported by Parks )
2. Initial burst of EMG activity, followed by inhibition throughout the period of
straining
3. Persistent increased EMG activity
4. Bursts of polyphasic potentials.
Distention of the anal canal (both digitally and by a balloon) was reported to
elicit a burst of EMG activity in the EAS followed by some decrease and finally a
sharp increase when the distention ceased69. The latter response was called the
closing reflex69. In paraplegic subjects, after the brisk increase in muscular activity,
complete inhibition ensued for the duration of anal distention69. This suggests that,
42
in normal subjects the inhibitory reflex is overshadowed by cortical excitatory EAS
activity.
The above descriptions were sequentially presented to follow the temporal
pattern of defecation (rectal distention, staining, distention of the anal canal). It is
now clear that the normal defecatory response involves inhibition of the pelvic floor
musculature in most instances70, so it is unlikely that the excitatory activity seen
during anal distention is part of normal rectal evacuation. How closely the pattern of
muscle activity seen during straining and anal distention resembles the situation
during actual defecation is difficult to determine. The presence of an observer
peering at the perineum together with an EMG needle electrode can hardly be
construed as mimicking the events of normal defecation.
Levator ani (Puborectalis)
The levator ani form a cradle for the rectal ampulla. Like the external anal sphincter
32 69 70 • • •
they are tonically active at rest ' ' . The puborectalis is almost a sphincter
anatomically, apart from the anterior 3 cm of its circumference which is made up by
the pubic arch (Figure 4). The puborectalis in fact acts as a powerful sphincter of the
33
upper part of the anal canal its forward pull creating the anorectal angle. The
puborectalis has an important sensory function in that stretching of its fibers leads to
the urge to defecate33.
Anorectal angulation is only present in adults and orthognate apes. It is
32
absent in the newborn and quadruped animals . The forward pull of the puborectalis
is responsible for the anorectal ring palpable on rectal examination at the upper anal
canal. Contraction of the puborectalis sling decreases the anorectal angle and pulls
the anorectal junction towards the pubis. This action effectively closes the upper
anal canal32'33'71.
32 70
Kerremans and Ihre showed that during voluntary contraction of the pelvic
floor musculature, coughing or straining, the external anal sphincter and puborectalis
43
showed almost identical electrophysiological characteristics suggesting that the two
muscles function as a single unit.
Conclusions
Muscles which are activated only voluntarily would be useless for the task of
maintaining continence as a person's attention would constantly have to be directed
to them. The automatic mechanism as indicated above is due to reflex activity. The
pelvic floor muscles are truly postural in that they are continuously active at rest (the
72
anal sphincter of quadruped animals is a fast twitch muscle as opposed to its
counterpart in the human). The reflex arc is made up of stretch receptors in the
pelvic floor muscles, an afferent neuron passes to the spinal cord, and an efferent
33
motor neuron in turn activates the muscle .
This reflex mechanism ensures not only that the muscles are constantly in
action, but also that their activity alters when a person walks, coughs or laughs. A
highly complex interaction between the reflex mechanisms exists to subserve normal
continence.
Anorectal Angle and the "Valve" Theories
Anorectal angle
There is a lack of uniformity in defining the anorectal angle (Figure 7) and
this, along with the measurement of other anorectal parameters has been standardized
by a working party73. Cine-defascography74'75 or video-proctography76 appear to
give the most reliable estimations of anorectal angle and are superior to balloon
77
defecography . Some authors have used the angle at the posterior rectal border,
while others measure the anorectal angle between the axis of the anal canal and the
central axis of the rectum; there is considerable interobserver variation when the first
78 79 • 80 81method is used ' and the latter is reported to be a more reliable technique ' .
73
Using the central anorectal angle , the average angle at rest is approximately 80°
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(120° in children82). Hip flexion increases this to around 90°. During defaecation this
angle opens to about 115°, while squeezing the anus and the Valsalva manoeuvre
decrease the anorectal angle to 85-100° (with the angle being more acute during the
former action). Changing position from lateral decubitus to sitting straightens the
resting angle, with no change from sitting to standing.
Figure 7: The Anorectal Angle as it appears radiologically42'73 during
videoproctography. The pubococcygeal line is drawn in both figures. The
anorectal angle can be estimated using the long axis of the rectum: angle
between lines "a" and "c" in (a.), or the long axis of the rectal centroid: angle
between line "PA" and "c" in (b.). The centroid is the centerpoint (P) of the
rectal image, such that a line between it and the apex of the anorectal angle
bisects the rectal image into two equal areas.
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It is generally agreed that the most important element in the system
comprising the internal and external sphincters and the levator ani complex is the
32 35 71
puborectalis sling ' * . Any damage to this muscle results in major defects of
continence. This muscle acts as a powerful sphincter on the upper anal canal and
32also creates the anorectal angle. Kerremans observed that the more acute the
anorectal angle, the lower the squeeze force required to retain a fecal bolus in the
rectum. The role of this angulation in the maintenance of continence was
investigated experimentally in our laboratory and is discussed in Chapter 1.
Flap valve
One of the major anatomical functions of the anorectal angle was considered
• •13 33 71
to be the creation of the flap valve mechanism at the anorectal junction ' ' . The
mucosa of the lowest part of the anterior rectal wall is forced into the upper anal
canal closing it off (Figure 8). This theory has been largely discounted in normal
subjects without obstructed defecation or prolapsing rectum, as radiological
observations during the Valsalva manoeuvre showed that the anterior and posterior
83rectal walls did not appose one another . In addition, rectal pressures were found to
83be consistently lower than those generated by the anal canal strengthening the
conclusion that continence did not depend on 'valvular' mechanisms.
Flutter valve
This theory was proposed by Edwards and Phillips34. They suggested that
normal continence was due partly to intra-abdominal pressure being transmitted at
the level of the levator ani, laterally to the side of the anal canal in the region of the
anorectal junction (Figure 9). The anal canal appears to be an anteroposterior slit34
radiologically and this pressure could compress it in a way similar to a simple flutter
or
valve (Figure 10). This theory was considered unlikely by Duthie since although
an occlusion was seen radiologically in the anorectal region when the rectum was
outlined by barium contrast, puborectalis activity could not be excluded.
46
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Kerremans also pointed out that the segment described as acting as a flutter valve
lies below the levator ani cradle at the level of the puborectalis sling. The flutter
valve mechanism, therefore, could not act by increases in intra-abdominal pressure.
In addition the flutter valve could not afford protection when the intrarectal pressure
rises. Another weakness of this theory is the fact that, in engineering terms, a flap
valve can only function if the conduit it would seal is not continuous (Figure 10).
Figure 8: The Flap Valve Theory. Diagram to illustrate how an increase in
















Figure 9: The anorectal flutter valve theory34.
Figure 10: Diagram of a simple flutter valve. In order for the flutter mechanism
to be effective, the conduit should be discontinuous at the point of the valve.
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A series of simple experiments were conducted in-vitro to check the validity
of the flutter valve theory (Chapter 2). The results of this study further weaken the
flutter valve theory.
A Summary of the Physiology ofDefaecation
The mechanism of defecation is still incompletely understood, despite
intensive investigation by several groups of workers. Based on the above
descriptions, the act of defecation would seem to progress as follows: Rectal fdling
stimulates receptors in the rectal wall, mesentery and pelvic floor musculature, and
sampling reflexes allow controlled contact with the upper anal canal. Once a person
is aware of the presence of material in the rectum, they need to determine whether
defecation is convenient. If it is not, the lower rectal contents are returned
proximally by a strong contraction of the levator ani and the EAS. This allows
recovery of the rectoanal inhibition initiated by distal rectal filling and allows the
return of IAS tone. If defecation is desirable, the anal canal opens and pelvic
musculature inhibition ensues (rectoanal inhibitory reflex) allowing some degree of
pelvic floor descent. This, combined with the squatting position straightens out the
axes of the anal canal and rectum, geometrically facilitating rectal evacuation.
Intrarectal pressure exceeds anal canal pressure by a combination of rectal
contractions and increase in intraabdominal pressure and this results in expulsion of
the rectal bolus. Basal sphincter and levator tone returns upon the relief of rectal
distention. Release of gas in the presence of other rectal contents can still take place
against a partially closed sphincter and an unrelaxed anorectal angle (this would
explain the associated characteristic sound). Faecal retention while passing flatus
may not be effective if the rectal contents are liquid, because anorectal angle does not
enhance continence to liquids (see Chapter 1).
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They say Man has succeeded where the animals fail because of
the clever use ofhis hands; yet when compared to the hands, the
Sphincter Ani is far superior: Ifyou place into your cupped hands a
mixture offluid, solid and gas and then through an opening at the
bottom try to let only the gas escape, you will fail. Yet the Sphincter Ani
can do it. It apparently can tell whether its owner is alone or with
someone, whether standing up or sitting down; whether its owner has
his pants on or off No other muscle in the body is such a protector of
the dignity ofman, yet so ready to come to his relief
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"The plight of a patient with frank fecal incontinence is a very
unhappy one indeed. There is the obvious association with
uncleanliness and the feeling of being a social outcast. Such a
person will not meet people, will not leave the house, or be able
to do the shopping. If the situation is known to the family the
patient may well be rejected as a result, especially in old age. It
is indeed a very grave social problem, particularly with the
elderly, and anything that will improve it is highly desirable. The
frequency of the problem is greater than is generally realised,
because patients will not discuss it and will not even tell their
nearest relatives or medical advisors. They manage to cope for
some years by wearing a great deal of padding, but finally even
this is of no avail."
The late Sir Alan G. Parks
(President's Address to the Royal Society of Medicine 1975)
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Faecal incontinence is a common, socially devastating condition which affects
12
all ages and remains a major unresolved clinical problem ' . The incidence and
prevalence are underestimated , especially in middle aged women in whom child
birth injury is the main cause . The results of conventional surgical correction for
12faecal incontinence are disappointing ' , except in cases of direct trauma to the
sphincter4. Although postanal repair and primary sphincter overlap repair benefit
some patients1'2'4, a proportion subsequently resort to colostomy. Further, patients
with severe congenital malformations and anorectal excision surgery have no
realistic alternative to stoma diversion5.
Aetiology of Faecal Incontinence
The causes of fecal incontinence can be either congenital or acquired, the
latter being by far the commonest. They can be summarized as follows:
CONGENITAL ANOMALIES
Spinal Dysraphism, Imperforate anus, Hirschprung's Disease, Sacral Agenesis
TRAUMA
6 7 • 8
Surgical: fistula surgery ' , hemorrhoidectomy ,
sphincterotomy6'9,
sphincter stretch10, pullthrough operations, low
anastomoses11
Obstetric: perineal tears12"14, pressure denervation or damage to
sphincters3'15"17
Accidental: war injury4, social injury18
COLORECTAL DISEASE
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Haemorrhoids8, Rectal prolapse19, Intussusception ofthe rectum20,
Inflammatory bowel disease, tumours
NEUROLOGIC DISEASE
Cerebral: tumour, vascular accident, dementia, trauma
Spinal: tumour, vascular accident, trauma
Peripheral: diabetes mellitus, multiple sclerosis, pudendal nerve injury
a a • • 15 16 21 22
Idiopathic ("Neurogenic"): Pelvic floor denervation ' ' '
MISCELLANEOUS
Laxative abuse, Diarrhoeal conditions, Fcecal impaction, Encopresis.
Treatment of Faecal Incontinence
Fascal incontinence is no exception in that treatment should be directed to its
23
cause. Incontinence attributable to trauma, is most likely to be treated successfully .
Despite the potential appeal of surgical intervention, however, many individuals can
be adequately managed by non-invasive means. Medical treatment should be offered
to those who have no antecedent history of trauma, those for whom the potential
benefits are problematic, those who are felt to be of high surgical risk and obviously
those who decline an operation.
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Non-Surgical Treatment of Faecal Incontinence







The aim of a bowel management program is to reeducate the bowel to empty
regularly and at a predictable time, thus establishing a routine for defecation that is
safe, convenient and dependable. If this is successful, patients with virtually no
sphincter control (e.g. with severe congenital abnormalities, spina bifida or trauma)
may be spared from the necessity for a diversion procedure. The bowel is kept in a
state of controlled constipation and stimulated to empty by the use of laxatives and/or
enemas given at regular fixed intervals. Reflex evacuation can be achieved by
massaging the abdomen to stimulate peristalsis and also utilizing the gastrocolic
reflex. This combination of optimizing fecal consistency, controlling the time of
defecation and stimulating peristalsis may result in socially acceptable continence in
a significant proportion of these patients, in whom a bowel action two to three times
a week may be adequate and, in fact, advantageous.
Perineal exercises
Elaborate regimes of perineal muscle exercises have been devised with
doubtful results. Exercise can increase the bulk of striated muscle and hence,
theoretically, the effectiveness of the external (but not the internal) anal sphincter and
puborectalis. It is, however, quite difficult to communicate the instructions of which
muscle to contract to the patients and this method has not gained widespread
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acceptance on its own. A more effective approach is to combine the exercise
program with biofeedback24.
Biofeedback
Operant conditioning or biofeedback involves the measurement of a
parameter pertaining to anal sphincter contraction (e.g. pressure25 or EMG26) and
allowing the patient a verbal or visual cue as to its effects. There have been
numerous publications that attest to the success of biofeedback training for
• 9^ 98
improving continence in idiopathic faecal incontinence " , in children with spina
bifida24 and in conjunction with transcutaneous nerve stimulation in a patient with
9Q
imperforate anus . Reports of success in other defecation disorders include severe
™01 oo oo
constipation in children ' and adults and obstructed defecation (anismus) " . A
number of portable biofeedback devices are available commercially. Such a device
has been designed by the author as a cheap alternative to the above and is being
assessed at the Royal Hospital for Sick Children (Figure 1).
Figure 1: Simple biofeedback unit designed by author. The circuitry involves a
standard Baxter pressure transducer and a CA3140 differential amplifier chip.
The response is graded on the LED display. The sensitivity of the device is
variable (its control is inaccessible to the patient).
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Electrical stimulation
Caldwell seems to have been the first to report electrical stimulation of the
36anal sphincter . He applied a stimulation current via secondary induction by two
electrodes connected to a coil in an attempt to control rectal prolapse. Hopkinson
and Lightwood reported their preliminary results on one patient with fecal
37 •
incontinence using an anal plug electrode for sphincter stimulation . The device
applied a tetanizing stimulation to the anal sphincter and pelvic floor through a plug
shaped electrode. They subsequently reported "good" results in nine patients treated
38 39with this method and similar short term results were reported by other workers .
Although perineal strengthening exercises might accomplish the same goal, the use
of electrical stimulation as well24'29, particularly in patients who are unable to
understand or perform such exercises, may offer some improvement. Glen40 reported
"good" results in a series of thirty patients with fecal and urinary incontinence. The
paucity of similar reports over the last fifteen years may imply failure or non-
acceptance of this method. Brindley41 first reported an implantable anterior sacral
root stimulator to control urinary incontinence and subsequently a pudendal nerve
stimulator to control fecal incontinence42. The approach of Williams and co-workers
whereby, by chronic low frequency stimulation, normal type II fatigueable muscle
fibers are transformed to type I fatigue resistant fibers43'44 appears to be the most
promising. The latter method will be discussed further in the following part of this
chapter (Gracilis transposition (stimulated).
Anal Plug
Previous attempts to occlude the lumen of sigmoid colostomies were
abandoned because of pressure necrosis45. Mortensen and Humphreys46 investigated
the efficacy of an expandable anal plug device. The plug is wrapped in a water
soluble coat and is inserted like a suppository. The wrapping dissolves after contact
with body fluids and the plug expands. The expanded plug sits in the upper portion
of the anal canal and can be removed by pulling on the gauze tape which protrudes
from the anal canal. The used plugs can be flushed away or disposed of in a similar
fashion to a sanitary towel. Nine out of their twelve patients completed the study for
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three weeks. The patients used on average eleven anal plugs per week. The plug was
in place for a median of twelve hours (range 1-25), with an 82% reported success
rate. Three patients found the insertion difficult.
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Surgical Correction of Faecal Incontinence
Where conservative attempts to treat faecal incontinence fail, surgical
correction may be attempted in appropriate patients. The surgical options include
muscle repair or supplementation procedures, anal encirclement procedures, faecal
diversion and possibly the insertion of an artificial anal sphincter. At the moment
there are only two methods of surgical treatment for faecal incontinence in which
large numbers of patients have been properly assessed over long periods of follow-
up, namely sphincter reconstruction and postanal repair. Sphincter reconstruction is
reserved in cases of demonstrable trauma to the sphincter ring, whereas postanal
repair is usually confined to patients with idiopathic or neurogenic faecal
incontinence, incontinence associated with rectal prolapse or associated with the
descending perineum syndrome. The results of surgical correction are summarized
briefly in the following paragraphs.
Anorectal muscle repairs
Apposition, Overlapping and Reefing of sphincters
The aim in these procedures is to reconstruct the damaged sphincter as much
as possible, and sometimes the choice of the procedure is determined by the extent of
the muscle damage and the amount of tissue available for reconstruction after
dissection. Overlapping may result in a stronger repair than simple apposition. In a
study of anterior sphincteroplasty in a population of 55 women with incontinence due
to obstetric or surgical trauma47, the authors report a failure rate of 29%.
Reefing, (plication of the deep parts of the external sphincter and puborectalis
sling anteriorly or posteriorly) is the operation commonly employed transvaginally
for posterior repair of rectocele and occasionally for anovaginal reconstruction
following obstetric trauma. Stenosis of the anal canal can be caused if the repair is
too tight. As the cause and degree of damage, the timing of the repair and the
operation details are hard to standardize, the results and relative merits of each
operation cannot easily be compared in the limited studies that are available45.
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Postanal pelvic floor repair
The late Sir Alan Parks believed that the anorectal angle is of paramount
importance in maintaining faecal continence and that the forward pull of the
puborectalis sling is the prime mechanism for its creation15. This mechanism was
thought to create a "flap valve" at the top of the anal canal to enhance continence,
especially during increases of intraabdominal pressure (for a more detailed
discussion of the anorectal angle and the valve theories, see: A Review of the
Physiological Faecal Continence Mechanisms, Chapter 1: Does anorectal angle
contribute to faecal continence?, Chapter 2: In-vitro assessment of the anorectal
flutter valve theory).
He developed the operation of postanal repair15'48 which was aimed to
recreate the anorectal angle without affecting resting anal pressure49. It has
subsequently been shown that the length of the high pressure zone is increased49'50.
An improvement in the resting and voluntary anal pressures has been reported in
some studies50"52. In contrast, some studies failed to show improvement of the
anorectal angle50'52, or improvement of this parameter compared to controls did not
correlate with improvement of faecal incontinence49. The long term clinical results of







n 16 124 42
Improved 88% 81% 66%
Fully continent 38% 24% 26%
Follow-up 15 months 3 years 6.2 years







There is little meaningful data concerning long term functional results and
morbidity of these procedures, because the literature, such as it is, essentially consists
of papers noting only a few cases45. The obvious conceptual advantage of using the
gluteus muscle for supplementing the anal sphincter is the fact that contraction will
more effectively result in closing of the anal orifice since the muscle normally acts as
an accessory sphincter when impedance of elimination is desired. Christiansen et
53
al reported their experience with seven patients receiving a bilateral gluteus
maximus transposition. Their group consisted of five women with incontinence
secondary to trauma and two men with history of anorectal atresia. Three women
improved, but the rest were not after one year. There was no change in rectal
sensitivity or volume retention tolerance in any of the patients, and only moderate
increase in the resting and maximal squeeze pressures was observed in the patients
who improved. As with the gracilis muscle transposition, narrowing of the anal
orifice may be a factor that contributes to improved function.
Gracilis transposition and electrical stimulation
The transposed Gracilis is the most widely used pedicled muscle graft for the
treatment of anal incontinence. The muscle may be transposed unstimulated54 or
stimulated using an implantable electrical stimulator44'55. Preliminary results of
stimulated graciloplasty for the correction of urinary incontinence have also been
reported56 (two out of the three patients studied achieved urinary control and the third
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reportedly improved). Electrical stimulation of the transposed sartorius has also been
reported in dogs43'57 and the biceps femoris in humans58.
Gracilis transposition (non-stimulated)
The gracilis muscle, the most superficial muscle in the medial aspect of the
thigh, is broad in the upper thigh, becomes narrow and tapers to a tendon which
inserts below the tibial tuberosity. The primary blood supply for this muscle enters
proximally, therefore, division at the insertion and mobilization of the muscle to the
proximal neurovascular bundle should not compromise viability. This may not be
the case as there is a relatively high incidence of ischaemic necrosis of the mobilized
muscle. It has been reported that the incidence of ischaemic necrosis can be
dramatically reduced by division of the muscle tendon several weeks prior to
mobilization to allow rudimentary vessels to open up between the segmental blood
supply59.
In 1952, Pickrel and associates54 developed a procedure using the gracilis as a
substitute anal sphincter and reported their experience in four children. Whereas this
operation is a useful and effective procedure for selected patients when a
supplementary sphincter is required or when multiple attempts at primary repair have
failed (e.g. young patients, those who have sustained trauma are those with anorectal
malformations), it nevertheless is an esoteric sphincter repair operation to be used
only in limited circumstances. The technique is described elsewhere45'54. Variable
results are reported, with improved continence ranging from 0-50% and full
continence achieved in 0-80% of patients59.
Gracilis transposition (stimulated)
Historical and experimental background
Baeten and associates60 reported the case of a female patient who had a
gracilis sling operation in childhood with a poor result, and subsequently had an
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electrical stimulator implanted at the muscle's motor point in adult life. She became
fully continent upon stimulation of the gracilis.
Electrostimulation of a muscle using a pulse generator to stimulate its
neurovascular bundle will convert fast twitch to slow twitch fibers which have far
greater resistance to fatigue61. This transformation is reversible upon cessation of the
stimulation62.
A canine model to study the effects of chronic stimulation on a Thiry-Vella
loop created by the sartorius muscle was described by Hallan et al43. Stimulation for
six to eight weeks at 2-4 Hz resulted in significant reduction of the muscle's fusion
frequency (22.2—>14.4 Hz). Holdback of liquid at 100 cmH20 applied to the colonic
reservoir proximal to the sphincter was maintained for 1.4 minutes prior to chronic
stimulation to 5.6 minutes post stimulation. Histology showed evidence of fibrosis,
atrophy and fatty change in parts of the muscle but also evidence of regeneration.
This study, however, did not contain unstimulated controls. In a subsequent study of
• • 57
a similar model , each Sartorius muscle was transposed around either end of a
Thiry-Vella loop. One muscle was stimulated for eight weeks and the other served as
an unstimulated control. Morphological changes of fast to slow twitch fibers were
observed in the stimulated muscles. The retention times of liquid at 85 cmH20
applied proximal to either neosphincter in each loop increased from 10 seconds to 5
minutes. The observed muscle fiber transformation was not essential for increasing
the acute retention of liquid in this model. Ideally there should have been
morphological data from unstimulated control animals (i.e. animals where neither of
the two muscles had been stimulated), especially since relatively high voltages of
stimulation were used (voltage increased from 0.75 to 2.75V at the end of the eight
week period).
A gracilloplasty procedure with investigation of the optimum stimulation
parameters was described in the rabbit63. Stimulation for more than six weeks at a
frequency of 10 Hz produced satisfactory transformation as evidenced by the
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decrease in summation frequency. A similar frequency of stimulation (12 Hz) was
used in the Human55'59.
Human studies
Cavina et al64 reported good initial results in 47 patients (65% improvement
in continence) following short term intermittent external stimulation of the
transposed gracilis. They used externally stimulated wires which were removed
following the period of stimulation. Such a technique could not have led to
conversion from fast twitch to slow twitch muscle.
Williams and associates presented their results of a model for the creation of
an anal neosphincter using the transposed, electrically stimulated gracilis muscle in
humans44'55. They now use a totally implantable electronic stimulator, the stimulus
parameters of which could be programmed and changed using an external
programming telemetry transmitter and which could be switched on or off by a
patient with the use of a magnet. Basal pressure of the anal canal did not change, but
squeeze pressure was enhanced upon stimulation (this was preceded by a transient
decrease). Transformation of fast fatiguable to slow non-fatiguable muscle fibers
was demonstrated morphologically and histochemically. These changes were
62 •reversible as previously reported if the neosphincter remained unstimulated for
more than 180 days. Some atrophy of the transposed muscles is reported in this and
other studies43'57'64. Endomysial collagen increased from 4.9 to 7.6% following
transposition and stimulation57 of the sartorius and the stimulation voltage had to be
increased from 0.75 to 2.75 V. These changes are thought to be due to the
transposition of the muscle. This effect is observed in humans as well: the voltage to
achieve stimulation and palpable contraction of the gracilis neosphincter increases
with time63.
The operation of electrically stimulated gracilloplasty is described in detail by
Williams59. They report the construction of an electrically stimulated neosphincter in
23 patients with faecal incontinence as well as ten patients as part of a total
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reconstruction after abdominoperineal resection of the rectum. The patients selected
for this procedure were those in whom a conventional operation to correct their
incontinence had either failed or was contraindicated and in whom a colostomy was
the only other option. Sixteen of the patients with incontinence are reported to have
functioning neosphincters, all of whom have improved and most have "acceptable",
though not perfect continence.
A new modification to this procedure using both gracilis muscles has been
reported66. Instead of fixing the gracilis tendon to the ischial tuberosity, both gracilis
are mobilized and wrapped around the anal canal and their tendons are fixed to one
another. This guarantees the presence of a greater muscle bulk and also possibly
enhancing the anorectal angle. The authors report a 90% success rate in a
heterogeneous group of ten patients (mainly related to trauma to the sphincter or
congenital conditions) with concomitant increase of resting and maximal squeeze
anal pressures.
Contraindications of electrically stimulated gracilloplasty
1. Damaged gracilis muscle. If there is any doubt about gracilis muscle function,
this should be tested by electromyography. In practice, this includes patients with
spina bifida and those with generalized neurological or myopathic disorders (e.g.
patients with multiple sclerosis or myopathic diseases affecting the limb muscles).
Mechanical damage or absence of the muscle may not be a contraindication as in
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some cases the biceps femoris may be suitable .
2. Disseminated malignant disease or local pelvic recurrence.
3. Lack of sufficient manual dexterity to use magnet controls of the electrical
stimulator.
4. Persistent perineal sepsis or Crohn's disease.
5. A cardiac pacemaker in situ.
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This technique, although promising is still in its infancy. It may, however,
become the optimum method of muscle transposition in the future.
Anal encirclement procedures
Thiersch operation
The original description of anal encircling procedures was advocated for the
management of rectal prolapse, but various materials have been implanted around the
anal canal in an attempt to enhance continence. These were: silver wire, merselene,
silastic ribbon or a Dacron impregnated silastic strip. The technique has also been
67 • •
reported in an canine ileostomy model . The main complications included infection,
erosion, persistent incontinence, faecal impaction, development of anal stricture and
pain. Corman45 reports a 65% success rate in 38 patients.
Fascia lata
Encircling the anal canal by a fascia lata sling was first reported by Stone in
192445. Fascia lata may be associated with less of the complications relating to the
presence of foreign material around the anal canal.
Anal encircling procedures suffer the limitation of creating a non adjustable
stenosis (albeit relative) of the anal canal which has a significant chance of being
either too narrow or too wide, who's reversal may, in some instances, be impossible.
Colostomy
Only rarely should colostomy be considered the preferred recourse in the
management of patients with faecal incontinence. The performance of a colostomy in
a patient with faecal incontinence is thought generally to be an admission of failure,
but it should not be regarded as such. Many individuals should be spared the ardours
and pain of futile attempts to perform esoteric reconstructive procedures when the
likelihood of success is extremely limited. Patients with severe neurological
73
dysfunction, major trauma or congenital absence of the perineal musculature may be
happier with the formation of a well sited colostomy than an incontinent perineal
colonic termination. Perhaps more frequently than in any other condition, those with
fecal incontinence need to be willing partners in the decision making process.
Artificial anal sphincter prostheses
A small but significant proportion of patients will remain helpless despite
exhaustive attempts to improve their continence mechanism. Some of these patients
may benefit from the insertion of an artificial anal sphincter.
The previous attempts to design and implant an artificial anal sphincter in
animals and humans are reviewed in the next chapter (Attempts to achieve
continence artificially: A Review).
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Incontinence is underreported, underestimated, represents an enormous social
and psychological problem and the current results of its management are poor. The
results of surgical correction for fecal incontinence are reviewed in the previous
chapter. For those patients whose incontinence failed to respond to conventional
means, there is little to offer except the implantation of an artificial sphincter. The
history and evolution of the devices designed to attempt to achieve continence of
urine and feces are reviewed in this chapter.
Artificial devices for the treatment of urinary incontinence
Urinary incontinence is by itself a socially disabling condition. Many
1 2
methods of treatment have been tried in the past, including penile clamps ' , external
collecting devices, indwelling catheters, surgery to increase the resistance of the
bladder neck and urethra, electrical stimulation3'4 and supravesical urinary
diversion5'6, but none is ideal6. Penile clamps and external continence devices are
cumbersome and non-physiologic. Indwelling catheters can become encrusted and
lead to recurrent urinary tract infections. Surgery on the bladder neck and urethra
may permanently increase the resistance, with the result that in some cases the
patient can empty the bladder only through intermittent catheterisation. Patients with
urinary diversion have a stoma and possibly an external collecting device or depend
on intermittent catheterisation.
The early designs
The idea of creating an artificial sphincter for control of urinary incontinence
is not new. Foley (also the inventor of the catheter that bears his name), reported a
12
device in 1947 that resembled a sphygmomanometer ' . It consisted of an inflatable
cuff that was placed around the anterior urethra in a tunnel lined by skin, and a
detachable pump that was carried in the patient's pocket and was connected to the
cuff by rubber tubing. This device was only suitable for male patients. To void, the
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user deflated the cuff. After the bladder had emptied, the patient inflated the cuff to
compress the urethra and become continent again. This artificial sphincter had two
main design defects: it was an external device, as inert materials were not available at
that time, and it had no mechanism for limiting the compression of the urethra. The
pressure applied frequently rose above arterial pressure causing ischaemia and
necrosis of the urethra. Therefore, it was never a practical apparatus and was soon
abandoned.
In 1973, Kaufman reported the implantation of a rectangular shaped silicone
gel prosthesis at the base of the bulbar urethra7. This produced permanent increase in
the urethral pressure and caused a relative stenosis (cf. Thiersch operation or
Angelchick prosthesis, apart from the fact that this prosthesis was non-encircling).
This device never gained popularity despite the preliminary reports of short term
7 9
success " and a reported success rate of 55% in 57 patients with post prostatectomy
urinary incontinence10.
In 1974, Giori disclosed the patent of a semi-passive implantable urethral
n
occluder (Figure 1).
Figure 1: The Giori patent7. Pressure on the inflation bulb occludes the
urethra. Pressure on the perineum squeezes fluid out of the deflation bulb,
allowing micturition to occur.
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The device was implanted through a perineal incision and operated by manual
pressure on the perineum: pressure on the inflation bulb forces fluid into the
sphincter end of the prosthesis, where the surrounding cuff or ring occludes the
urethra. Pressure on the cuff forces fluid through the flap valve to open the urethra.
The above design is reported to have been used "successfully" in a series of
unpublished trials11. It is not in clinical use in so far as can be determined.
The first devices which would open and close the urethra at will were
1215 12
reported in 1973 " . Summers , patented a device whereby a cuff occludes the
urethra by reversible filling from a balloon reservoir. This appears to be a volume set
device with a magnetically operated valve. No evidence that this device has been
tested in-vivo could be found.
13 •
The device invented by Buuck (original patent filed in 1973 and
subsequently called the AMS 721) was the first of a family of artificial sphincter
devices patented and produced by American Medical Systems (AMS). These
devices will be discussed in detail in the next section of this chapter, as they
remained the only clinically (and commercially) viable implantable artificial
sphincters.
Rosen described a prosthesis to occlude the urethra16"19 in 1975. This
prosthesis is only suitable for male patients. The device is composed of a three-
pronged clamp, two arms of which are parallel one on each side and a single, central
arm carrying a cylindrical balloon opposing them (Figure 2). These arms fit
transversely across the urethra. The balloon is connected via reinforced tubing to a
reservoir bulb containing isotonic saline and a release valve. Compression of the
bulb inflates the balloon elevating and compressing the urethra to achieve
continence. Voiding is allowed to occur on deflating the balloon by pressing the
release valve. The author presents 16 patients, with satisfactory results in ten (an
extra four patients are mentioned anecdotally with "excellent outcome"). Maximum
follow-up was for two years. The device was not set to apply a predetermined
pressure on the tissues and presumably this was set empirically. The inside edges of
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the fixed prongs could cause localized high pressure application points on the tissues,
which would lead to necrosis and urethral erosion. This is also complicated by the
fact that there is no relief valve to maintain a constant safe pressure on the urethra,
nor a mechanism to dissipate potential high pressure transients in the system and
prevent them from being applied on to the tissues.
Squeeze to release Squeeze to occlude
occlusion urethra
17
Figure 2: The artificial urethral sphincter described by Rosen .
In summary, this sphincter is based on the Foley device, but is fully
implantable. By being a volume dependent system, however, it suffers from the
inherent deficiency that the pressure within the urethral occluder is neither controlled
nor monitored. Volume controlled sphincters have had a poor success rate and have
not gained favour with many urological surgeons. This device, therefore, remains of
historical interest only.
A magnetically operated device with the magnet placed in the vagina was
assessed in merino sheep20 and produced no ischemia for up to 33 weeks. The
21




AMS 721, AMS 761, AMS 742(A, B, C), AMS 792, AMS 800
These devices were described in a series of patents13'22"25, produced
commercially and implanted in a large number of patients. The currently available
device is the AMS 800. A review of the results of the implantation of this device and
an analysis of 4130 complications reported to the FDA are analyzed in the following
chapter. A summary description of each device appears in Table 1.
Early collaboration between the medical device industry and NASA was
critical to the success of this effort to reduce patient risk and health care costs by the
incorporation of high reliability aerospace components in this new prosthesis. To
ensure availability of the NASA technology to the entire medical community,
NASA's methodology emphasizes projects that lead to the development of
commercially available medical products incorporating NASA technology. The
development of this improved artificial sphincter is an example of a successful
26transfer of aerospace technology to medicine .
Detailed analysis of the engineering drawings and operation of the devices is
described in Appendix 3.
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Model Mechanism Special Features Year
Filed
Ref.
AMS 721 Inflate bulb (R side)
Deflate bulb (L side)
Pressure regulated by mechanical valve
(V4). Balloon does not regulate pressure.
1973 13
AMS 761 Inflate bulb (R side)
Deflate bulb (L side)
Pressure Regulating Balloon Reservoir
(PRBR). Valve (V4) still present. Only
assessed for short period. Superseded.
27
AMS 742 Single deflate bulb
(scrotum or labium)
PRBR. Refilling time controllable by
variable resistor. (A, B, C models






PRBR. Single control assembly contains
resistor and one way valves. System must





As AMS 792 but
incorporating a coil,
remotely controlled.
Induction coil incorporated in the design to
open the cuff when inductively heated






Volume controlled device, with balloon
incorporated onto pump case. No pressure
regulation. Not used clinically.
1990 24
AMS 800 Single deflate bulb
(scrotum or labium)
As AMS 792, but control pump assembly
incorporates a shutoff valve for long term
deactivation. Can be left primed at
implantation and activated non surgically.
1984 25
Table 1: Summary of the features of the AMS sphincters.
The idea of the pressure regulating balloon reservoir was included early in the
22
design process . A silicone balloon with a sigmoid pressure-volume relationship is
incorporated (Figure 3). The pressure increases upon inflation up to a plateau level
and this ensures that the system pressure does not exceed a maximum level which is
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considered safe when applied on to the tissues. By using balloons of different wall
thickness, the level of the plateau can be varied.
Balloon Inflation Volume
Figure 3: Pressure volume relationship of a typical pressure regulating balloon.
It is possible for the sphincter to be set to operate at a pressure level slightly
lower than the plateau pressure and this would have the added advantage that the
operating pressure can be varied by subsequently injecting fluid in the system
without the necessity to surgically replace the balloon (this is the method used by the
author - see Chapter 6).
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The AMS 721
This was the original device released by AMS13 (Figure 4). Its operation was
assessed in eight mongrel dogs for up to six months and inflation periods of up to 12
28hours . Satisfactory continence does not appear to have been achieved and the
description of the rest of the results is sketchy and weak scientifically. Nevertheless,
this device was implanted in humans and was in use for approximately three years. It
was very difficult to implant due to the large number of components which
necessitated extensive tunneling and dissection. A pressure regulating balloon
reservoir was incorporated in a subsequent modification of the device (AMS 761) in
order to overcome the problem of high pressure being applied to the urethra by
overdistension of the reservoir or other possible malfunction. It also became obvious
that the complexity of the design and the critical central role of a collection of spring
loaded valves of different characteristics were contributing to an increased number of
complications and this device was being rejected both by patients and clinicians.









Figure 4: The AMS 721. The bulbs are implanted subcutaneously and the
reservoir intraperitoneally. The position of the one way valves is not shown.
91
The AMS 742A and AMS 742, 742B, 742C22
The evolution of this device (Figure 5, Figure 6) was necessary to minimize
the components that had to be implanted in order to make implantation more
straightforward, make it more convenient for the patient to operate and reduce the







Figure 5: AMS 742A. This device was quickly superseded by The AMS 742




Control assembly incorporating all
hydraulic functions pertaining to





Figure 6: The AMS 74222.
The design of the cuff and control block assembly provides for two models:
the 742B and 742C. The B model is used for ease of tubing connection with urethral
cuff placement and the C control assembly is used for ease of tubing connection with
vesical neck cuff placement.
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In one study , a total of 47 patients (41 male and 6 female) had implantation
of the AMS 742. Of the 42 patients who had primary activation 34 experienced
continence without further surgical revision. The remaining five patients who
primarily had deactivated devices subsequently had the devices activated and the
patients were dry. Of the eight patients with initial failures two had infection and six
had primary cuff erosion of the urethra. In four of the eight patients the cuff was
replaced, and the device was deactivated and then activated after three to four
months. All four of these patients were continent. Follow-up for these patients
ranged from 6 to 30 months. Overall, 43 of the 47 patients were continent (90%).
Compared to the previous model this simplified design provides for much
easier implantation, more reliable function related to cuff pressures and to cuff
configuration, and more flexibility in the selection of the site for cuff placement. In
addition, this new device has enabled the development and use of a new concept of
primary and secondary activation. Delayed activation allowed tissue healing to occur
29in four cases where the cuff was revised and represents an added advantage to the
design.
Other patented but untried devices
The patents filed by AMS are quite broad and include some interesting ideas
that have not been applied clinically. They were almost certainly included in order
that full commercial protection against minor patent modifications could be afforded.
22
The Burton patent , includes another two designs in addition to the AMS
742: it describes a device with a double balloon reservoir and a manual deactivation
valve which, when depressed, would empty the cuff by transferring fluid between the
two reservoirs. This device has not been produced commercially to the knowledge of
the author. A minor modification to strengthen the anchoring of the cuff is also
described. The other device described is essentially the AMS 792. The slow leakage
re-equilibration pathway (a resistor made from porous glass material) is first
described in this patent.
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Polyak describes a modification of the above, whereby a heating coil is
incorporated in the cuff mechanism. Another coil is inserted into the rectum and it
inductively heats up the coil in the cuff. The theory is that the heated coil will deform
and open the cuff. Perhaps not surprisingly, this device has neither been produced
commercially, nor been tried in a clinical setting. In a subsequent patent 24, Polyak
discloses another mechanism, whereby both the pump and reservoir components are
30
incorporated into one assembly resembling that of an artificial penile prosthesis .
This design would be quite bulky and would not compensate for increases in intra¬
abdominal pressure. It was not developed further. In the same patent, a magnetically
operated deactivation valve incorporated in the control pump is disclosed. Once




This is the currently available device. It was introduced in 1980 by Burton
25 • •and patented in its current form in 1984 " (Figure 7). A detailed review of the





automatic cuff refill feature
Figure 7: The AMS 800 artificial urethral sphincter. The control mechanism
incorporates an automatic re-equilibration feature and a long term deactivation
mechanical valve.
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The AMS 800 sphincter involves several modifications to the control valve
that simplify its implantation and operation by the patient. The device is implanted
using the chosen size of cuff around the urethra and a reservoir of the appropriate
plateau pressure (these are currently available with plateau of 51-60, 61-70 or 71-80
cmH20). The device is suitable for both males and females (the pump is implanted
in the scrotum or the labium as appropriate). It is implanted fully primed with radio-
opaque fluid in its deactivated state (cuff empty and deactivation button engaged).
After approximately three to six weeks to allow for tissue healing, the device is
activated for the first time by sharply squeezing the bulb. The cuff closes in
approximately three to five minutes. Further pumping of the bulb moves fluid into
the reservoir and empties the cuff, thus opening he urethra. The cuff closes
automatically once again after several minutes, when micturition is complete. The
unit can be deactivated by pressing the deactivation button on the pump before
refilling of the cuff commences. One must ensure, however, that the bulb always
remains full as one pumping stroke must always remain available to allow
subsequent re-activation.
This device has been implanted in an estimated seventeen thousand patients
worldwide. A review of its complications is presented in the following chapter.
The AMS 800 around bowel in urology31'43
Reconstruction of the urinary tract after diversion has been successful in
patients with normal innervation of the lower tracts. However, the possibility of
urinary incontinence after such major surgical procedures has dissuaded many
surgeons from attempting urinary undiversion in patients in whom the continence
status cannot be determined accurately before the operation or who were known to be
. * .... 31incontinent before the original diversion. Light, Flores and Scott first reported the
implantation of the AMS 792 around the bowel neourethra of a patient with urinary
• 32undiversion in 1983 and they reported on two further patients shortly afterwards .
The potential use of the artificial sphincter around bowel extended the versatility of
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the device and offered many possibilities for reconstructive procedures involving
bowel.
Most of our understanding of the effects of the AMS 800 sphincter on bowel
is based on animal35'44'45 and human studies35 by Engelmann and his co-workers.
The device was assessed by implantation around isolated intestinal loops in New
Zealand rabbits. Twenty two animals are reported in the first study44 and 40 in
subsequent reports35'45. Ten animals were sham operated and six acted as controls.
The evaluation included the effect of varying closing pressures of the cuff on the cuff
six weeks after implantation. This was assessed macroscopically, by
microangiography and histologically. The sphincter was able to achieve continence
during perfusion of the intestinal loop, holdback pressures being dependent on the
cuff pressure. 60 to 80% of cuff pressure was transmitted on to the bowel. Atrophy
was present to some degree at all sphincter pressures. Mucosal ulceration was noted
at cuff pressures above 80 cmH20. Microangiography showed rarefaction of
mucosal blood supply and neovascularisation at the level of the fibrous sheath and
the cuff border. Sphincter related complications (cuff erosion and atrophy) were
pressure dependent and seen mainly in high pressure groups (Table 2).
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Total Pressure Sphincter related
number (cmH20) complications
Number %
6 0 1 17
4 40 1 25
5 60 2 40
7 80 2 28
4 100 4 100
Table 2: Sphincter related complications were pressure dependent in rabbit
intestinal loops45.
Other consistent changes were the development of a fibrous sheath around the
bowel beneath the cuff and the cuff itself and fibrous peritoneal reaction and
intestinal adhesions at the cuff site.
35
Similar results were reported in 24 dogs with a Koch's pouch . The device
was activated twice per day for up to 29 weeks. There was no erosion of the device
at cuff pressures less than 80 cmH20 and this was taken to be the maximum safe
pressure that can be applied on to the bowel.
36
Protection of the bowel wall may be afforded by interposing omentum or a
rectus muscle flap43 between the sphincter cuff and the wall of the bowel. This may
act as a cushion to dissipate some of the applied pressure and also to protect the
37bowel from crenation into the high pressure areas inside the cuff folds. In addition,
it may provide an improved blood supply.
The features and trouble-shooting of the device are reviewed by Light34 who
also presented their experience with implantation of the device around the ileum in
33
augmentation ileo(caeco)plasties in 14 patients (Light and Engelmann ). The main
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complication appeared to be incontinence due to unpredictable bowel contractions
causing increases in intra-vesical pressure. Long term results are available in four of
37these patients . Various components of the sphincter were revised at least seven
times over an eleven year period in one patient. Atrophy and erosion occurred at a
cuff pressure of 80 cmH20 in this patient. In the second patient, following several
complications, a 51-60 cmH20 balloon was inserted and the device was working
satisfactorily at 6.5 years. In the third patient the device was working well at a cuff
pressure of 61-70 cmH20 after 3.5 years. In the fourth patient, multiple
complications related to atrophy and infection and a continent diversion was
eventually performed. Implantation of the device in association with the LeBag
technique in two female patients was successful in one . The other died six weeks
-5Q
post-operatively of unrelated reasons .
Mitrofanoff recommends implantation of the artificial sphincter as a means to
achieve continence in a failed continent diversion procedure46. In their study of two
females (follow-up 20 and 32 months respectively) they did not use the standard
control pump, but an injection port and a balloon. By implantation in a
retroperitoneal position, the balloon lost its pressure regulating capacity and acted as
a variable pressure compartment allowing accurate determination of the closing
pressure by injecting or withdrawing specific volumes of fluid.
Seven cases of implantation of the device in neobladder procedures have been
reported by Grise et al41. Satisfactory continence was achieved in four cases (follow-
up 3-36 months). Burbige reports such placement in nine patients 15 to 28 years
36 • •
old . A total of 15 complications was experienced in eight patients and 13
secondary procedures were necessary. Follow-up ranged from two to four years.
The most common complication encountered was atrophy of the bowel wall deep to
the cuff, which was heralded by a gradual onset of stress urinary incontinence that
progressed to continuous leakage in eight patients 6-10 months post-operatively. All
eight patients underwent successful replacement with a smaller cuff. Another patient
continued to have night-time enuresis. The patient in whom an omental wrap was
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f „" .■follow-up time was not rer.
el wall did not require replacement, but the
.
The Craggs artificial sphincter controlpump design
More recently, Craggs presented47 and patented a newly designed system
initially claiming to have overcome the mechanical problems associated with
mechanical control devices48'49 (Figure 8).
Figure 8: The original design of Craggs48.
It comprises a fluid filled reservoir (10), a control mechanism (1), an inflation
bulb (13), a deflation bulb (9) and a cuff which is placed around the urethra (8). A
preset pressure is theoretically applied onto the tissues and this is controlled by
injecting or withdrawing (11, 15) fluid from two self sealing compartments (12, 16).
Analysis of the fluid pathways in the patent document is not entirely clear, but the
device is designed to maintain tonic occlusion of the urethra, the pressure being
exerted by the balloon (14, 10). The same pressure is applied on a leaf "valve"
mechanism (6) which is maintained in the closed position until unseated by operation
of bulbs 9 or 13. Operation of bulb 13 is supposed to lift the valve and allow fluid at
high pressure to inflate the sphincter. Operation of bulb 9 is supposed to allow
102
equilibration to a non-activated state. The author of this thesis cannot see how this
could be possible, as squeezing on bulb 9 would develop the same level of high
pressure as that in bulb 13. Perhaps it is not surprising that the clinical results have
been totally unsatisfactory, with an almost 100% failure rate50.
The control pump was redesigned in a subsequent design51, but is too
complicated to show any clinical promise (see analysis of the engineering drawings
in Appendix 3). The new pump (12) and an anti-stress incontinence feature (13)
51 52have been combined in the latest version ' (Figure 9).
Figure 9: The latest design by Craggs51,52.
The anti-stress incontinence balloon is placed in the peritoneal cavity, so that
intra-abdominal pressure changes are reflected onto the cuff pressure. This has been
shown to occur experimentally in an in-vitro model50.
Another weakness of his design is the fact that a "relief valve" mechanism is
not incorporated. In the AMS 800 design, the maximum pressure that can be applied
on the tissues is determined by the plateau level of the balloon reservoir. In that
device, the pressure is truly regulated so that it cannot increase beyond a maximum
value. In addition, the way the term "regulated" is used in the description of the
Craggs device50 is wrong. The pressure in that device is regulated in the sense that it
can be adjusted or varied, but is not limited and could increase to dangerous levels
quite readily if there is any malfunction.
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This device and its modifications are unlikely to prove clinically useful for
the above reasons.
The Cleveland Clinic design3
A magnetically activated sphincter prosthesis has been designed to overcome
the difficulties encountered with the AMS 800 sphincter by patients with poor







jacket / / Bellows shield
Internal magnet Reservoir bellows
^-Urethral cuff
Figure 10: The magnetically activated sphincter prosthesis reported by
Fukumura et al53.
The device operation is controlled by an external magnet. When the external
magnet is in place, the metal bellows of the reservoir are compressed and the
sphincter cuff is closed. Removal of the external magnet from the skin over the
implant allows the bellows to expand, thus opening the sphincter. The applied
pressure is varied by injecting or withdrawing fluid from the system via an injection
port and choosing a magnet of different strength. The effects of this device on skin
53blood flow has been tested on minipigs . The pressure applied to the skin was
reportedly set to either 10 or 20 mmHg, but the authors do not report how this was
measured. Blood flow decreased significantly at 20 mmHg and skin ulceration was
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caused in all five experimental animals. One animal in four suffered pressure
necrosis to the skin at 10 mmHg.
This device has the following disadvantages:
1. It "defaults" to the activated position if there is a problem with the magnet, or if
the patient loses the magnet. Bladder outlet obstruction is, therefore, a real
possibility.
2. The strength of magnets decays naturally with time and deactivation of the device
may become impossible at an unpredictable point.
3. This is a volume set device and, as already discussed, this may be associated with
ischemic complications as tissue pressure can rise uncontrollably in the absence
of a pressure regulating/relief mechanism.
4. The patient may experience complications if an MRI scan is needed.
In conclusion, this device appears to have increased the number of potential
ischemic complications when compared with the AMS prosthesis. For the above
reasons, the author of this thesis believes that it has no place in the treatment of
incontinence.
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Artificial devices for the treatment of faecal incontinence
Attempts have also been made to develop a mechanical prosthetic anal
sphincter54"57 but to date these have suffered from many complications. The methods
used to occlude bowel (anus or stoma) can be classified as follows:
1. Methods that use external occluding devices:
58
a) Deformable button
b) Fluid filled device with surface cover59'60
c) Balloon catheter61
d) Magnetically secured devices54'62"66
e) Disposable anal plugs67
2. Implantation of other valves:
68
a) Porcine aortic valve
b) Transposition of the pylorus69
3. Methods that use implantable active devices (prosthetic sphincters!:
12 • • 7 16
a) The Summers , Giori and Rosen sphincters
b) The AMS 721 in a canine ileostomy model70
71
c) The AMS 721 in a minipig colostomy model
d) The Haber patent72
e) The AMS 800 as an anal sphincter41'73"75
f) The AASP 2000 Glasgow Neosphincter76




In 1952, a patent was granted to Surface for a colostomy control button
(Figure 11). The device consisted of a hollow gum rubber plug and an aluminium
face plate. An introducer stretches the device to allow insertion. The device then
returns to its original shape and occludes the lumen of the bowel. It was available in
a range of lengths and diameters and was accepted by the American Medical
Association's Council on Physical medicine and Rehabilitation77. This device was
marketed but there was concern about it being used inappropriately by some patients
without supervision so the effort was allowed to lapse. There is an anecdotal report
that the device had been used successfully by one patient for 22 years1 \
With current knowledge and development of silicone elastomers and







into a button shape
after removal of
inserting rod
Figure 11: The Surface deformable button58.
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Fluid filled device with surface cover59,60
Based on the successful use of a fluid filled occlusive device similar to the
above in patients with failed continent ileostomy valves59, Pemberton and co-workers
evaluated extending the use of this device to conventional ileostomies without
reservoirs in a canine model60. The occlusion period was increased gradually from
two to six hours a day and animals were studied over periods ranging from 18 to 22
weeks. All four animals tolerated complete occlusion of up to six hours a day and
were continent during that period. There was evidence of proximal dilatation of the
ileum acting as a reservoir. This approach has led to the development of a
commercially available device (Continent Ileostomy Valve®, Model 236, Waters
Instruments Inc., Rochester, Minnesota).
Balloon catheter61
This simple method involves the use of a Foley type catheter to occlude the
lumen of the ileostomy. The catheter was kept in place by applying traction and
fixing it on a surface faceplate. Nine piglets were studied (five with a constructed
reservoir and four without) for six weeks. Occlusion periods were gradually
increased from three to eight hours. All animals were continent during the occlusion
periods and there was no morphological evidence of bowel damage. Proximal
accommodation increased more markedly in the animals with the reservoir.
Magnetically secured devices54,62"64
Willital reports the implantation of a magnetic prosthesis to occlude the
bowel (Figure 12). The implant consists of two halves of a samarium cobalt ring
which are positioned around the upper anal canal through a sacral approach without
opening the bowel. Occlusion of the bowel is achieved by a special anal
tampon/plug made of polyformalvinyl foam which incorporates another magnet. The
tampon is stabilized inside the lumen by means of the magnetic attraction force







Figure 12: The magnetically secured anal plug
54
Six children (age range 3-15 years) with anorectal malformations were
• 63
implanted with the device . Complete continence with no complications was
reported in the short term, but the device suffered many infective complications and
eventual erosion and was not developed any further, despite two further anecdotal
reports attesting to its short term success in adults62 and children64.
Disposable anal plugs




A porcine aortic prosthesis acting as a one way valve was implanted in a
canine ileostomy model. The bowel was emptied by intermittent catheterisation.
The animals were continent for the eight week study period.
It is obvious that emptying can only be achieved if the bowel contents are
liquid. This preliminary study does not address the long term effects of the ileal
contents on the biomaterials or the response of the valve cusps to repeated intubation.
Transposition of the pylorus69
Transposition of the pylorus to control an ileostomy was performed in six
mongrel dogs69. Four animals were used as controls. The study animals were
terminated at 1, 2, 3 and 7 months. The effluent in the first group was described as
paste like, whereas in the control group it was liquid. All control animals died within
nine days despite fluid replacement.
Even though this study shows an apparent decrease in transit time, this should
be balanced with the known adverse consequences of disposing with the pyloric
control on gastric emptying.
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Methods that use implantable active devices (prosthetic sphincters)
The Summers12, Giori7 and Rosen16 sphincters
The devices reviewed have potential use as artificial enteric sphincters11.
They are not a viable possibility in the opinion of the author for the reasons already
outlined.
The AMS 721 in a canine ileostomy model70
The first study to assess this device in the gastrointestinal tract was performed
70 • •
by Delaney and his co-workers . They implanted the AMS 721 prosthesis in 15
dogs. The purpose of their study was to:
1. determine the sphincter pressure necessary to restrain the passage of intestinal
contents
2. measure intraluminal pressure underlying the cuff of the sphincter
3. measure blood flow changes in tissue under the cuff
4. determine short term intestinal tolerance to various cuff pressures and
5. observe chronic changes with long term sphincter activation.
The sphincter pressure was measured directly from the cuff and the
intraluminal pressure was measured using a perfused catheter system. The
intraluminal pressure was always lower than cuff pressure by approximately 20-55
cmH20 and was seldom measured to be greater than 40 cmH20. Intraluminal
pressure correlated with intestinal content holdback pressure. The blood flow was
measured by the rubidium dilution method at post mortem and showed that mucosal
flow decreased to 50% of baseline at a cuff pressure of 120 cmH20. Other intestinal
layers were not significantly affected at that pressure. A cuff pressure of 275 cmH20
for 18 hours uniformly caused necrosis and ulceration. Long -term (three month)
observation revealed two main problems: infection and the development of a fibrous
ill
ring around the cuff causing obstruction. Mechanical complications were not
reported.
The AMS 721 in a minipig colostomy model71
Von Scheming and co-workers reported a less successful study in five
minipigs with end sigmoid colostomies around which the cuff was implanted in a
71second stage procedure . Test animals developed a range of complications (pump
bulb migration and erosion, infections - local and generalized). The sphincters




The designer of this device claims that it achieves continence by reproducing
the anatomy of the rectal valves (even though the contribution of these inconstant
features of the colon to faecal continence has not been established). Activation and
deactivation would presumably be achieved by using a control mechanism similar to
the AMS 800 sphincter. This device has three active pressure exerting elements
(Figure 13). There are, therefore, several places of increased pressure application on
the bowel without any pressure dissipating "hammock" effect (see Chapter 3). There
is no evidence that this device has been tried clinically in an animal model or in
humans.
72
Figure 13: The Haber device designed to simulate the rectal valves.
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The AMS 800 as an anal sphincter41,73"75,78"80
The first report of an AMS 800 like device implantation is by Chandler and
81 • •co-workers . They implanted the artificial sphincter around an ileostomy in 18
female beagle dogs for up to 36 weeks. The control pump used in this study had not
been described previously in any of the patent disclosures and there is no evidence
that it has ever been used in any other study. It involves a manually activated
equilibration channel instead of the typical resistor. This component resulted in
unreliable operation of the device. Eight hours of daily occlusion at 50-55 mmHg
(68-75 cmH20) resulted in dependable continence without causing damage to the
bowel. Mucosal thickness was reduced and stunting of villi was observed under the
sphincter. Occlusion also resulted in increased accommodatory capacity of the ileum
without incurring defects in ileal absorptive or secretory function, but promoted
anaerobic bacterial growth. Pressure beneath the cuff (intraluminal pressure) always
slightly exceeded holdback pressure, but the slope of both lines was 0.57. This
means that the system was set in such a way that approximately 60% of the cuff
pressure was transmitted on to the tissues.
Twelve animals died or had to be killed before the study was completed. One
half of these were due to small intestinal obstruction or volvulus mostly due to
adhesions to the cuff. Two dogs developed obstruction due to the development of a
fibrotic ring just proximal to the sphincter cuff. The above complications occurred
sporadically as late as 29 weeks after implantation. Two device malfunctions
occurred which were due to a faulty one way valve in a pump and a ruptured balloon.
78
Sofia et al implanted a version of the AMS 800 with a larger cuff around the
rectum/colon in fifteen dogs for up to twelve months. Eight animals had an
abdominoperineal resection of the rectum and the rest had their anal sphincter
divided in three places. The device was activated two weeks after implantation and
they received weekly enemas as they suffered frequent faecal impaction. Continence
was maintained in seven out of the fifteen animals for periods of 4-8 hours at a cuff















73 8 29 4
60 8 29 4
50 8 25 4
Table 3: Duration of continence depends on cuff pressure78.
Histology revealed mucosal stunting and a degree of fibrosis in all other
layers, but no ulceration in these seven animals. Complications observed in the same
four out of the fifteen animals were infection, device extrusion/ulceration. Infection
was successfully treated in three out of the four cases and the device was successfully
replaced in two out of the four instances of extrusion.
79
Another study was performed in pigs by Satava and co-workers . Thirteen
swine were implanted with the AMS 800 prosthesis in two stages: a perineal
colostomy was first performed and this included placement of the cuff and
intraperitoneal balloon. The control pump was implanted subsequently. The device
was activated for 22 hours a day and follow-up duration was two to six months. The
clinical and mechanical complication rate was unacceptable (Table 4).
There is little doubt that a combination of factors contributed to the
unacceptably high complication rate and death. The pump prototype and other
system components were unreliable. The pressure applied by the cuff to the tissues
was not measured. The bowel was occluded for a prolonged period by the sphincter.
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3 <5 weeks Death Unrelated
3 Prior to
activation
Sphincter erosion ? Ischaemia,
?technical
2 2, 4.5 months Sphincter erosion ? Ischasmia
2 Balloon erosion
into bowel














9 (69 %) Death Various
Table 4: Summary of the results of implantation of the modified AMS 800
sphincter in pigs .
Shoshany and Pena in 199480 implanted the AMS 800 extraperitoneally
around the rectum in 12 minipigs using the posterior sagittal approach. Five mini-
pigs had the sphincter activated in a total of 15 occasions. The device was effective
in maintaining continence when activated, but the complication rate (infection,
erosion, colonic obstruction and mortality) was prohibitive.
In view of these results, it is perhaps surprising that the device was ever
implanted in humans41'73"75.
• 82In their study, Heiblum and Cordoba used an artificial sphincter, again
made of silicone elastomer, which was placed subcutaneously around an end
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colostomy in six patients. The device used was a simple, wrap-around inflatable
cuff, attached to a silicone tube of approximately 5 mm in diameter, through which
air was passed to inflate the cuff. Subcutaneous infections developed around the
prosthesis in three patients. In two of these, the infection was treated successfully
with antibiotics; in one case, the prosthesis had to be removed. In the other five
patients, complete continence to stool and gas was achieved.
Christiansen and Lorentzen report the first implantation of the AMS 800
device for anal incontinence in a human in 1987. A 67 year old patient with
Myasthenia Gravis reportedly benefited from the device: resting anal pressure and
squeeze pressure increased as shown in Table 5 after three months. The patient felt
that the anal canal was slightly narrow, so faecal softening-bulk forming laxatives
were administered. Another complaint was that the sphincter had to be de-activated
twice during defecation as a five minute automatic re-occlusion time was not
adequate.





47 53 73 89
Table 5: Summary of anal manometry in first patient with implantation of the
AMS 800 sphincter for anal incontinence. Cuff Pressure 66-74 mmHg. Cuff
circumference 11 cm.
A report by the same author on five patients followed shortly74 followed by a
75cumulative report on twelve patients mainly with neurological causes of
incontinence (9) but also trauma or absence of the sphincters (3). The device
appeared to effective with solid or semi-solid stool but not with diarrhoea, its
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effectiveness was also seemingly enhanced by the maintenance of the anorectal
angle. The same complaints regarding the feeling of obstructed defaecation were
reported by patients suggesting that the cuff circumference should be increased.
A further two patients with anorectal malformations in whom the AMS 800
sphincter has been implanted have been reported41. One patient was fully continent
after one year, whereas the other suffered occasional leakage of liquid and flatus.
These early results were encouraging, but the ischemic complications that were
reported when the device was implanted around bowel in urinary diversion
procedures (see discussion above) did not encourage the manufacturers to continue
the development of the device for the control of faecal incontinence.
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The AASP 2000 Glasgow Neosphincter76
It can be seen from the above discussion that urinary incontinence has been
successfully treated using an inflatable circular cuff applied to the outer layer of the
urethra37'44'45'83, whereas a modified prosthesis of similar circular design when used
around bowel in animals and humans, was less successful and also produced
36 78 79
intestinal ischaemia at operating pressures which maintain continence ' ' . This
was probably because the rectum is not "circular" and the application of a circular
cuff produced crenation of the bowel wall in localized high pressure points within
37
the folds . These early results did not encourage any further research or
development of this device.
• 76 •
We have, therefore, developed an artificial anal sphincter prosthesis (Figure
14) which attempts to simulate the normal physiology of the anorectum.
Figure 14: The AASP 2000 Glasgow Neosphincter.
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In summary, this device involves a pressure regulating balloon reservoir, a
control pump and a sphincter element. The latter consists of a linear inflatable
expander (24c) and a silicone gel filled pillow (24a,b) placed transversely across the
rectum. Upon activation, the expander gently squeezes the bowel against the pillow.
The pressure is distributed evenly by the expander and dissipated smoothly by the
hammock effect of the pillow (Chapter 3) thus minimizing the possibility of pressure
ischaemia. The device also introduces angulation of the intestine which has been
shown to enhance continence and reduce the pressure required to achieve holdback of
semi-solid faeces (Chapter 1).
The stages of its design, development and assessment will be detailed in the
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A successful continence device? Review of 4000









Urethral erosion and tissue migration 139
Iatrogenic complications 142










The records of the 4130 complications reported during an eight year period in
3508 patients in whom an artificial urinary sphincter had been implanted were
reviewed. 86.6% of patients had only one revision, 10.9% had two revisions, 1.6%
and 0.6% had three and four revisions respectively, whereas ten patients (0.3%) had
revisional surgery on five to ten occasions. Mechanical complications were reported
in 22.1% of cases. 3135 detailed records were further analyzed. In these, 91% of
complications occurred in male and 9% in female patients. Complications identified
to be related to the mechanical components of the device were reported in 566
patients. These were related to the urethral cuff (48.4%), pump (34.3%), balloon
(9.2%), and tubing and connectors (2.6%, 5.5%). Infections were reported in 12.9%
of cases. The patterns of total revisions and revisions due to infection followed a
double exponential decay curve. 50% of revisions were performed within eight
months and 90% within three years of implantation. Complications were still
reported up to 17.5 years post implantation. The implications for the design of
artificial implants are discussed.
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Introduction
A significant contribution to the treatment of urinary incontinence has been
the introduction of the inflatable artificial urinary sphincter. Artificial urinary
sphincter implantation is currently an accepted form of treatment due to urethral
insufficiency1"11. However, acceptance within the urological community was slow
because of the complications or mechanical complexity of the previous designs and
12 13 • •
the initial high rate of postoperative complications ' . Since the initial AMS 721
model was implanted in June 197214, the device has undergone multiple
•3
modifications and improvements leading to the development of the current
model15'16, the AMS 800. This device is now more reliable and both its operation
and the insertion procedure have been simplified. The increasing understanding of
the effects of the device on the bladder, in combination with more appropriate patient
selection and monitoring17"20 has led to a reduction of complications and contributed
to the growth of its acceptance and use in recent years. This model is now the gold
standard for the patient requiring an artificial urinary sphincter. It is a contractual
obligation of the implanting Surgeon/Medical Unit to report any complications and
also to return the explanted components to the manufacturer for examination. All
complications/revisions are summarized and kept on a database by the FDA which is
available in the public domain. This review analyzes the reports between 12/02/86
and 21/06/94.
The results are related to the estimated numbers of implanted devices per year
and the complication rates reported previously in smaller studies.
130
Methods and Design of the Study
This study is a retrospective review of patient reports recording complications
while implanted with the AMS artificial urinary sphincter during the period between
February 1986 and June 1994 (8.4 years).
Source of information: Diogenes Database which includes the FDA (USA)
Pharmaceutical Information and Medical Device Reports (MDR) complication list.
• 21
The results of the search were obtained on microfilm . The raw data were manually
extracted from the microfilm and summarized for each patient by the author. A 42
field computerized relational database was designed and constructed by the author in
order to analyze the data. The main database fields included date and duration of
implantation, number of revision, sex, patient diagnosis, infective/mechanical
complications for each component of the device (pump, balloon, cuff, connectors and
tubing), presence of urethral erosion and tissue migration.
Some of the early records were incomplete and these were not included in the
final analysis. The results are analyzed according to the following categories:
• General aspects, duration of implant, sex, diagnosis.
• Infection.
• Urethral erosion and tissue migration.
• Iatrogenic complications
• Mechanical malfunction and complications caused by each of the components.
The results were plotted with a curve fitting computer program by a least
squares iterative process using the Marquardt-Levenberg Algorithm. The lines were
drawn using a cubic spline interpolation method.
The world literature on artificial urinary sphincters was reviewed and
marketing data on the AMS devices were obtained from the manufacturers'




The reports reviewed produced 4130 entries for 3508 patients. These
included multiple revision procedures in the same patients. 86.6% of patients had
only one revision, 10.9% had two revisions, 1.6% and 0.6% had three and four
revisions respectively, whereas ten patients (0.3%) had revisional surgery on five to
ten occasions (Figure 1). 3690 reports involved the AMS 800 sphincter and 71
involved previous AMS models which were replaced by the AMS 800 either
routinely or after malfunction.
3135 detailed records were further analyzed. In these, 91% of complications
occurred in male and 9% in female patients. The original diagnoses of the patients
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Figure 1: Number of revisions (n=4130) in 3508 patients. Most patients (86.6%)
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The complications are broken down according to the initial diagnosis and
these are summarized in Chart 1 (male patients) and Chart 2 (female patients).
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Chart 2: Initial diagnosis of female patients with complications.
The miscellaneous diagnosis group consisted of a small number of each of the
following conditions: abdominal aortic aneurysm repair and pelvic neuropathy,
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bladder neck incision, cerebral palsy, cystic fibrosis, cystitis, dementia, diabetic
neuropathy, epispadias, exstrophy, multiple sclerosis, myasthenia gravis,
myelodysplasia, peripheral vascular disease, rectourethral fistula, sacral agenesis,
sacrococcygeal teratoma, urinary undiversion.
Most revisions took place during the first year post implantation. The
number of revisions declined with time (Figure 3 and Figure 4) and followed a
double exponential decay relationship (Table 1). 50% of revisions were performed
within eight months and 90% within three years of implantation. Complications
were still reported up to 17.5 years post implantation.
Figure 2: Artificial urethral sphincter implants by aetiology in 3135 patients
with complications.
Figure 3 shows a histogram of the number of complications reported per year
post implantation. The longest interval between implantation and revision reported
was 17.5 years. This was the first complication reported in a male patient who
suddenly became incontinent. This was found to be due to pump failure of a
previous model of the sphincter (probably AMS 742) which had been implanted in
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Figure 3: Histogram of the number of revisions performed each year in the 3508
patients.
Months post implantation
Figure 4: Number of revisions performed each month after implantation in the
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Table 1: Parameters of exponential equations governing the revision data.
Infection
There were 472 reports of infection of the device or its components out of the
4130 complications (11.4%). Out of these, 404 had complete records and were
further analyzed: the infection rate was 12.9%. In 224 of these cases (55%) all three
components were reported to be infected. The breakdown of the infections is
summarized in Table 2 for complete and incomplete records.
The timing of infections is shown diagrammatically in Figure 5 - Figure 9 and





















Figure 5: Histogram of the timing of infection of the device post implantation.
404 patients with complete records.
Months post implantation
Figure 6: Breakdown of developing infections suffered by the 404 patients.
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Infection n=4130, (%) % of total
infections
n=3135, (%) % of total
infections
Any infection 472,(11.4%) 100% 404, (12.9%) 100%
Pump infection 316, (7.6%) 67% 284, (9%) 70%
Balloon infection 302, (7.3%) 64% 275, (8.8%) 68%
Cuff infection 321,(7.8%) 68% 292, (9.3%) 72%
All components 244, (5.9%) 52% 224, (7.1%) 55%
Table 2: Breakdown of infective complications in all case reports (n=4130) and
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Figure 7: Timing of pump revision due to infection in 284 patients,
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Months post implantation
Figure 8: Timing of balloon revision due to infection in 275 patients,
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Figure 9: Timing of cuff revision due to infection in 292 patients,
a. Yearly breakdown, b. Monthly breakdown.
Urethral erosion and tissue migration
There were 432 reports of patients suffering urethral erosion. The timing of
this complication also follows a double exponential decay relationship (Figure 10,
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Table 1). This complication was reported as late as 14 years post implantation. In 18
of these patients the urethral erosion was reportedly associated with the presence of
cuff infection (Figure 11). All of the erosions in the presence of infection occurred
within six years of implantation. There were also five reports of urethral erosion
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Figure 10: Timing of urethral erosion in 432 patients.
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Years post implantation
Figure 11: Timing of urethral erosion and simultaneous infection in 18 patients
There were 127 reports (3.1% of complications) of the device components
(excluding the cuff) migrating into other tissues, the greatest proportion (59.8%)
being caused by the pump (Table 3). In 83 of these the tissue of migration was
reported: abdominal wall (15=18.7%), bladder (9=10.7%), colon and rectum
(4=4.5%), labia (7=8.4%), retroperitoneum (1=1.2%), scrotum (33=39.7%), testis
(2=2.4%), vagina (11=13.2%), wound incision (1=1.2%).





Table 3: Breakdown of tissue migration of the sphincter components (excluding
the cuff) in 127 cases.
21
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The timing of tissue migration of components (excluding the cuff), is shown
in Figure 12. There appears to be a delayed rise in the incidence of this complication
(Figure 12a) which is reported to occur even after 10 years post implantation. An
exponential decay relationship can once again be plotted (Figure 12b), but the
mathematical fit is less precise for this (Table 1). The dotted line of the plot in
Figure 12b represents a sixth order polynomial regression of the monthly data
2
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Figure 12: Timing of urethral erosion in 127 cases.
a. Yearly breakdown, b. Monthly breakdown.
Exponential and polynomial regression curve fit of the data.
Iatrogenic complications
There were 26 reports of iatrogenic complications (0.6%). In 22 cases (85%)
the urethra was injured. There were two reports of bladder and one report of rectal
injury. In the remaining case, the cuff was inadvertently placed around the vagina.
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Mechanical malfunction and complications caused by each of the components
These accounted for 22.1% of the total number of complications reported.
The total number of cases (4130) and the number with detailed records (3135) are
analyzed as shown in Table 4.
Total (N=4130) Detailed records (N=3135)
n % n %
Pump 325 35.6% 194 34.3%
Balloon 115 12.6% 52 9.2%
Cuff 400 43.8% 274 48.4%
Tubing 27 2.9% 15 2.6%
Connector 47 5.1% 31 5.5%
Total 914 100% 566 100%
Table 4: Breakdown of mechanical complications of the components of the
artificial urethral sphincter.
As the distribution between the two types of records is almost identical, the
complete records will only be analyzed when temporal data is required (pump,
balloon and cuff).
Pump
Failure of the pump was reported in 325 (7.9%) of the patients, accounting for
35.6% of mechanical complications. The reason for the mechanical failure was
stated in 95 of these reports (Table 5). Duration of implantation was available in 194
of the 325 patients and this is plotted in Figure 13. The parameters of the
exponential decay equation governing this data are shown in Table 1. The longest
interval between implantation and revision reported was 17.5 years. This was the
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first complication reported in a male patient who suddenly became incontinent. This
was found to be due to pump failure of a previous model of the sphincter which had
been implanted in January 1976 and this was changed to the new model in May
1993.
Complication n Complication n
Shutoff valve leak 4 Fracture of pump 4
Shutoff valve block 13 Fracture of tube insert 3
Resistor blocked 23 Airlock 22
Resistor flow too fast 11 Fibrosis - stiff pumping 3
Resistor flow too slow 4 Pinhole ?iatrogenic 3
Balloon valve leak 1 Sabotage 2
Cuff valve blocked 1 Twisted tubing 1
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Figure 13: Timing of mechanical complications of pump in 194 cases,
a. Yearly breakdown, b. Monthly breakdown.
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Balloon
There were 115 complications over a period of 8.5 years post implantation
directly attributable to the balloon. These accounted for 12.6% of the total
mechanical complications. Severe atrophy due to a high balloon pressure was
reported in 23 (20%) of these cases, tissue migration or displacement was reported in
25 (22%) and rupture or leakage of the balloon in 67 (58%) of cases. There were,
however 356 reports of replacement of the balloon to one of a higher plateau pressure
due to late onset of incontinence. Duration of implantation data was available in 271
of these and this is plotted in Figure 14.
Figure 14: Timing of re-insertion of a higher pressure balloon in 271 cases,
a. Yearly breakdown, b. Monthly breakdown.
Cuff
In 400 cases the cuff was reported to be malfunctioning, making it
responsible for 43.8% of mechanical complications. In 155 (39%) of these cases the
cuff leaked or ruptured. Duration of implantation details were available in 90 and
these are plotted in Figure 15. In five cases (1.25%) there was urethral obstruction
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and urinary retention shortly post-op which was probably caused by displacement of
the cuff.
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Figure 16: Timing of insertion of additional cuff around the urethra.
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A second cuff operated by the same balloon and pump was implanted in 52
22
patients after the initial report of the procedure in 1993 .
Tubing and connectors
In total 74 complications relating to the above components were reported
(1.8% of total records). 27 were related to the tubing and 47 to the connectors. In 8
cases the tubing eroded through the skin. Leaks were attributed to the tubing in 19
cases and to the connectors in 45. There was one incident of a blocked connector and
one case where the cuff and balloon were connected the wrong way round. No
blockage due to kinking of the tubing was reported. Overall, these components were
responsible for 8% of mechanical failures.
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Literature Review
A literature review on the artificial urinary sphincter was also performed. This
chapter will concentrate on the results of the AMS family of devices (the other reported
devices are described in the previous chapter and in Appendix 3). The main findings of
the published reports on the AMS sphincter are summarized in Table 6. Out of a total
of 3321 patients, 275 (8.3%) were implanted with non AMS 800 models (the breakdown
of these was as follows: 7.6% AMS 721, 21.1% AMS 742 and 71.3% AMS 791/2).
In analyzing the data, it became apparent that several groups reported their
experience in stages as the implant numbers built up. In so far as can be determined
from these papers, the latest and most encompassing paper is included in Table 6 in
order to avoid duplication of patient numbers. Thus, the patients reported in several
earlier reports1"5'7"10'12"14'19'23"32 may be included in the latest publications by Scott6,
20 33 •
Mundy and Salisz and Diokno which report on the global/long term experience of
their teams.
Ref. Model Study Follow Total Improved Revisions U.E. Inf. Mech.




34 742a,b,c 31 6.5 32.2 16
35 721 25 12 8.3
36 various 1 21 38 24 14
37 various 4 19 79 32
38 742 2.5 3 to 30 47 (91) 13 4






Ref. Model Study Follow Total Improved Revisions U.E. Inf. Mech.








41 721 2.5 11 18 82 27 9 45
41 742b,c 2.5 15 60 24 13
42 791,792 2 27 89 5
43 various 3 to 48 30 93 6.5
44 791,792 2.5 22 0
45 791,792 43
46 800 41 92.7 (87.8) 26.8 9.6 12.1
47 various 10 31




10 33 76 18
17 various 45
50 800 12 to 14 10 100 (80)
51 various 47
52 800 20 90 15
53 800 2 6 to 12 15 100 (73)
54 various 6 95 (75) 10.5 10.5 13
55 792(34),
800(10)
18 44 91 (64) 30 10
56 various 1
57 800 12 1 to 32,
(14)
109 83.5 (92.7) 26.5 3.7 2.7 17.4
58 800 14 4 (100)
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Ref. Model Study Follow Total Improved Revisions U.E. Inf. Mech.








60 800 117 90 15






14 40 82.5 62,5 2.5 7.5
63 800 (25) 46 85 15 13
64 800 11
65 800 5 7 to 60,
(26.2)
42 85 (76) 9
66 800 35 45 88 60 20
6 All 16 406
67 800 2 100
68 800 5 1
69 various 16 (75)
70 800 7 62 84 (29) 35
71 800 5 8 to 66,
(40)









74 various 24 to 72 20
75 800 8 12, 106 86.3 58.4 28 15
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Ref. Model Study Follow Total Improved Revisions U.E. Inf. Mech.





76 various 7 340 93.3 7
77 800 7 60 36 84(1 year),
62(5 years)
58.3
78 800 2 100
79 792, 800 5 44 90 (90) 36 11 6.8
80 800 2 100
81 800 5 (30) 45 80 40
20 All 18 200 95 10.5 5 7
82 800 3 6 to 31,
(12)
27 80 39
83 800 33 2
84 various 1 25 0 0
85 800 4 1 to 36,
(20)
37 (94) 11
86 800 13 87 (87) 25 12.5
87 800 126 9 7
88 various 6 to 94,
(41.6)
166 75.3 19.3 6.6 1.2 7.8
89 800 3 to 36 7 57
90 800 8 37 90 38
33 various 12 57
91 various 9 71
92 various 12 to 60,
(20.3)
18 88 0 22
93 800 64 90 22 4.8
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Ref. Model Study Follow Total Improved Revisions U.E. Inf. Mech.




22 800 15 80
Total number of reported patients: 3321 (male 73.2%, female 26.8%^
Table 6: Summary of results and complications of implantation of the artificial
urinary sphincter from published studies. (References cited chronologically).
Since different studies involve different numbers of patients and each does not
report the same types of complications, in order to determine the overall success rates
and the global rate of each complication from these studies, the following formula was
used:
y\nxr(%) 1
Rate(%) = ' J
2."
Where n is the number of patients in each report and
r is the individual rate of the complication reported in each study.
The results are summarized in Table 7.
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Global rate Number of patients
Improved 84.8% 2017
Fully continent 78.5% 940
Revisions (total) 33.5% 1441
Urethral erosion 11.7% 1169
Infection 6.1% 1045
Mechanical complications 13.9% 1425
Table 7: Calculated global success rates and complications of implantation of the
artificial urinary sphincter from the published studies.
Increased detrusor instability resulted from the implantation of the
sphincter17'27'51'69'74'79'94"97 and deterioration of the upper tracts was also reported in
7.4% of cases4'27'51>55>56>62'64'74'79 (28 out of 382 patients) including one patient who
• 79
developed renal failure and required hemodialysis .
Implantation of the AUS after previous radiotherapy was reported in several
studies60'86'93'98"100 and this is not considered an absolute contraindication of
implantation, provided strict adherence to operating technique detail and asepsis is
observed.
• • • 33
Iatrogenic complications as high as 10.5% of cases were reported in one study .
In one study91, seven patients implanted with the sphincter became pregnant.
Three delivered normally and four by cesarean section without any complications. In
71
another study , two became pregnant and reported stress incontinence and increased
frequency. Both these sphincters were deactivated throughout the third trimester.
There were two cases of insertion of the sphincter in patients with renal
68 •
transplant . In 64 cases, the sphincter and a penile prosthesis were implanted
simultaneously61'85. One group of authors61 report that this combination does not lead to
153
increased complication rate, even though in their series of 60 patients the rate of
revisions averaged at 0.98 per patient.
20
The balloon was replaced to one with a higher plateau pressure in 7% of cases .
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Discussion
Approximately 150 to 200 AMS 800 units are sold in the UK every year, with
proportional usage in Europe and the USA, which corresponds to a worldwide
implantation rate in excess of 2000 units per year (figures from AMS representative).
During the period of the review, therefore, approximately 16800 devices must have
been implanted, giving a global complication rate of 24.6% for all complications.
The implantation by astiology is reported by AMS101 to be as follows: prostatectomy
59%, spina bifida 12%, spinal cord injury 9%, neurogenic bladder 5%, stress
incontinence 5% and miscellaneous 10%. The literature also includes anecdotal
68 71 91
reports of its usage in patients with renal transplantation , pregnancy ' and
overoptimistic reports61 of implantation in conjunction with penile implants61'85. The
available figures on implantation by aetiology are almost identical to those reported in
this review (Figure 2).
Most revisions took place during the first year post implantation as previously
reported76. The number of revisions declined with time (Figure 3 and Figure 4) and
closely followed a double exponential decay relationship (Table 1). 50% of revisions
were performed within eight months and 90% within three years of implantation.
Complications were still reported up to 17.5 years post implantation, emphasizing the
need for prolonged surveillance of these patients.
Less non-AMS 800 model revisions were reported in the FDA database than
in the literature. This may reflect the fact that the database included reports from
2 3 7 8 13 29 35 381986 onwards, whereas most revisions involving the previous models
45,47,55,59,102,103 pjace prjor to or soon after the introduction of the AMS 800 in
1983.
Infection rate of 11.4% to 12.9% is suggested by the analysis in this review,
which is higher than the overall reported in the literature (6.1%). Assuming that the
4130 reports in the FDA database come from a population of approximately 17000
implanted patients, then the complication rates should be divided by a factor of «4 to
account for that, and thus to reflect the global patient complication rate (this assumes
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that the annual marketing data obtained verbally are accurate and remained constant
throughout the period of the review). The infection rate of all three components of
the prosthesis becoming infected together represents approximately 6-7% of the
complications in this analysis. As a rule, both early (possible contamination during
the implantation procedure) and late infections were reported to the FDA, whereas
only documented infection of the whole prosthesis was consistently reported in the
literature. This may be reflected in the mathematical analysis of the decay curves
(Table 1, Figure 9): the exponential time decay coefficients are almost identical for
the total number of infections and infection of each component separately, whereas
the amplitudes are almost equal only for the individual components (Table 1). This
indicates a residual number of infected cases at the start of the analysis, which may
represent the numbers of early contamination during the procedure.
The urethral erosion rate in this review is approximately 13.8%. The
calculated global rate reported worldwide is 11.7%. The timing of this complication
also follows a double exponential decay relationship (Figure 10, Table 1). The
balloon pressure in the cases with urethral erosion was not reported consistently in
• • ... 38the reviewed papers, making analysis impossible. In one study , all patients with
urethral erosion had been implanted with balloons with plateau pressures >80
cmH20. None of the patients who had reservoirs with pre-selected pressure <70
cmH20 had urethral or vesical neck erosion.
This complication was reported as late as 14 years post implantation and all
of the erosions in the presence of infection occurred within six years of implantation.
This again emphasizes the requirement for long term follow-up. There were also five
reports of urethral erosion related to the passage of a urethral catheter; these
developed between 10 and 18 months after implantation. Self catheterization has
been reported as an adjunct to artificial sphincter implantation in cases of incomplete
bladder emptying44. The low rate of this complication in this review indicates that
careful self catheterization may be safe.
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Much of our knowledge on pressure tolerance of tissue beneath the AMS 800
sphincter come from the experiments of Engelmann and his group104"106. This was
implanted around intestinal loops in 22104 and 40105 New Zealand rabbits to evaluate
its possible use for continent urinary diversion. This evaluation included the effects
of varying closing pressures of the cuff on these isolated bowel loops. Six-weeks
postoperative investigations included pressure/flow studies, autopsies,
microangiography and histologic evaluations. The sphincter was able to achieve
continence during perfusion of the intestinal loop, maximum pressures being
dependent on cuff pressures. However, sphincter-related complications (infection,
erosion and atrophy of bowel beneath the cuff) were pressure dependent and seen
mainly in high pressure groups (Table 8).
Cuff Pressure
(cmH20)
Number of animals Number of erosions
(%)
0 6 1 (16.7%)
40 4 1 (25%)
60 5 2 (40%)
80 7 2 (28.5%)
100 4 4(100%)
Table 8: Pressure tolerance of the rabbit small intestine104'105.
In a canine model (n=24), balloon pressures of 70 to 80 cmH20 were well
tolerated by the bowel for up to 29 weeks with no evidence of erosion106. The human
sigmoid colon tolerates 70 cmH20 whereas ischasmic erosion occurred at balloon
pressures of 81-90 cmH20106. If we assume that the sensitivity of the urethra to
ischasmic injury is similar to that of colon, then the 61 to 71 cmH20 balloon should
be implanted at the first procedure. The actual pressure applied on the tissues is even
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lower as only part of the cuff pressure can be transmitted. This is of the order of 60%
to 75%.105"109 (see also, Chapter 3, Chapter 4, Chapter 6 and Chapter 8 for the setting
of the sphincter pressure and tolerance of porcine and human colon to sphincteric
compression).
Pressure atrophy occurs to a certain degree in all patients and may be due to
tightness of the cuff or a high balloon pressure. At a certain critical point (usually
four months post activation), cuff efficiency diminishes since there is inadequate
pressure transmitted to the underlying tissues and this presents clinically as
recurrence of stress incontinence. Correction requires re-operation to insert a smaller
cuff or replace the balloon to one with a higher pressure plateau. Due to the safety
feature of the balloon plateau pressure, merely injecting fluid to the system does not
restore cuff efficiency. Change of the balloon to one with a higher plateau pressure
due to subsequent development of stress incontinence was necessary in 8.6% of the
20
patients reported to the FDA. The figure of 7% was reported in one large series .
This cannot be a complication solely attributable to the balloon as there was no
evidence of mechanical failure in these cases, nor could it be related to a properly
sized cuff being too loose at implantation. The cause was almost certainly a
combination of gradual tissue atrophy deep to the cuff in addition to slow leakage of
fluid from the system by diffusion. This is corroborated by the delayed onset of this
complication.
Another measure which was introduced to decrease the incidence of urethral
• • • 38 ...
erosion was primary deactivation . The device remains deactivated for the period of
post-operative healing (typically six weeks) and is activated subsequently. This
involved a subsequent surgical procedure to inject fluid in the system or connect the
control pump38'41'103. The necessity of this was obviated when the AMS 800 model
was introduced16 which includes a manual long term deactivation button (shutoff
valve). This allows the device to remain deactivated and can be activated for the first
58 65 81time by percutaneous manipulation ' ' . In order to further reduce the incidence of
ischaemic complications it has been suggested that the device be kept deactivated
57 58
during the night as well ' .
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Another way to rectify stress incontinence was reported more recently and
22 #
involves the implantation of two cuffs in tandem claiming success in excess of
95%.
As there was a significant incidence of upper tract
deterioration4'27'51'55'56'62'64'74'79 and exacerbation of detrusor instability17'27'51'69'74'79'94"
07
post implantation, it is important that full urodynamic assessment is performed
prior to implantation. If the bladder capacity or compliance is low, or if there is
detrusor instability, augmentation cystoplasty or a similar procedure should be
considered at the same time as artificial sphincter implantation17'19'27'28'79'95'110'111.
Long-term follow-up of these patients is, therefore essential.
The device components (excluding the cuff) migrated into other tissues in
3.1% of the patients, the greatest proportion of these (59.8%) being caused by the
pump (Table 3). The AMS pump is an extremely light, sub-miniature device. For it
to cause relatively so many complications indicates that the design, size and shape of
this component is critical (see Chapter 3 and Appendix 3).
There appears to be a delayed rise in the incidence of tissue migration of
components (Figure 12) which is reported to occur even after 10 years post
implantation. An exponential decay relationship can once again be plotted (Figure
12b), but the mathematical fit is less precise for this complication (Table 1). The
dotted line of the plot in Figure 12b represents a sixth order polynomial regression of
the monthly data (r =0.72) which demonstrates this rise which indicates a significant
late morbidity.
Implantation of the AUS after radiotherapy was reported in several
studies60'86'93'98"100. Mundy considers this a relative contraindication of
implantation20'99, quoting an erosion risk of 57%. Despite reports to the
contrary93'100, the risk of urethral erosion after implantation in these circumstances
appears to be increased60'86: urethral erosion was reported in two of 20 patients
(10%) with previous pelvis radiotherapy, compared to 5 of 95 (5.3%) in the non-
irradiated group60. In another study86, urethral erosion in 16 patients (13 who had
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undergone external beam radiotherapy and three with Iridium implants) was 12.5%.
As the urethral erosion rates reported above were well within the global rates (13.8%
in this review, calculated rate from literature 11.7%), it would seem reasonable that
these patients are not deprived of this implant if meticulous technique (including
primary deactivation) is adhered upon and patient selection is appropriate.
There were 26 reports of iatrogenic complications (0.6%) in this review. The
33
iatrogenic complication rate was reported to be 10.5% in one study of 57 patients ,
almost exclusively due to injury to the pelvic viscera. This report, however, involved
very difficult patients in whom an average of 2.8 anti-incontinence procedures were
performed prior to artificial sphincter insertion.
Mechanical failure accounted for 22.1% of the complications reviewed (see
Table 4) and ranges between 5% and 78% in the literature (average 13.9%).
Approximately 1/3 of the mechanical complications were related to pump
malfunction, the majority of these (40%) due to some malfunction of the fluid
equilibrating resistor and 18% related to the shutoff valve. The current AMS 800
pump (see Attempts to achieve continence artificially: A Review and Appendix 3) is
an extremely reliable, ingenious yet simple piece of equipment. It has undoubtedly
contributed greatly to the clinical success of the device.
The cuff was involved in over 40% of mechanical complications, mainly due
to leakage (39%). Leakage was almost exclusively present at the site of a cuff fold.
This cuff consists of an outer, firm monofilament knitted polypropylene
(Dacron) backing and an inner silicone pliable cuff shell, which is in contact with the
tissues. Once the cuff is placed in position and inflated, the lumen assumes a
polygonal shape due to the development of (usually three) cuff folds. This has two
disadvantages:
112
1. The cuff causes "crenation" of tissues into the folds . These folds represent
disproportionately high pressure zones (see Chapter 3) and may contribute to
pressure ischaemia/necrosis at that point. The fact that no rotational variation of
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108 • •
the intraluminal pressure was observed in an early study is probably a reflection
of the relative insensitivity and poor directional discrimination of the fluid
perfused pressure measuring equipment employed.
2. It allows for silicone memory and creep phenomena to weaken the cuff at the fold
and eventually cause leakage.
Because of the memory effect, once established, these folds persist so they
are present both during inflation and deflation. With deflation, these cuff folds come
into contact with the outer monofdament knitted polypropylene backing, resulting in
friction between the two inner surfaces of the cuff which becomes significant with
repeated pumping. This friction promotes the creep phenomenon whereby the
silicone molecules tend to migrate away from one another resulting in thinning. This
eventually results in a cuff leak that almost invariably occurs at the apex of one of the
folds87.
In an attempt to improve the cuff, a lubricant surface treatment was
introduced by AMS in 1983: the inner surfaces of the cuff shell were coated with a
gel of friction reducing fluorosilicone. A new narrow backed cuff design was also
87introduced in 1987 in order to address the urethral atrophy problem. The incidence
9 87of leakage reported decreased from 12.5% to 1.3% and revisions for pressure
atrophy from 24.6% to 9%. Both these studies were performed by the same group of
investigators and involved similar lengths of follow-up.
The introduction of kink proof tubing and special connectors and tooling for
intraoperative tubing connection, may explain the relative paucity of complications
pertaining to these components (8% of mechanical complications, 1.6% overall).
The device, however, has several disadvantages:
• Currently the cost is in excess of £2500 and this means that it cannot be readily
available to many patients. The current patent16 will expire in approximately
seven years and market competition may eventually solve this problem.
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• The contour of the cuff moulding template could be changed to produce a cuff
20
which on inflation would uniformly constrict the lumen instead of creating a
multiple cushion effect.
• There is no compensation for stress incontinence due to increases in
intraabdominal pressure (despite claims to the contrary11), as the resistor is
interposed in the fluid path between the cuff and the balloon and the non spring
loaded ball valve on the cuff side of the pump16 does not reliably remain open
during fluid surges caused by e.g. coughing. The design of Craggs113 includes an
intraperitoneal balloon to solve this problem, but the pump mechanism in
unreliable (refer to previous chapter and Appendix 3). A new valve has been
designed by the author114 to solve this and other problems as discussed in Chapter
3 and Appendix 3.
• There is no way to alter the hydraulic pressure in the system except by re-
operating to exchange the pressure regulating balloon for one with a higher
20
pressure plateau. Mundy suggests that this is correctable if an access portal with
a self-sealing membrane could be incorporated into the device: this could be
impaled transcutaneously to measure and adjust the system pressure. The author
disagrees with this suggestion as the system operates at the plateau pressure of the
balloon. Thus, the pressure cannot be increased beyond the plateau by injecting
fluid until the balloon approaches the point of rupture. This represents a safety
mechanism whereby the pressure cannot rise to above the said plateau level which
might cause ischemic injury to the tissues. Otherwise, the only way that this
adjustment of pressure may be achieved is to either set the system to operate at a
pressure level on the rising slope of the balloon sigmoidal pressure-volume curve
(this method was employed by the author in the survival animal experiments, see
Chapter 6) or to design a balloon with several plateau levels. The latter is a very
attractive idea which, however, might be impossible to implement.
• The balloons are available with plateau pressures of 51-60, 61-70 or 71-80
cmH20. If the balloon is required to be changed to the next one in the range, the
162
pressure of the new unit could be anywhere between 1 and 19 cmH20 higher.
20
This critical parameter, therefore, should be set to a much tighter tolerance .
In conclusion, the AMS 800 artificial urinary sphincter is a successful and
safe device which, when implanted in carefully selected patients, has a high success
rate with relatively low rates of complications. Any attempt to develop another
prosthetic sphincter for the human genitourinary or gastrointestinal tract should result
in a device with at least comparable engineering tolerances and specifications.
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Studies were performed using an in-vitro model to assess the relative
importance of sphincter pressure and anorectal angulation in maintaining faecal
continence. Water and a semi-solid material were infused separately into porcine
intestine compressed by an inflatable cuff until leakage was observed. Angulation of
the bowel with respect of the cuff was 180° and then 90°. With water, holdback
pressure was independent of angulation. In contrast, when semi-solid material was
used, angling the bowel to 90° increased holdback pressure by at least 100%.
Measurements made in solid tubes demonstrated that both a restriction in the
tube and an unconstricted 90° bend produced a resistance to flow of the semi-solid
material which was dependent on flow rate.
These data suggest that liquids are retained in the rectum by occlusion




Faecal incontinence is a common, unresolved socially devastating condition.
Continence depends on the coordinated action of the anal sphincters
(internal/external) and the pelvic floor musculature1"5. The sphincters produce
occlusion pressure over the length of the anal canal, while the puborectalis and
levator muscles produce occlusion in the upper anal canal. The puborectalis also
produces angulation between the anal canal and the rectum. The presence of an acute
«••• *67
angle at this site has been considered important in maintaining continence ' . Indeed,
the postanal repair operation for idiopathic faecal incontinence was designed to
2 8 i • • 9 10
correct the obtuse anorectal angle ' commonly found in that condition ' . More
recently, the role of angulation has been questioned and occlusion pressure has been
11 12 •
accorded the major determinant of continence ' . The relative contribution of each
mechanism for the maintenance of continence remains uncertain.
A fuller understanding of the mechanisms of continence is important, since it
may allow treatment options to be improved. To this end we have studied, in-vitro,
the flow properties for fluid and a semi-solid material in both rigid tubes and bowel
to determine the relative effects of angulation and occlusion on the resistance to flow.
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Materials and Methods
Study 1 : Flexible Tube (bowel), liquid and semi-solid material
A circular inflatable cuff (75 mm long, 18 mm wide) was placed around a
segment of porcine colon 36 mm wide, with a 1.5 mm wall thickness, in a manner
similar to a previously reported model for studying fluid holdback13'14. The cuff and
bowel were supported in a rigid frame so that the bowel proximal to the cuff could be
placed at an angle of 180° or 90° (Figure 1). The cuff was inflated to a
predetermined inflation pressure and water at a flow rate of 1 ml/min was infused
into the proximal bowel (placed at 180°) using a syringe driver. The intraluminal
pressure at which water leaked through the cuffed portion of the bowel was measured
by a 2 mm catheter tipped transducer (Gaeltec Ltd., Skye, U.K.). This was repeated
for a range of cuff pressures. The proximal bowel was then placed at an angle of 90°
to the cuff and the holdback pressures determined as before. Semisolid material in
the form of commercially produced pure collagen aqueous suspension (6% collagen,
94% water) was then infused into the bowel under similar conditions using a ratchet
driven injector and holdback pressures measured. All measurements were repeated
three times.
The rheological characteristics of the material had been evaluated using a
controlled stress rheometer and were found to be comparable to those of faeces15
(Appendix 2).
Colonic pressure under the cuff was measured at each inflation pressure using
the "pullthrough" technique.
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Figure 1: In vitro model for measuring the retention characteristics of bowel at
90° and 180° angulation.
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Study 2 : Rigid Tubes, semi-solid material
Three cylindrical glass tubes (diameter 28 mm) were constructed (Figure 2):
these were (a) straight, (b) straight with 50% constriction and (c) 90° bend with a
constant radius (+/- 2% at apex of angle). A 55 mm long bolus of the collagen
suspension was placed in each tube in turn. The inner surfaces of the tubes were first
coated with a 1% aqueous solution of hydroxypropyl-methylcellulose which
simulated the lubricant properties of colonic mucus and ensured that there was an
airtight seal between the bolus and the tube. Air pressure was applied to the end of
each tube using a syringe pump. The pressure when the flow of the bolus became
constant (see Figure 3) was noted and the experiment repeated at flow rates between
20 and 120 ml/min (linear velocity of approximately 3 to 20 cm/min). These flow
rates were chosen to approximate that of feces during defecation16 (64 seconds for
complete evacuation). The experiment was repeated with the constricted (Figure 4,
Figure 5) and angled tubes (Figure 6, Figure 7).
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Figure 2: Experimental setup for studying semi-solid material flow in glass
tubes.
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Figure 3: Recording of pressure to achieve flow (y axis) of semi-solid collagen
gel in a straight glass tube without a constriction versus time. Pressure reading
is taken when flow becomes constant (plateau).
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Figure 4: Recording of flow of semi-solid collagen gel in straight glass tube with
50% constriction. Constant flow is achieved prior to the bolus reaching the
constriction (small solid arrow). Flow through constriction produces a further
increase (two open arrows) to a new plateau. Extrusion is completed and gel
bolus drops (curved arrow).
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Figure 5: Recording of flow of semi-solid collagen gel in straight glass tube with
50% constriction. Reading taken at faster paper speed; the point at which flow
commences is noted (pen mark).
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Figure 6: Flow through unlubricated glass tube with 90° constriction. The bolus
moves after the wall adhesion force is overcome (first small arrow). A new
plateau is reached because of the presence of the angulation in the tube (thick
arrow). Further increase noted at the end of the extrusion due to adhesion on
the tube coupling.
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Figure 7: Flow through lubricated glass tube with 90° constriction. The bolus
moves without measurable wall adhesion (thick arrow), reaching a plateau at
constant flow rate (long arrow). A new plateau is reached because of the
presence of the angulation in the tube ( second long arrow).
Study 3 : Rigid Tubes, semi-solid material, plug flow versus laminar flow
The experiment was repeated as described in Study 2 above, but the bolus
was replaced by two smaller boluses, one coloured red and the other undyed (Figure
11). This was designed to determine whether, at the flow rates studied, the material
flowed in a "laminar" or "plug" flow manner.
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Results
The pressure exerted on the bowel under the cuff was directly proportional to
cuff inflation pressure. The holdback pressure when water was infused into the
bowel varied directly with cuff inflation pressure (Figure 8). There was no difference
between angulation of 180° and 90° (unpaired t-test, p=0.93). Semi-solid material
was retained at lower cuff pressures than for water. At 180° there was a linear
relationship between cuff and holdback pressures (r = 1.00). Angulation of 90°
improved retention by 100% at low cuff pressures and >300% at 50 mmHg. The
bowel ruptured above intraluminal pressure of 150 mmHg (Figure 9).
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Figure 9: Holdback pressure for semi-solid in Bowel at 90° and 180°
angulation. Circular cuff Sphincter.
Flow characteristics of the semi-solid material in the glass tubes are shown in
Figure 10 to Figure 11. For each of the tubes, pressure required to move the bolus
increased with flow rate. The 50% constriction required approximately 80 mmHg
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Figure 10: Pressure to drive semisolid material through three glass tubes at
different flow rates.
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The material exhibited "plug flow" characteristics in each tube at flow rates
between 20 and 120 ml/min (3 to 20 cm/min). There was no intrusion of any of the



















Figure 11: Experiment to determine flow mode of the collagen gel faecal
substitute. If flow was laminar, the first bolus of the material would intrude
into the second (b.). If the material exhibited "plug flow" characteristics, the




The evidence as to whether anorectal angulation is important in maintaining
continence is conflicting. Although an obtuse angle is found in patients with
9 ••28*
idiopathic faecal incontinence , the success of the postanal repair operation ' which
was designed to recreate the acute anorectal angle without affecting anal pressure3,
does not correlate with the degree of anorectal angulation achieved17"19. Further
doubt has been cast on the role of angulation in creating a flap valve, when it was
observed radiologically that the anterior rectal wall did not make contact with the top
12of the anal canal during the Val-Salva manoeouvre . Despite this, it is recognised
clinically that patients who have a divided sphincter and poor anal canal tone but a
preserved puborectalis and anorectal angle can be remarkably continent, although
unable to avert the call to stool.
The present study has shown that to retain liquids in excised bowel required a
mucosal seal in which the pressure was greater or equal to intrareservoir pressure,
irrespective of angulation. For semi-solids, however, the situation was different:
angulation of the bowel improved retention of semi-solids at all occlusion pressures
between 0 and 50 mmHg.
15 20 21Tests to determine the physical properties of faeces ' ' have shown that
15 21 20
they vary considerably in viscosity ' , hardness and consistency . The semi-solid
gel suspension was chosen because it is a homogeneous substance whose physical
properties (density and viscosity) are comparable to those reported for soft faeces15.
On inspection, it had the appearance of soft, well formed stool.
Glass tubes were used to examine the dynamics of flow of the semi-solid
material. The minor discrepancy of the shape of the tube at cross section at the apex
of the tube was mathematically proven to be negligible (see Appendix 1). Flow
around a 90° bend without a constriction required extra pressure, while flow through
a 50% constriction required even greater pressure, thus both a bend and narrowing in
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a rigid tube introduced resistance to flow for the semi-solid. Detailed theoretical
analysis of flow through bends is lacking and is presented in Appendix 1; bends
23
can be thought of as an equivalent length Leq of rigid tubing which introduce an
additional frictional force as if an extra length of tubing equal to Leq were interposed.
The value of Leq for a 90° angled tube similar in diameter to the human anorectum is
180 cm 23. Leq for a flexible tube may be even greater than that for a rigid tube24.
Although our in-vitro models did not attempt to replicate the complexities of
the dynamic pressure/volume and angulation changes in the anorectum, we have
demonstrated that to retain a semi-solid resembling soft faeces in a tube it is not
necessary to seal it. The requirement is that the resistance to flow be equal to or
greater than the force tending to move it. Thus, by extrapolation, semi-solid material
in the rectum does not need a flap valve to keep it from moving into the anal canal.
It would appear that angulation or constriction alone would provide sufficient
resistance to prevent movement, even when the rectum is subjected to a minor degree
of external pressure. With higher degrees of intra-abdominal or peristaltic pressure,
both angulation and occlusion pressure require to be enhanced. The opposite effect,
i.e. reduction of resistance to flow by anorectal angle becoming more obtuse and
opening of the anal sphincter, occurs during simulated defaecation as observed during
. i 11,25-27proctography
The mechanism for the control of fluid is different; liquids flow easily round
bends and require a complete seal to contain them in a tube. For a sphincter to
provide a liquid seal the intraluminal pressure must be equal to or greater than the
12
pressure on the liquid. In the Val-Salva study , liquid barium filled the rectum and
it was observed that the seal was maintained by contraction of the anal sphincter
muscles alone. The data from the present study suggests that if semi-solid contrast
had been used, there may have been no requirement for the sphincter muscles to
respond so vigorously.
Continence to liquid stool is explicable in terms of a delicate balance of
pressures. When that balance is disturbed, for example by liquid stool distending the
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rectum with increasing intrarectal pressure, then leakage will occur unless sphincter
pressure can match rectal pressure. Where damage to the sphincter prevents the
creation of an effective pressure barrier, then there will be incontinence to liquid but
not necessarily solid stool. It is recognized that there is periodic relaxation of the
28 29
internal sphincter muscle to allow sampling of rectal contents ' . The preservation
of angulation between the rectum and anal canal probably allows this to occur safely,
retaining semi-solids and solids within the rectal ampulla while gas and liquid flow
into the upper anal canal.
Our findings may also explain the lack of correlation between angle and
success of the postanal repair operation17"19. In particular, the observation that a 50%
stenosis creates more resistance to flow than a 90° angulation suggests that an
operation which produces a relative stenosis may also improve continence for formed
motions. Therefore, either the creation of stenosis, or the recreation of angle or both
would be beneficial in preventing the flow of semi-solids. A longer anal canal length
and a relatively fixed perineum, which would achieve a fixed anorectal angulation,
27also appear important in the maintenance of continence .
In conclusion, these in-vitro studies confirm that for the retention of semi¬
solid material, angulation enhances the resistance to flow for any given occlusion
pressure, suggesting that angulation does provide a physiological benefit in
continence. Angulation, however, provides no benefit in the retention of liquid.
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The flutter valve theory was proposed by Edwards and Phillips1 (See:
INTRODUCTION and HISTORICAL PERSPECTIVE: A Review of the
Physiological Faecal Continence Mechanisms). They suggested that normal
continence was due partly to intra-abdominal pressure being transmitted at the level
of the levator ani, laterally to the side of the anal canal in the region of the anorectal
2 3
junction. This theory was considered unlikely by Duthie and Kerremans .
A series of simple experiments were conducted in-vitro to check the validity
of the flutter valve theory.
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Materials and Method
The abdominal cavity was simulated by a perspex cylinder with perforated
ends on which porcine large intestine was secured in order to simulate the
gastrointestinal tract. The "intra-abdominal" pressure was increased by air
insufflation through a side port (Figure 1). The intestine was filled with collagen gel
simulating feces (Appendix 2) or left empty. The behaviour of the system was
observed during the air insufflation with the bowel filled (Figure 2), and repeated






Figure 1: Diagrammatic representation of the in-vitro model designed to test the
validity of the flutter valve theory.
The air pressure was applied through a modified gas perfusion pressure




Intestine filled with collagen gel
The behaviour of the gel is depicted diagrammatically in Figure 2. The
observed changes are exaggerated for clarity. Pressure to achieve flow was of the
order of 200 mmHg. As the inflation pressure increases, a compressive force is
applied on the circumference of the bowel, which tends to constrict it (Figure 2b,c).
As the ends of the bowel are open to the exterior (e.g. anal canal) the force causes the
material to flow through these orifices to the outside (incontinence).
Figure 2: Results of insufflation with bowel filled with gel simulating faeces.
With further increases in pressure, the bowel wall protrudes through the
orifices. This is also clearly shown in the next experiment (Figure 3).
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Intestine empty
The results of this study are depicted diagrammatically in Figure 3. The
empty bowel collapses and the lumen is obliterated progressively almost as soon as
the pressure is applied (>25 mmHg). Once all the air is squeezed out, the whole
length of the bowel is collapsed. The bowel wall readily protrudes through the two
orifices (Figure 3b)
Figure 3: Results of insufflation with the bowel empty.
Discussion
The flutter valve theory was proposed by Edwards and Phillips1 based on
crude radiological methods. They suggested that normal continence was partly due
to intra-abdominal pressure being transmitted at the level of the levator ani, laterally
to the side of the anal canal in the region of the anorectal junction. The anal canal
appears to be an anteroposterior slit1 radiologically and this pressure could compress
it in a way similar to a simple flutter valve (Figure 4). This theory was considered
unlikely by Duthie since although an occlusion was seen radiologically in the
anorectal region when the rectum was outlined by barium contrast, puborectalis
activity could not be excluded. Kerremans also pointed out that the segment
described as acting as a flutter valve lies below the levator ani cradle at the level of
the puborectalis sling. Radiological observations during the Valsalva manoeuvre
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showed that the anterior and posterior rectal walls did not appose one another5. Even
although the rectal segment examined in their study is above the proposed level of
the flutter valve, the fact that increases in the intra-abdominal pressure did not cause
the rectal wall to collapse at this level makes it impossible for this pressure to have
caused collapse at an even lower level which lies out-with the peritoneal cavity. In
addition, rectal pressures were found to be consistently lower than those generated by
the anal canal5 strengthening the conclusion that continence did not depend on
passive 'valvular' mechanisms.
In empirical terms also, the presence of such a valve mechanism is impossible
as, in normal subjects without obstructed defecation, an increase in intra-abdominal
pressure is an effective manoeuvre to initiate or complete evacuation.
The flutter valve mechanism, therefore, could not act by increases in intra¬
abdominal pressure. In addition the flutter valve could not afford protection when
the intrarectal pressure rises. Another weakness of this theory is the fact that, in
engineering terms, a flap valve can only function if the conduit it would seal is not
continuous.
This model was designed to investigate the possibility that a flutter valve
mechanism may, indeed, exist. During the experiments pressure measurements were
made initially, but they were not analyzed as pressure changed depending on the rate
of inflation. In any case the absolute measured pressure is irrelevant in this case, as
the model does not serve to show the behaviour of the material, but to observe
whether a flutter valve mechanism does exist or not.
The conditions of this experiment cannot represent true changes of intra¬
abdominal pressure as the abdominal wall is not rigid, but it serves as a simple in-
vitro approximation. Although the position of the bowel is also simplified, this
model proves that a flutter valve mechanism cannot operate in the anorectal region if
the bowel contains any material. Increases in ambient pressure would cause the
contents of the bowel (be these solid, liquid or gaseous) initially empty. Once
emptying is complete, the bowel wall would protrude through the anal orifice. An
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increase of intraluminal pressure, however, could still overcome this phenomenon
and result in emptying of the luminal contents.
It has, therefore, been proven that the bowel does not act as a biological
Heimlich one way valve in the anorectal region.
Figure 4: Diagram of a simple flutter valve (Heimlich valve). In order for the
flutter mechanism to be effective, the conduit should be discontinuous at the
point of the valve.
In engineering terms, the only way that a flutter valve mechanism could exist
and protect against increases in the endorectal pressure is either for the lumen to be
discontinuous inside a rigid container (Figure 4), or for a segment of intussusscepted
bowel to be present interposed between the bowel termination and the outside. Only
if this intussussception was fixed and complete, would it enhance holdback of
intraluminal contents in response to increases in ambient (intra-abdominal) pressure.
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An artificial anal sphincter1 was designed to reproduce the normal physiology
of the ano-rectum by flattening and angulating the bowel without causing crenation.
It was shown in the laboratory that by eliminating crenation, occlusion pressure was
evenly distributed without localized high pressure points under the device . Further,
the design facilitates the creation of angulation of the bowel with a relatively large
area of distribution of the occlusion pressure, allowing the device to be set at lower
operating occlusion pressures than that required for circular designs yet still achieve
continence(Chapter 1). Each of the components of the device was studied separately
and the whole system was assessed in an acute and survival animal model.
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Introduction
Attempts have been made to develop a prosthetic anal sphincter but to date
these have suffered from many complications. In contrast, urinary incontinence has
been successfully treated using an inflatable circular cuff applied to the outer layer of
the urethra (see Chapter: Attempts to achieve continence artificially: A Review). A
prosthesis of similar circular design has been used for faecal incontinence in
animals2,3 and humans4"8, but produced intestinal ischaemia at operating pressures
2 3which maintain continence ' . This was probably because the rectum is not "circular"
and the application of a circular cuff produced crenation of the bowel wall in
localized high pressure points within the folds9 (see also Chapter 4). These early
results did not encourage any further research or development of this device.
It is recognized from our knowledge of the dynamics of flow that it is not
necessary to completely seal a tube to prevent flow of a solid/semi-solid if an acute
angle is incorporated in the system. Using this principle we have demonstrated in an
in-vitro study (Chapter 1) that the inclusion of angulation in a tube reduces the
occlusion pressure required to hold back solids and semi-solids but is of no benefit
for fluids or gas10.
An artificial anal sphincter1 is evaluated, which is designed to reproduce the
normal physiology of the ano-rectum by flattening and angulating the bowel without
causing crenation. This prosthesis is described in a previous Chapter (Attempts to
achieve continence artificially: A Review). Detailed analysis of the engineering
drawings and development of the device is presented in Appendix 3.
The engineering parameters of the three principal components of the device
(the pressure regulating balloon reservoir, the control pump and the sphincter
element) and also those of an evolution component (manually operated switch) were
studied both in-vitro and in-vivo. The function of the device was also assessed in
acute (Chapter 4) and survival (Chapter 6) experiments in a porcine model. The
preliminary assessment in humans is described in Chapter 8.
208
In an attempt to harmonize and simplify the procedures of licensing medical
devices throughout the European Community, the CE marking policy has been
introduced. If a device carries the CE mark, it means that the European Community
Directives have been followed and the device is likewise approved. In the UK the
competent authority for CE marking is the Medical Devices Agency (MDA).
Medical devices are classed into Class I, II or III depending on whether they are
passive, biologically inactive or biologically active respectively. By definition, Class
III includes all self powered devices. Classification of a device in one class allows
for automatic approval of modified designs, assuming the changes do not reclassify
the device. This device was classified in Class lib and a design dossier has been
submitted for CE approval.
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Materials and Methods
Study 1: In-vitro assessment
The pressure regulating balloon reservoir
A silicone balloon was used to act as a fluid reservoir and provide the
pressure required to drive the system. Two prototypes were studied, one constructed
by five and another by six consecutive dips into molten silicone prior to thermal
curing (Biosil Ltd.). The balloon was connected to a syringe and inflated with
increasing volumes of water, while at the same time the pressure generated inside the
balloon was measured by a fluid filled transducer (Baxter Ltd.). The measurements
were performed both while injecting and withdrawing water and the results plotted to
construct a hysteresis curve. All measurements were repeated five times.
The controlpump
This was similar in operation with the AMS 800 unit which is described
elsewhere (Attempts to achieve continence artificially: A Review, The Future,
Appendix 3).
The shutoff valve
The shutoff valve consisted of a simple piston type valve that could be closed
by applying pressure manually on its superior aspect. The valve could be opened by





Figure 1: Diagrammatic representation of the shutoff valve in its open
(activated) and closed (deactivated) positions.
The pressure required to open the shutoff valve was assessed as follows: the
pump case was impaled with a #21 needle connected to a pressure transducer (Baxter
Ltd.) so that the pressure generated inside the bulb could be measured while
pumping. This pressure is applied to the bottom of the shutoff valve and should lift it
off its seat after a critical level is exceeded. The pressure waveform was
continuously recorded on a chart recorder (Gould Model 8188-2202-09). The
measurements were repeated at a range of pressures applied by the balloon on the
shutoff valve.
The vacuum pressure developed in the bulb was also assessed by squeezing
the bulb and clamping the expander outlet tube while the shutoff valve was closed.
Upon releasing the bulb, a negative pressure is developed which is proportional to
the elasticity of the bulb.
Similar measurements were performed on a specimen AMS 800 pump.
The fluid equilibrating resistor
This component consisted of a narrow tube (diameter 0.15-0.2 mm), braze
welded inside a stainless steel cuff and held in place inside the pump casing by a Y-
shaped steel catch (Figure 2).
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Figure 2: Photograph of the fluid equilibrating resistor and the securing catch.
The resistor on the left shows evidence of corrosion (see results section).
Testing was effected in the following ways:
1. The resistor was connected to a variable pressure head and allowed a timed leak.
This was repeated for a range of resistor fluid path diameters and at a range of
head pressures.
2. The control pump was connected to a variable pressure head and allowed a timed
leak. This was repeated for a range of head pressures.
3. The control pump was connected to a variable pressure head and pumped twenty
times. The volume of fluid pumped and the time taken to complete the operation
were measured. This experiment was repeated for a range of head pressures.
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The one way ball valve assembly
The pressure gradient across the one way ball valves was determined by
simultaneously recording the pressure during pumping by two transducers placed on
either side of the valve. This was achieved by impaling the pump case at appropriate
points. Their operation was also checked visually during pumping.
The self sealing injection port
This was assessed visually after impalement and by applying pressure to the
bulb with the pump outlets clamped.
The sphincter element
The sphincter element consists of a rectangular expander which comprises
two components vulcanized together, interconnected by a large central
communication (Figure 3). It is fixed by two straps on to a rectangular silicone gel
filled pillow. The distance between these two components (i.e. the effective lumen
through stool could pass) is set by using specially designed cylindrical sizers of
diameters 20, 22.5, 25 mm (Chapter 6). The bowel is placed between the two
components of the device and the expander is connected to the balloon via the
control pump.
Figure 3: The expander element viewed side on (top drawing) and from above
(bottom drawing) to show the central communication between the two
components. The linear dimensions are also defined.
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Two prototypes were assessed: one with cutout of 1 mm and the other with
cutout of 3.5 mm (dimension a in Figure 3). All units subsequently used in the
survival animal experiments had a 3.5 mm cutout and length (L) of 55 mm.
The expander was inflated with water to increasing volumes and the pressure
generated inside measured. The two prototypes were connected in series and their
linear dimensions measured under isobaric conditions (Figure 4) in order to
determine the most suitable geometry of the device.
X
v=v1+v2




Figure 4: Experimental set up to assess the linear expansion and compliance of
the different expander elements.
The pressure-volume relationship of the expander was also studied while it
was fixed to the pillow. The lumen was set by using the three specially designed
cylindrical sizers described above. The contact angle created by the expander on the
pillow was assessed by placing a thin sheet of paper between these two components.
Upon progressive inflation of the expander, the paper assumed the contour of the
expander and the angle between the tangent at each side of the expander was
measured with a goniometer.
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Pressure transmission onto the pillow was studied by impaling the pillow and
measuring the pressure inside it with progressive inflation of the expander.
All the above measurements were performed at three predetermined distances
between these two components (20 mm, 22.5 mm, 25 mm) set by the previously
described cylindrical sizers. In addition, the pressure-volume relationship was
performed on the expander alone without it being fixed to the pillow. One expander
was used for the angle measurements and two for all other experiments.
The pressure distribution under the expander was measured with the straps set
at 22.5 mm and the expander inflated to 40 mmHg. Thawed porcine bowel was
placed between the expander and pillow and the pressure profile was measured at the
midpoint of the expander and also at three points in the periphery by a catheter tipped
microtransducer (Gaeltec Ltd., Model CTU1) using the station pullthrough
technique.
The holdback properties of this device were assessed using the same
methodology used for the circular sphincter as described in Chapter 1. The simulated
faecal material developed (Appendix 2) was also used for this experiment.
The manually operated switch
Due to the frequent malfunctions of the control pump shutoff valve and fluid
equilibrating resistor, a manually operated switch was employed in the latter animals
in an attempt to solve these problems. It consisted of a commercially available pipe
occluding unit (clip) placed around a length of silicone tube (Figure 5) and then
encapsulated. The whole unit was autoclaved prior to implantation. This unit was
designed in an attempt to overcome the problems caused by the control pump in
order to conclude the cycle of the experiments. It was not developed any further.
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Figure 5: The manually operated hydraulic switch.
One of these switches could be implanted in series between the balloon and
the pump in order to ensure reliable deactivation of the system. The other could be
connected in parallel with the pump to bypass a potentially blocked resistor. This
would provide a manually activated/deactivated shunt pathway allowing operation of








Control pump with potentially
leaky shutoff valve and
blocked resistor
Figure 6: Connections of the two manually activated hydraulic switches.
Study 2: In-vivo assessment
The pressure regulating balloon reservoir
The "six-dip" balloon was used in the in-vivo experiments. Pressure-volume
relationships of the balloons were performed at implantation in 15 of the survival
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animals and also in 12 animals just prior to termination with the balloon in situ in
order to assess the effect of long term implantation.
The controlpump
The function of the control pump was assessed visually prior to implantation.
The cause of complications or malfunctions was assessed as far as possible by
manipulation of the pump and also by impaling the self sealing port percutaneously
under general anaesthesia.
The sphincter element
The 55 mm expander with a 3.5 mm cutout was used in the in-vivo
experiments. The expander was separated from the pillow by the 22.5 mm sizer in
all the implanted animals. Pressure-volume relationships of the sphincters were
performed at implantation in 14 of the survival animals and also in 11 animals just
prior to termination with the sphincter in situ in order to assess the effect of long term
implantation.
The pressure-volume of the whole system was also studied at implantation in
13 animals and at termination in seven.
The pressure profile under the center point of the expander at increasing
inflation pressures was also measured in the animals at implantation. It was not
possible to repeat this measurement at termination due to the development of a
capsule around the sphincter.
The manually operated switch
The switches were operated at approximately two weeks post-operatively
once the tissue oedema resolved. Their appearance was also checked radiologically
when indicated and the pressure inside the casing was assessed by impaling the
switch percutaneously under a general anaesthetic (Chapter 7).
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Results
Study 1: In-vitro assessment
The pressure regulating balloon reservoir
The pressure-volume relationship of the balloon prototypes is shown in
Figure 7. The plateau pressure of the six dip balloon was approximately 100 mmHg
and that of the five dip balloon 72 mmHg. Both curves showed the hysteresis
phenomenon.
Balloon Inflation Volume (ml)
Figure 7: Pressure-Volume relationship of the balloon prototypes. Solid line





The shutoff valve unseating pressure of the AMS pump pre-implantation was
435 mmHg (S.D.=26.6) at 0 mmHg head pressure. When tested after implantation,
this was found to be 466 mmHg (S.D.=42) at 0 mmHg head pressure and 418 mmHg
(S.D.=54.6) at 100 mmHg head pressure. The differences were not statistically
significant between the pre- and two post implantation readings (p=0.05 and p=0.28)
and amongst the two post implantation readings (p=0.08).
The mean unseating pressure of all valves tested was 312 mmHg
(S.E.M.=98.8) at 0 mmHg head pressure and 325.7 mmHg (S.E.M.=98.4) at 80-100
mmHg head pressures. There was no statistically significant difference between
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Figure 8: The effect of head pressure (applied by the balloon) on the control
pump's shutoff valve unseating pressure.
The operation of the AMS shutoff valve was also much more positive than
that of the artificial anal sphincter (Figure 9-Figure 11). This pressure was not
dependent on the presence or absence of head pressure (i.e. balloon pressure) in the
AMS device, whereas its presence compromised even further the reliability of the
AASP device.
The vertical travel of the shutoff valve was assessed radiologically (Chapter
7) and was found to be approximately three times greater in the AMS pump,
allowing it to provide a much more positive lock and enhanced reliability.
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Figure 9: Measurement of unseating pressure of the AMS shutoff valve. Upon
squeezing the bulb, the pressure inside it increases up to the point of unseating
of the shutoff valve (oblique arrow). It then decreases abruptly (vertical arrow).
The trace is the same at head pressures of 0 and 100 mmHg.
(Vertical scale — 10 mmHg/mm).
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Figure 10: Measurement of unseating pressure of the AASP shutoff valve (no
head pressure). Upon squeezing the bulb, the pressure inside it increases up to
the point of unseating of the shutoff valve (oblique arrow). It then decreases but
not abruptly (downwards arrow) indicating some form of impedance to flow or
unreliable shutoff valve opening. (Vertical scale = 10 mmHg/mm).
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Figure 11: Measurement of unseating pressure of the AASP shutoff valve with
a head pressure of 100 mmHg. Upon squeezing the bulb, the pressure inside it
increases up to the plateau before the shutoff valve is fully unseated (oblique
arrow). It then decreases but not abruptly (open arrow) indicating that in the
presence of head pressure, impedance to flow or unreliable shutoff valve
opening is exaggerated. (Vertical scale = 10 mmHg/mm)
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Figure 12: Dynamic measurements at various points inside the pump during its
operation.
The appearances in Figure 12 are self explanatory. There is a significant
pressure gradient (>25 mmHg) across the fluid outlet pathway on the balloon side of
the pump.
The fluid equilibrating resistor
The flow rate increased as the diameter of the resistor lumen increased
(Figure 13). The resistor lumen diameter of the prototypes was 0.15-2 mm. This




Figure 13: Plot of resistor flow rate versus luminal diameter at 100 mmHg
pressure gradient.
The timed liquid flow through three whole pump units is shown in Figure 14.
Flow rate is linear and represents the composite leakage of all the fluid pathways
across the whole pump (resistor, ball valves, resistor housing).
0 10 20 30 40 50 60 70 80
Pressure (mmHg)
Figure 14: Timed fluid flow through the whole pump as a function of applied
head pressure at the balloon side of the pump.
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Figure 15 and Figure 16 depict the stroke volume and stroke refill duration of
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Figure 15: Stroke volume versus applied head pressure for six pumps.
40 60 80 100 120
Pressure (mmHg)
Figure 16: Stroke refill duration versus applied head pressure for six pumps.
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The stroke volume decreased significantly from a mean of 1.21 ml
(S.D.=0.11) to 1.05 ml (S.D.=0.14) with increasing head pressure (p<0.02). This
indicates the presence of shunting across the resistor during pumping which slightly
compromised pumping efficiency. This effect would become more pronounced with
increasing resistor flow rates. Based on these results the critical resistor diameter (or
flow rate) which would not compromise pumping efficiency during normal operation
can be calculated.
The mean stroke refill time increased from 3.7 sec (S.E.M.=1.16) to 4.7 sec
(S.E.M.=1.74). This change was not statistically significant (p=0.22). The refill time
of the AMS 800 pump bulb was less than 2 sec under all study conditions.
One pump (hexagonal symbol in Figure 15 and Figure 16) had a longer stroke
refill time. This was due to a combination of two factors: it had a soft bulb which did
not allow effective suction upon pumping and it also had a narrow inlet pathway on
the expander side which further impeded fluid flow.
The suction pressure of the AASP 2000 pump bulb with the expander side
occluded was studied in six pumps. The bulb created an average suction pressure of
345 mmHg (range = 285-390, S.E.M.=39.5) - Figure 17. The AMS pump specimen
studied, created a suction of >500 mmHg.
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Figure 17: Demonstration of suction created by the pump bulb. The bulb is
squeezed and the expander side tubing clamped and the bulb released. The
pressure inside the bulb is continuously measured.
The one way ball valve assembly
The pressure gradient across the ball valves was less than 2 mmHg. The
valves had a tendency to adhere onto the valve seat during the pumping action. This
resulted in pump malfunction due to blockage of the fluid path and could usually be
rectified by manually distorting the pump casing until the ball slipped off its seat.
The self sealing injection port
There was invariably visible fluid leakage from the previous puncture holes
upon application of pressure onto the bulb with the outlets clamped.
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The sphincter element
Figure 18 depicts the inflation pressure-volume relationship of the two
prototype expanders (cutout 1 mm and 3.5 mm: dimension a in Figure 3). The
inverse of the slope at each point of the curve represents the compliance of the
expander. The curve of the unit with a=3.5 mm is shifted to the right. Both curves
fit third order polynomial regressions as follows:
a=lmm ^ = 176-55i^ + 5.32'2-O.H^3 r2=0.996
a=3.5mm y/ = 76-25^ + 2.3/ - 0.05/ r2=0.996
VExpander (ml>
Figure 18: Pressure-volume relationship of the two prototype expanders with
cutouts of 1 mm and 3.5 mm.
229
The above changes are reflected in the total linear elevation of the expander
(dimension T2 in Figure 3). As it can be seen from Figure 19, for each inflation
volume, there is more linear expansion of the prototype with a 3.5 mm cutout
between the two elements of the expander.
Figure 19: Total linear elevation or expansion (dimension T2) of the two
prototype expanders versus inflation volume.
None of the other linear dimensions changed significantly between the two
expanders at the range of inflation volumes studied (Tji partial linear elevation, L:
length, W: width. Defined in Figure 3).
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In order to calculate the compliance of the prototypes, certain mathematical
manipulations had to be made. The slopes at each point of each curve in Figure 18
are defined by the equations obtained after differentiation of the two polynomial
regressions. The following equations are, therefore, obtained:
a=l mm ^- = -55+ 10.62"-0.422"2
d%
a=3.5mm = -25+ 4.62-0.152"2
d%
Note that the above equations are valid only for the range of the data that the
polynomial regressions show a high correlation (i.e. 6 to 18 ml for a=lmm and 8 to
24 ml for a=3.5mm). The above equations were solved and the data plotted in
Figure 20. As the y/ axis represents Pressure (P) and the x Volume (V), then dy//dx
represents dP/dV, i.e. the inverse of the compliance. Therefore, by plotting the
inverse of the y/ axis data from the plots in Figure 20, we can obtain an estimate of
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Figure 20: Plot of calculated slope of pressure-volume relationships of the two



























Figure 21: Plots of pressure versus volume relationships of the two expander
prototypes, superimposed on to the calculated compliance curves.
The calculated compliance is approximately 0.1 ml/mmHg for both expander
prototypes but, as can be seen from Figure 21, the increased cutout depth has allowed
the device to remain useable with the same compliance over a greater range of
inflation volumes (8->22 ml as opposed to 8-> 15 ml).
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Figure 22 and Figure 23 show the pressure-volume relationships of two
expanders used in the survival animal experiments at increasing expander/pillow
separations from 20 mm to infinity (no pillow). Expander "A" was a prototype
where the 3.5 mm cutout was set manually, whereas in expander "B" and subsequent
units this dimension was measured and accurately set. As expected, at similar
inflation volumes the pressure increases more rapidly with decreasing separation
between the two components. The shape of the curves at 22.5 and 25 mm closely
match that without the pillow and for expander "B" the two are identical.
VElp„d„(ml)




Figure 23: Pressure-volume relationship of expander "B" at increasing pillow
separations.
VExpander (ml)
Figure 24: Measurement of contact angle between the expander and pillow at
progressive inflation pressures.
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At approximately 5 ml inflation volume (22,5 mm and 25 mm original
separation), the expander just touches the pillow. The contact angle becomes more
acute as the inflation volume (and hence the pressure) is increased. The regressions
for the three sets of data are linear with excellent correlation (r = 0.97, 0.98 and 0.91
for 25 mm, 22.5 mm and 20 mm separation respectively). At inflation volumes
greater than 10 ml, more angulation is caused by the device at 22.5 and 25 mm
separation than at 20 mm.
Figure 25: Pressure inside expander "A" as a function of progressive inflation
at increasing pillow separations.
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Figure 26: Pressure inside expander "B" as a function of progressive inflation
at increasing pillow separations.
Figure 25 and Figure 26 present the results of the measurements of the
pressure inside the silicone gel pillow with increasing expander inflation. Pressure
inside the pillow began to increase at expander volumes of approximately 5 ml. The
increase becomes less pronounced with increasing separation of the expander and
pillow. This indicates that some pressure is dissipated by a "hammock" effect
created by the pillow.
The following diagram was constructed by generating data by a 3-D curve
fitting computer program to interpolate the points between the experimental pressure
measurements.
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Figure 27: Pressure distribution on porcine bowel placed under the expander
which was inflated to 40 mmHg. the straps were set at 22.5 mm separation as
for the in-vivo experiments.
The pressure under the expander is distributed evenly without any localized
high pressure points (Figure 27). Pressure transmission (operating occlusion
pressure) on to the central portion of the bowel is approximately 60% of the internal
expander hydraulic pressure.
There was no difference in the holdback pressure for water at bowel
angulations of 90° and 180°. Figure 28 shows the holdback characteristics of the
expander/pillow complex for semi-solid material. Holdback pressure enhancement is
observed, especially at low sphincter pressures. Even when the sphincter is not
inflated, a pressure of 36 mmHg has to be exerted before leakage is observed.
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Figure 28: Holdback of semi-solid material versus expander inflation pressure
for the AASP 2000.
The manually operated switch
In-vitro operation of the switch was satisfactory, and the presence of the thin
silicone casing did not interfere significantly with tactile feedback and manipulation
during activation and inactivation.
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Study 2: In-vivo assessment
The pressure regulating balloon reservoir
The pressure versus volume curves of the balloons at implantation and at
termination are plotted in Figure 29
Walloon (ml)
Figure 29: Comparison between the pressure versus volume curves of the
balloons at implantation and at termination. The data from one encapsulated
balloon are excluded.
The relationship is sigmoid as already demonstrated in-vitro. The rising slope
of the sigmoid begins at a volume of approximately 15 ml and the plateau is achieved
after 20-25 ml of inflation and maintained beyond inflation volumes of 50 ml. there
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is no statistically significant difference between the pre- and post- implantation data
(p=0.88).
In one animal the balloon became encapsulated due to the delayed onset of
chronic prosthesis infection secondary to a bullous skin condition. The inflation
characteristics of this balloon were analyzed separately and are shown in Figure 30.
Upon inflation, the balloon pressure increased along a sigmoid curve as before, but at
the expected plateau pressure and volume, the pressure continued to rise after only a
short plateau. This was due to stretching of the capsule, which ruptured at a balloon
volume of approximately 35 ml and pressure of 350 mmHg.
Walloon (ml>
Figure 30: Pressure-volume relationship of the balloon which became
encapsulated. The capsule becomes stretched after the balloon is inflated to 25




The operation of the control pump was unreliable and unsatisfactory. The
problems encountered can be classified as relating to the shutoff valve, the resistor,
the ball valves, the pump casing and injection port and the construction of the pump
control channels and are summarized in Table 1.
The shutoff valve consisted of a simple piston type valve. This was easily
displaced from its seat and caused inadvertent activation of the device leading to
colonic obstruction. Sometimes the valve became partially displaced and acted as an
unwanted one way mechanism that allowed flow from the balloon to the expander
once again causing intestinal obstruction.
The narrow single lumen of the resistor had the tendency to get blocked due
to corrosion (Figure 2) or debris left inside the casing during the manufacturing
process. In one case, the resistor became dislodged from its place and caused
intermittent obstruction by abutting onto the lateral wall of the pump casing.
In the ball valves there was a tendency to adhere onto the valve seat causing
obstruction. They were made with polypropylene in the earliest version of the pump
and it was initially thought that the adherence was due to electrostatic forces. They
were subsequently replaced with ruby balls but the problem persisted. On close
inspection through the pump casing under X2 magnification, it was demonstrated
that the balls were being lodged into the valve seat during pumping. This caused
distortion of the relatively soft silicone rubber which allowed the ball to become
firmly embedded in the outlet channel causing subsequent obstruction to flow.
The pump casing stiffness was subjectively inconsistent. The bulb was too
soft in at least two pumps which resulted in a decrease in suctioning efficiency.
Fracture of the pump casing causing leakage of fluid occurred in one animal.
Gradual fluid leakage necessitating replacement occurred on three occasions. Visible
fluid leakage from the impalement sites of the injection port was observed in all
explanted pumps.
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The manufacturing of the pump allowed small particles of silicone to remain
inside the voids and channels of the control mechanism casing. The presence of free
particles tended to cause resistor blockage. The presence of irregularities, especially
on the shutoff valve seat caused valve leakage.
The design of the casting of the control mechanism was also unsatisfactory.
This allowed the presence of very narrow, angulated and tortuous channels inside the
casing instead of direct fluid paths and caused impedance to flow. This was not the
case for the AMS 800 valve, which had wide, short and straight fluid flow pathways
(compare Figure 1 and Figure 2 with Figure 3 in Chapter 7).
Complication Number of episodes Animal IDs.
Shutoff valve malfunction 3,18,1,7,1,4,5,11,4,
15,4,2
2, 4,5,6, 7, 8,12,13,
15, 16, 19, 20
Resistor blocked 1, 13, 15, 19, 20
Resistor slow 7, 16
Resistor displaced 6
Ball valve malfunction 4,6
Casing fracture 5
Bulb too soft 2, 15, 16, 19
Fluid paths too narrow 4, 7,15
Table 1: Summary of pump complications.
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The sphincter element
Figure 31 shows a plot of the sphincter internal hydraulic pressure versus the
pressure measured at each inflation pressure by the pullthrough method (operating
occlusion pressure). The slope of the regression line represents the proportion of
transmission; this is approximately 60%.
PExpander (mmHg)
Figure 31: The proportion of pressure transmitted from the sphincter onto the
bowel was 60%.
The pressure inside the sphincter increased more rapidly at similar inflation
volumes at termination (Figure 32). This indicates that the compliance of the system
decreased after implantation. This difference was statistically significant (pO.OOOl).
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Figure 32: Plot of expander pressure-volume curves at implantation (solid
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Figure 33: Plot of pressure-volume curves of the whole system (balloon, pump,
expander in-situ) at implantation (solid symbols) and at termination (open
symbols).
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The pressure-volume relationship of the whole system at implantation and at
termination is shown in Figure 33. There was no statistically significant difference
between the data at implantation and at termination (p=0.46). The shape of the
curves is sigmoidal and the plateau is at 100 mmHg. The rising slope of the sigmoid
is at approximately 20 ml and the plateau begins at approximately 40 ml. These
curves appear shifted to the right as compared to those of the balloon. There was no
statistically significant difference between the pressure-volume relationship of the












Table 2: Comparison between the non-encapsulated balloon and whole system
pressure-volume relationships pre and post implantation.
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The manually operated switch
Six animals had these devices implanted. The malfunction was discovered
after activation was attempted for a control animal which had been deactivated for a
prolonged period. This was due to the creation of vacuum inside the silicone casing
of the switch when air was reabsorbed by diffusion due to a concentration gradient
between it and the tissues. This created a force which collapsed the casing on to the
switching element causing unwanted activation. Because of the collapsed casing, the
switch could not be deactivated and became unusable (Figure 34). The pressure
inside the casing was found to be -60 mmHg. Inadvertent activation occurred after as
little as 9 days in one instance. Repeated measurements with time were made in two
switches and the results appear in Figure 35. Use of this component was, therefore,
abandoned and it was not developed further.
Figure 34: Unwanted activation of the hydraulic switch following absorption of
air from the inside of the silicone casing. This creates a vacuum and collapses
the casing onto the switch element.
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Two pressure regulating balloon prototypes were evaluated in-vitro: one
manufactured by five and the other by six consecutive "dips" into molten silicone.
The pressure-volume relationships of both consisted of sigmoidal curves reaching a
prolonged plateau and showed hysteresis between the inflation and deflation phases.
This is a well recognized property of silicone elastomers and it is utilized in artificial
sphincter designs to provide pressure regulation below a chosen safe maximum level.
The plateau pressure of the "5-dip" balloon was approximately 72 mmHg and this
was thought to be appropriate for the animal experiments. As the amount of atrophy
expected was not known in advance, it was decided to use the "6-dip" balloon
(plateau = 100 mmHg) set at 60-70 mmHg operating pressure. This had the
disadvantage of relying on a critical volume to maintain the operating pressure. It
did, however, offer the possibility to increase the operating pressure to a higher level
if required by injecting fluid into the system. Based on the survival animal data
(Chapter 6) and the results of the blood flow experiments (Chapter 8), it is
anticipated that the 72 mmHg balloon will be used in the preliminary human studies.
This level is compatible with previously reported levels of pressure that can be safely
applied onto the bowel in animals11'12 and humans9. The mechanical properties of
the balloon did not change during the implantation period (Figure 29, Table 2) unless
it became encapsulated (Figure 30). This occurred only in the presence of chronic
infection. The balloon also maintained pressure regulation for the whole system
during implantation (Figure 33), despite encapsulation of the expander with
consequent decrease in the compliance of that component (Figure 32). The
differences of the above data are normally distributed so it is reasonable to compare
them with the t test. Even though non-parametric methods exist to assess the
stochastic dominance of each curve and statistically compare them, the fact that the
balloon and system sigmoid plots are visually overlapping and the unpaired t tests
show no statistically significant differences strongly suggests that, if these tests were
employed, the results would support the above conclusion.
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The control pump used for these experiments was manufactured specifically
for this study on a small scale using non-specialized tooling and materials. This fact
has taken its toll on function and reliability both in the short and long term. The
design of the casing of the control mechanism is outlined in Appendix 3. This
allowed the presence of very narrow, angulated and tortuous channels inside the
casing instead of direct fluid paths and caused impedance to flow. There was a
significant pressure gradient across the fluid outlet pathway on the balloon side of the
pump (>25 mmHg, Figure 12) which appeared to be due to the narrow and angulated
fluid passageways as the pressure gradient across the ball valve is less than 2 mmHg.
This was not the case for the AMS 800 valve, which had wide, short and straight
fluid flow pathways (compare Figure 1 and Figure 2 with Figure 3 in Chapter 7).
The ball valves were susceptible to "valve-lock" during operation. This was due to a
soft valve seat which allowed the ball to become lodged inside it during the pumping
action. A specially hardened valve seat is incorporated in the AMS device13'14 which
did not suffer from this problem.
The shutoff valve consisted of a simple piston type arrangement as already
discussed as opposed to its "waisted" barrel shaped counterpart in the AMS design.
The valve travel of the AMS valve was also three times greater (Figure 2, Figure 3 in
Chapter 7). These features offered increased reliability as indicated by the higher and
more consistent unseating pressure of the AMS shutoff valve (Figure 9 - Figure 11).
The fit of the shutoff valve inside its channel in the AASP 2000 must have been
imperfect and allowed lateral movement which in many cases only allowed the valve
to partially open. This created a one-way flow effect which caused partial
obstruction sometimes in the direction of flow to the balloon and sometimes in the
direction of flow towards the expander. The former caused colonic obstruction as the
expander could not empty and the latter incontinence.
The presence of the fluid equilibrating resistor seemed to compromise
pumping efficiency in both designs as it allowed some fluid to shunt into the
expander during refilling of the pump bulb. The bulb of the AMS pump was made of
stiffer material than that of the AASP which allowed it to create a greater suction and
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have a faster bulb refill time. The diameter of this resistive channel is, therefore,
critical. A single channel of 0.15-0.2 mm was used in the AASP design which
produced an automatic re-occlusion time of approximately 5 minutes under ideal
experimental conditions. This channel, however, had the tendency to block by debris
left in the pump during the manufacturing process or stenose due to corrosion. AMS
used a porous glass material13'14 of high composite connectivity (Appendix 1) which
was much less susceptible to blockage by small particulate debris. This material,
however, is susceptible to a different complication: if a gas bubble reaches the edge
15-17of the material, a high electrostatic field is created at the gas/fluid/solid interface " .
This would denature any traces of proteinaceous material that might have been
inadvertently introduced into the system fluid, cause crystallization of the contrast
material at the interface and change the surface properties of the glass material. The
above combination of effects would cause gradual deterioration, effectively causing
stenosis and blockage of the resistor.
The advantage of having a resistor is that it provides automatic re-occlusion
with no extra operations by the patient. This is especially useful in the control of
micturition. Automatic re-occlusion, however, may not allow for complete bladder
emptying in some cases if the 3-5 minute total re-occlusion time is less than the
required voiding time. Even if the required voiding time was the same as the re-
occlusion time, complete bladder emptying could still fail: when the sphincter is first
deactivated urine will flow from the bladder to the outside across a high pressure
gradient (Pressure gradient for urine flow = Bladder pressure - Sphincter pressure).
Throughout the duration of micturition the bladder pressure will be decreasing and
the sphincter hydraulic pressure increasing exponentially. Towards the end of
micturition this pressure gradient will be severely reduced and, unless the bladder is
completely emptied during the earlier part of the sphincter automatic re-occlusion
period, a significant residual volume will remain inside it. Even an automatic re-
occlusion time of 10 minutes would almost certainly not maintain the sphincter
deactivated for long enough to allow bowel evacuation to be completed during
evacuation, especially in the presence of semi-solid stool and bowel angulation
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(Chapter 1). In addition, a higher re-occlusion time would require an effectively
narrower resistor channel, which would have a greater chance of blockage. The
AMS 800 pump characteristics, therefore, are not suitable to control an anal sphincter
18
and the design of a new pump which circumvents these problems is being patented
and will be discussed at the end of this thesis.
The device presented attempts to circumvent the problem of bowel ischaemia
by introducing angulation of the bowel in order to decrease the pressure required to
achieve continence (Chapter 1) and by applying this pressure in a gentle way to avoid
the creation of localized high pressure points. By employing a linear expander gently
flattening the bowel against a silicone filled pillow, a "hammock" effect is created on
either side of the occluded bowel. This evenly distributes the occluding pressure
(Figure 27) without the creation of single high pressure points (Chapter 4) and
without "crenation" of the bowel which can be caused if a circular cuff was used9.
The creation of the hammock effect is important as it is well established
mathematically that if the contact surface between two pressurised chambers is
distorted (e.g. folded sphincter cuff), the hammock effect disappears at the contact
point. Under these conditions, all of the internal pressure of the system would be
applied at that point (e.g. the apex of the cuff fold. See also Chapter 4). Holdback
pressure enhancement by angulation of the bowel is obtained for semi-solid material,
especially at low sphincter pressures (Figure 28). The results of this experiment are
different to those for the circular cuff (Chapter 1: Figure 9), in that the holdback
pressure does not increase exponentially with increasing inflation pressure. The
latter effect is probably due to a combination of angulation and constriction
introduced by the relatively narrow cuff (the lumen of the uninflated cuff had a radius
of 11.9 mm, whereas the calculated flow through the AASP neosphincter would be
equivalent to that through a circular orifice with 14.6 mm radius, see Appendix 1).
Since resistance to flow is proportional to the fourth power of the radius of the
conduit, the above parameters indicate that the resistance to flow would be 2.26 times
greater through the circular cuff than the AASP 2000.
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Extensive in-vitro studies were performed in order to determine the best
geometry of the expander to ensure operation over a wide range of inflation volumes.
This feature would be required to achieve the control of a sufficiently large lumen to
allow the passage of bulky stool. The multiple compartment/concertina type of
arrangement was employed to allow sufficient linear expansion for this to occur
(Figure 3, Figure 19). The sphincter width was also chosen to closely resemble the
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length of the human anal canal high pressure zone .
A series of mathematical manipulations were applied to indirectly calculate
the compliance of the expander prototypes (Figure 20, Figure 21) based on their
pressure-volume relationships. The calculated compliance is approximately 0.1
ml/mmHg for both expander prototypes but, as can be seen from Figure 21, the
prototype with an increased cutout depth between the two elements of the concertina
has allowed the device to remain useable with the same compliance over a greater
range of inflation volumes (8->22 ml as opposed to 8->15 ml). An apparent
paradoxical behaviour of the expander compliance at the limits of the operating
inflation volume range is shown in this figure. This represents a flaw in the
mathematical analysis which was plotted deliberately to discuss this point and should
be ignored. The smooth part of the compliance curves corresponds to the range of
volumes for which the pressure-volume data for each expander closely fit a third
order polynomial regression. The paradox, therefore, occurs at the limits of this
range and simply plots the inverse of the slopes of the polynomial equations and is of
no relevance to the behaviour of the expander.
The pressure-volume characteristics of the expander were studied while it was
attached to the pillow, at different levels of separation between the two. The
separation was standardized by interposing specially constructed cylindrical sizers
(diameter 20, 22.5 and 25 mm) between the expander and the pillow. The shape of
the curves at 22.5 and 25 mm closely match that without the pillow (Figure 22,
Figure 23) and in expander "B" the two are identical (Figure 23), indicating that the
expander with a 3.5 mm cutout will operate under optimal conditions at a separation
of 22.5 and 25 mm. At both these separations, a more acute contact angle was
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achieved. This is a reflection of the difference of the shape of the apex of the
expander at the moment it abuts onto the pillow at different degrees of separation.
Creation of a contact angle is, therefore, another desirable feature of this device. The
lumen created when the two components were separated by 20 mm was too small,
whereas the whole system was too floppy at 25 mm and allowed displacement
between the expander and the pillow to occur readily. A separation of 22.5 mm,
therefore, appeared to be the best compromise and the two components were
calibrated using the 22.5 mm sizer for all the in-vivo survival experiments. In
mathematical terms, this was equivalent to fluid flow through a circular orifice of 29
mm diameter (Appendix 1).
Not all of the sphincter hydraulic pressure was transmitted onto the bowel
wall, as part of it was dissipated to overcome the elastic properties of the expander:
under the conditions described, approximately 60% of the expander internal
hydraulic pressure was transmitted onto the bowel (Figure 31), which is similar to
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previously reported transmission factors for the circular cuff device (0.57 , 0.6-
0.811'12, 0.7621).
The risk of ischemic complications would be expected to increase with
increases of sphincteric occlusion pressure beyond a safe maximum; in fact, the
22
number of revisions in a large series where the AMS circular cuff was assessed was
proportional to the balloon pressure employed and increased once balloons of
plateaus >70 cm H20 (52 mmHg) were used. For all the above reasons, the setting of
this pressure is one of the most critical factors of the preliminary assessment of the
device.
Much of our knowledge on pressure tolerance of tissue placed beneath
• J J 12 23
artificial sphincters come from the studies of Engelmann and his group ' ' on the
23 11
AMS 800 device. This was implanted around intestinal loops in 22 and 40 New
Zealand rabbits to evaluate its possible use for continent urinary diversion. This
evaluation included the effects of varying closing pressures of the cuff on these
isolated bowel loops. Sphincter-related complications (infection, erosion and
253
atrophy of bowel beneath the cuff) were pressure dependent and seen mainly in high
pressure groups. In a canine model (n=24), balloon pressures of 70 to 80 cmH20
12
were well tolerated by the bowel for up to 29 weeks with no evidence of erosion .
The human sigmoid colon tolerates 70 cmH20 (52 mmHg) whereas ischasmic
9 12
erosion occurred at balloon pressures of 81-90 cmH20 ' (60-66 mmHg). The actual
pressure applied on the tissues is even lower as only part of the cuff pressure can be
transmitted. This is of the order of 60% to 80%.11,12'20'21'24'25. The novel design
features of the AASP described above should allow it to be set at an operating
occlusion pressure of approximately 40 mmHg (balloon pressure 70 mmHg,
transmission factor 60%). The experimental results presented in this thesis suggest
that this would be a safe choice in the minipig (Chapter 6) and humans (Chapter 8).
At present, the device is undergoing reliability testing by specially designed
cycling equipment and also accelerated aging in a high temperature oven prior to a
pilot study in human patients.
This artificial anal neosphincter appears to fulfill the required design criteria
set at the beginning of the development process. The future development of the
device would entail the design of a new and reliable control pump. Such a device,
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The pressure distribution in the lumen of porcine bowel surrounded by a
circular cuff was studied in an in-vitro model. The cuff occluded the lumen by the
creation of a "triple cushion" effect. Directional variation of the pressure distribution
inside the cuff lumen was demonstrated. In addition, the pressure was found to be
disproportionately higher inside the cuff folds than in the center of the lumen. This
could potentially cause crenation of bowel inside these folds and result in ischasmia.
The retention properties of such a cuff placed around the colon were studied
for liquid, semi-solid and gas at different bowel angulations in a non-survival in-vivo
porcine model. It was found that angle appeared to enhance the holdback of semi¬
solids but not of liquid or gas. Blood flow to the compressed colon was assessed by
a Laser Doppler probe and was found to decrease at a higher rate than that of the
increase in applied occlusion pressure.
The anatomical positioning of the AASP 2000 artificial Neosphincter was
also assessed in preparation for the survival experiments.
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Introduction
The results of the in-vitro experiments and theoretical analyses of fluid flow
and holdback that were presented so far (Chapter 1, Appendix 1), indicate that the
inclusion of angulation would allow an artificial anal sphincter to be set at a lower
operating pressure yet still achieve continence of semi solids.
It has been reported1 that the pressure distribution inside the lumen of the
urethra surrounded by an inflatable cuff sphincter, shows no directional variability
and such a sphincter has been used successfully for the control of urinary
incontinence (see previous section). A modified urethral sphincter cuff has been
implanted around bowel and has been assessed for the control of fecal incontinence
in animal models2"4 and in humans5"9. The above results and also the results of the
9-21
implantation of this device around bowel segments for other reasons " indicate that
bowel is less tolerant to circumferential pressure application than the urethra.
In this set of experiments, the effectiveness of a similar circular cuff sphincter
was assessed in-situ in an acute non-survival porcine model. The pressure
distribution inside the cuff lumen was plotted in order to compare it with previously
reported experiments for the urethra1. The effect of increasing occlusion pressure on
colonic blood flow was also assessed by the Laser Doppler method.
Finally, the anatomical placement of the AASP 2000 Neosphincter prototype
was studied in preparation for the survival animal experiments.
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Materials and Methods
ln-vitro and in-vivo measurements of intraluminal pressure and the effects of
stool consistency and angulation:
Study la: In-vitro measurement of intraluminalpressure distribution in the
circular cuff
Segments of porcine intestine were placed in a specially designed mechanical
jig (see Chapter 1) and a circular sphincter (AMS cuff 75 mm circumference, 15 mm
width) was placed around the bowel. A catheter tipped microtransducer (Gaeltec
CTU1) was inserted into the lumen of the bowel proximal to the cuff through a small
incision and fixed in place by a purse-string suture. The device was inflated by
injecting water and the cuff pressure (PCuff) measured by a solid state pressure
transducer (Baxter Uniflow, model DPT). Upon inflation, the bowel lumen was
occluded by the creation of a "triple cushion" effect (Figure 1). Another catheter
tipped microtransducer was then placed in the center of the cuff lumen and rotated by
360° while the pressure was continuously recorded (Figure 2).
Water was infused into the bowel at a rate of 1 ml/min and the pressure at
which leakage was observed through the sphincter was noted (P^ak)- At each
inflation pressure, a catheter tipped microtransducer was placed inside the cuff fold






Figure 1: Occlusion of the bowel lumen by a circular cuff. Upon inflation, a
"triple cushion" effect is created which compresses the bowel to close the lumen.
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Study lb: Itt-vivo assessment ofthe circular cuffsphincter
A circular cuff sphincter (width 22 mm) has been tested in a study of 6 female
minipigs. Each animal was given a premedication dose of Atropine Sulphate
0.04 mg/kg and Azaperone (Crow Chemical Co. Ltd) 0.2 ml/kg intramuscularly.
Anaesthesia was induced and maintained with Halothane (5% and 1-2%
respectively) via an endotracheal tube. The peritoneal cavity was approached via a
mid-line incision and the rectum was mobilized. The circular cuff was placed snug
around the lower rectum through a mesenteric window.
The cuff was then inflated with water and the pressure inside it measured with
a pressure transducer (Baxter Uniflow model DPT). At each inflation pressure, the
intraluminal bowel pressure was measured by a catheter tipped transducer (Type
CTU1 Gaeltec Ltd, Isle of Skye) using the station pullthrough technique. The active
surface of the transducer was orientated onto the dome of the cuff cushion.
The bowel proximal to the cuff was then filled with either air, saline or semi¬
solid material (faeces, toothpaste or a mixture of oatmeal, KY jelly and calamine
lotion in water to achieve a paste of "soft" or "hard" consistency - see Appendix 4).
Pressure was applied manually on to the proximal bowel until the gas, liquid or solid
just leaked through the cuff sphincter. The pressure at which leakage occurred was
measured by a catheter tipped microtransducer secured inside the lumen of the
proximal bowel by a purse-string suture. This procedure was performed at no bowel
angulation (180°) and repeated at various degrees of angulation of the bowel at the
site of the cuff (90°, 135°).
Study 2: Measurement of blood flow
The working principle of Laser Doppler flowmetry has previously been
22-25described in detail " . In this study we used the PeriFlux PF2 Helium-Neon Laser
unit (Perimed Ltd, Sweden) with the following characteristics: wavelength 632.8 nm,
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probe light output 1 mW, fiber diameter/separation 0.7/0.7 mm (one emitting and
two receiving fibers), measurement radius 1 mm, frequency shift limit 12 KHz, gain
setting xlO, time constant 3 s. A specially made flanged probe was used which
rested on the bowel with minimal application of pressure.
Six adult female pigs were used. The probe was placed on the colon just
distal to the expander avoiding the taenia coli and a reading was taken once steady
state conditions were reached as determined by the presence of a pulsatile flow signal
and a steady reflected signal. The colon distal to the sphincter was divided in four
animals and left in-situ in the other two. The measurements were repeated with
progressive inflation of the cuff. At each cuff inflation pressure, the operating
occlusion pressure on the bowel was determined by measuring the intraluminal
pressure by a catheter tipped microtransducer (Gaeltec, CTU1) using the station
pullthrough technique. Blood flow values were given in relative perfusion units (V
xlO) and these were correlated with the measured operating occlusion pressure.
Study 3: Anatomical positioning of the AASP 2000 prototypes
Five adult female animals were used in this preliminary study. Under
halothane anaesthesia, an infra-umbilical midline laparotomy was performed. The
small bowel and uterine horns were retracted and the descending colon/rectum
delivered into the wound. The AASP 2000 prototype was placed as low in the pelvis
as possible. In two animals the placement of the expander or pillow through a
window of the colonic mesentery was studied. In another animal, rehearsal
implantation of the whole system was performed. In the last two animals, the whole
system was implanted and its operation was assessed as follows: the expander was
passed through a small window in the rectal mesentery and the pillow attached
anteriorly by the securing straps. The expander was progressively inflated with water
in a stepwise manner and the system pressure measured by a solid state transducer
(Baxter Uniflow model DPT). The operating occlusion pressure was measured by
the station pullthrough technique as above. The bowel was then transected
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approximately 5 cm distal to the Neosphincter and a catheter tipped microtransducer
was placed into the lumen proximal to the sphincter through a small incision and
secured with a purse-string suture. The proximal bowel was filled with either saline
or toothpaste and the sphincter activated. Pressure was applied manually on to the
proximal bowel until the liquid or solid just leaked through the Neosphincter. The




The vital statistics of the animals are summarized in Table 1.
S.D.
BP (sys/diast, mmHg) 82/51 6.7/5.4
Bowel width (mm) 38.7 4.8
Bowel thickness (mm) 1.45 0.5
Table 1: Vital-statistics of animals used in the acute experiments.
Study la:
The pressure distribution inside the cuff lumen was heterogeneous (Figure 2):
it varied according to the angular orientation of the microtransducer and the peaks
corresponded to the domes of the cuff cushions (Figure 1). The leakage pressure was
approximately 49% of the cuff pressure (transmission factor = 0.49, Figure 3). The
transmission factor inside the angle between the cuff cushions increased rapidly with
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Figure 2: Pressure inside the lumen of bowel surrounded by a circular cuff
sphincter as a function of angular orientation of the pressure measuring
transducer. Peaks of pressure correspond to the sites of the cuff cushion domes.
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pcuff (mmHg)
Figure 3: Plot of cuff inflation pressure versus holdback pressure for liquid
(PLeak) or pressure inside the angle between the cuff cushions (PAngie) circular
sphincter.
Study lb:
Approximately 80% of the cuff pressure was transmitted onto the bowel wall
at the sites of the cuff cushion domes (transmission factor = 0.79, represented by the
slope of the regression line in Figure 4).
The transmission factor for holdback of liquid at 180°, i.e. no bowel
angulation (Figure 5) was virtually the same in the in-vitro and in-vivo studies (0.49
and 0.47 respectively). There was no difference in the holdback characteristics of
bowel at 180°, 135° or 90° (Figure 6, Table 2).
The transmission factor for holdback of gas was <0.20 in all animals and at
all angulations with no statistically significant difference between the presence or
absence of angulation (p=0.35).
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As the semi-solid substance used in the experiments was not standardised,
meaningful comparison between the different animals is not possible. The following
generalization can, however, be made: for all semi-solids tested, leakage occurred at
a higher intraluminal pressure for any given cuff inflation pressure and the presence
of bowel angulation appears to enhance this phenomenon even further.
Figure 4: Operating occlusion pressure (Ppunthrough) in porcine bowel as a
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Figure 5: Plot of cuff inflation pressure versus holdback pressure of circular
sphincter for liquid (PLeak) without bowel angulation.
pc„ff (mmHg)
Figure 6: Plot of cuff inflation pressure versus holdback pressure of circular
sphincter for liquid (PLeak) at no bowel angulation (180°) and angulations of
135° and 90°.
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Bowel Angulation Transmission factor
2
r
00 o o 0.47* 0.75
135° 0.48 0.42
oo 0.57* 0.55
All data 0.47 0.53
Table 2: Transmission factors for holdback of liquid in bowel by circular cuff
sphincter. *: p=0.22.
Study 2:
The baseline blood flow was 111.2 (S.D.=51.5) relative perfusion units
(RPU's). As the baseline blood flow range was wide (Figure 7), the standardised




Figure 7: Blood flow in the six animals studied versus increasing cuff inflation
pressure.
ppu«h,oU9h (mmH9)
Figure 8: Blood flow in the six animals as a percentage of baseline flow versus
increasing cuff inflation pressure.
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Blood flow decreased with increasing cuff inflation pressure in four animals,
but showed a paradoxical increase in another two (r =0.30, slope= -0.87 shown in
Figure 8). In these two animals, the distal colon was not divided. If these two
animals are excluded from the analysis, the correlation becomes stronger without
affecting the slope of the regression line which represents the rate of decrease of
blood flow at increasing cuff inflation pressure (r =0.51, slope=-0.84 shown in
Figure 9). Overall, when the cuff inflation pressure was increased, the blood flow
decreased at almost the same rate (-0.84) as the rate of increase in the operating
occlusion pressure (0.79, Figure 4).
Ppumhrough (mmHg)
Figure 9: Blood flow as a percentage of baseline flow in the four animals in




Once the anatomical placement of the device was established in the first three
minipigs, the holdback pressure characteristics of the AASP 2000 prototype were
studied without bowel angulation in a further two animals by using the same
methodology as that in Study lb above.
The expander pressure transmission factor for liquid was virtually identical
when studied by the station pullthrough method or by measuring the holdback
pressure (0.48 and 0.45 respectively, Figure 10). Holdback pressure was also slightly
greater for semi-solid material (toothpaste).
0 20 40 60 80 100 120 140
PExpander (mmHg)
Figure 10: Fluid retention characteristics of bowel with Neosphincter prototype.
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Discussion
In this set of experiments, the disadvantages of the circular cuff sphincter
have been demonstrated. The pressure distribution inside the cuff lumen is not even:
localized areas of high pressure exist at the domes of the cuff cushions and also
inside the cuff folds. It has been reported1 that the pressure distribution inside the
lumen of the urethra surrounded by an inflatable cuff sphincter, shows no directional
variability. This was not shown to be the case for bowel in this study. This may be
due to the fact that variations of external pressure can be measured more readily
through the thinner bowel wall, but it is more likely that the relatively crude
perfusion catheter used by Blok and his co-workers1 was neither sensitive nor
selective enough to detect the changes in pressure distribution. The risk of ischaemia
may be increased as the triangular lumen of the circular cuff may cause crenation of
the thin wall of the bowel into the high pressure zones of the cuff folds16. It is well
established from engineering analysis of the "hammock effect", which is created
when two compliant pressurized surfaces abut on one another, that if a point of
disruption of the smooth contour of an inflatable element exists (e.g. the apex of the
• • • • • 26cuff fold in this case) the pressure inside this element is reflected into the lumen .
This was confirmed in this study by the fact that pressure transmission inside the cuff
fold approached 100%.
As it is well demonstrated that the bowel is not tolerant to the application of
excessive circumferential occlusion pressure2"4'9"21, the even distribution of
intraluminal pressure afforded by the AASP 2000 Neosphincter represents a definite
design advantage.
A sphincteric effect based on the creation of the "triple cushion" effect has
another disadvantage when used to occlude the bowel lumen. As the thin bowel wall
cannot buffer a heterogeneous pressure distribution, low pressure zones are
interposed between high pressure areas and this, combined with the poor fluid sealing
properties of the bowel mucosal surface, increases the chance of fluid leakage
through these low pressure paths. This is reflected by the fact that the operating
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occlusion pressure measured at the cuff cushion domes is much greater than the
holdback pressure for liquid at the same cuff inflation pressure (transmission factors
of 0.79 and 0.47 respectively). The AASP 2000 does not appear to suffer from this
disadvantage because the pressure distribution inside its lumen is even (Chapter 3)
and the transmission factors for the operating occlusion pressure and holdback
pressure versus expander pressure are almost identical (0.48 and 0.45 respectively).
Another advantage of this design is that the transmission factor can be set to a
required level by adjusting the slack of the securing straps of the expander (see
Chapter 3, Chapter 6 and Appendix 3).
The effect of angulation was as expected and followed the principles
demonstrated in Chapter 1. There was no difference in the retention properties for air
or water between angled and straight bowel, whereas angulation seemed to enhance
the retention of semi-solids. No quantitative comparisons for semi-solid holdback
can be made due to the heterogeneity of the substances tried (Appendix 4). For this
reason, a standard gel simulating faeces was designed (Appendix 2) and evaluated
(Chapter 1).
The blood flow in the colon was measured by Laser Doppler flowmetry. The
22 25
working principle of this method has previously been described in detail " . The
technique has been used to assess gastrointestinal blood flow in animals27"34 and
humans33'35"43 and was shown to have a measuring depth of 6 mm in human
colon44'45, i.e. transmural measurements are obtained. A review of this technique and
its evolution will appear in Chapter 8. The equipment available has the disadvantage
of measuring blood flow in a very small volume of tissue and in addition it is very
sensitive to movement artefacts, hence the wide variation of baseline blood flow
reading. A new method of blood flow measurement which does not have the
disadvantages of the static Laser single point method used here will be described in
Chapter 8.
For the above reasons, the blood flow decrease was standardised for all
animals by measuring the percentage compared to the baseline flow value for each
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occlusion pressure. When the cuff inflation pressure was increased, the blood flow
decreased at almost the same rate as the rate of increase in the operating occlusion
pressure (-0.84 % per mmHg occlusion pressure and 0.79 mmHg occlusion pressure
per mmHg cuff inflation pressure respectively). It has been shown in this study,
however, that the operating occlusion pressure is not a true representation of the
efficacy of retention of liquid by a circular cuff sphincter. In this case, the relevant
transmission factor is 0.47 mmHg holdback pressure per mmHg cuff inflation
pressure. This means that when a circular cuff is used as a sphincter around bowel, it
causes a disproportionately higher decrease in blood flow for a modest increase in
holdback pressure.
Following the above discussion and the design analysis of the AASP 2000
outlined so far, it seems that this device has definite advantages over a circular cuff
sphincter and its assessment in survival animal experiments and in human volunteers
will be described in the subsequent chapters of this thesis.
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In this experiment, the bowel transit time of the Yucatan minipig was studied
in three of our experimental animals using the radioopaque marker and chromic
oxide ingestion methods. Both methods had drawbacks and these are discussed. The
latter was less disruptive, but was only suitable to determine the mouth to anus time.
The mouth to anus time was less than 24 hours. Within the limitations of small
number of animals in the radioopaque marker study, the mean colonic transit time
was found to be of the order of 28 hours; the presence of the deactivated neosphincter
did not appear to influence the transit time.
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Introduction
Measuring colonic transit time can be of value in the investigation of patients
with slow transit constipation. Transit can be measured by ingesting a number of
radioopaque markers and obtaining an abdominal X-ray every day to count the
number and distribution of the remaining markers in the colon1. Segmental and total
• 12*
colonic transit time can thus be estimated. This was found to be variable ' , but it
has been reported that in normal people most of the markers (80%) should be
expelled by the fifth day1.
The transit time was studied in the experimental animals in order to establish
its length and also to determine whether it is affected by the presence of the
neosphincter. It was not possible to X-ray the animals daily, as a general anaesthetic
or heavy sedation was required each time an X-ray was taken. A simplified method
was, therefore, attempted whereby three different markers were administered one on
each day, and an X-ray taken on the fourth day . The mouth to anus time was also
assessed using the chromic oxide ingestion/excretion method4.
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Materials and Methods
The radiological and chromic oxide studies were performed simultaneously in
order to minimize intra-animal variations and also avoid the potential interference of
the administration of a general anaesthetic to the transit time.
Radioopaque marker study
Three kinds of radioopaque markers were used: lead shot, nylon rings and
Teflon rods measuring approximately two to four millimeters. The study animal
received 20 markers each day mixed with food. One kind was given on each day.
The animal was then anaesthetised on the fourth day (technique described in Chapter
6) and a plain X-ray of the abdomen obtained (Figure 1, Figure 2). The number of
remaining markers were counted and the mean colonic transit time (MCT) was
calculated by the formula :
MCT= 1.2x(N1+N2+N3)
Where N].3 are the numbers of each type of marker remaining in the abdomen.
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Figure 1: Radioopaque marker study in non-operated animal. Twenty markers
were given on each day for three days. X-ray taken on fourth day.
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Figure 2: Radioopaque marker study in animal with deactivated prosthesis.
The study was performed twice on three animals. One of the animals had no
operation, the second had a deactivated device in-situ and the third animal was
studied on separate occasions when the sphincter was activated and deactivated.
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Chromic oxide ingestion study4
1 or 10 grams of chromic oxide were mixed with a small amount of wet diet
and then added to the morning feed. 50 grams of fresh faeces were collected
approximately every two hours following feeding of the marker powder until 17:00
and again the next day. Gloves and masks were worn whenever the chromium
powder or feces were handled.
The following reagents were prepared and used for the analysis:
- Phosphoric Acid - Manganese Sulphate Solution:
30 ml 10% w/v MnS04.4H20 solution in 1 liter 85% H3P04
- Potassium Bromate Solution:
4.5% w/v
- Calcium Chloride Solution:
109.32g CaCl2 . 6H20 made up to 1 liter
- Stock Silicate Solution:
2.78g Na2Si03. 5H20 made up to 1 liter
- Stock Chromium Solution:
2.8285g K2Cr207 made up to 1 liter (1 mg/ml)
The feces were prepared for analysis as follows: a fecal sample was
dehydrated and ground. 0.5g of dried ground sample was ashed at 600° for 1 lA hours
and then cooled. 1.5 ml H3P04 - MnS04 solution and 2 ml KBr03 was then added,
the sample covered with a watch glass and digested on sandbath until effervescence
stopped and a purple colour appeared. The solution was cooled and filtered and
made up to 100 ml in a volumetric flask containing 2.5 ml CaCl2 and 5 ml Silicate
solutions.
An Atomic Absorption Spectrophotometer, Perkin Elmer 2380, (Perkin Elmer
Ltd., Post Office Lane, Beaconsfield, Bucks, HP9 1QA) was used to measure the
absorption of chromium at a wavelength of 340 nm. An absorption curve was drawn
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from the absorption of standard solutions. Each standard solution contained the
following:
- 3 ml H3PO4 . MnS04 solution
- 4 ml KBr03 solution
- 5 ml CaCl2 solution
- 10 ml Na2Si03 solution and
- 0, 0.5, 1.0, 1.5, 2.0, 2.5, 3.0 or 4.0 ml of Chromium solution.
Each mixture was then made up to a total volume of 200 ml. The resulting standard
solutions contained Chromium at concentrations of:
0, 2.5, 5.0, 7.5, 10.0, 12.5, 15.0 and 20.0 /ig/ml.
The Atomic Absorption was read at 340 nm and the chromium concentration
determined from the graph made from the above standard solutions.
Calculation:
Let X = reading in /j.g/ml:
X(/sg / ml) x l00ml(totalvolume) y \000(g / kg) 1
1000(jug / mg) \000(mglg) weight(g)





The study was performed on the same three animals. Two had no operation
and the third had a deactivated device in-situ. The study was performed four times in
the first animal (twice using lg and twice using lOg of chromic oxide), twice in the
second animal (using lg of chromic oxide) and once in the third (using lOg of














#20 no-operation no-operation no-operation
#20 no-operation no-operation no-operation
Table 1: Summary of the experimental animal details.
Results
Radioopaque marker study
The results of this study are summarized in Table 2. It appears that activation
of the sphincter prolongs the transit time, but its mere presence does not. Statistical
analysis is not possible due to the small number of animals. Counting of the markers
was not possible on one occasion because the animal chewed the markers (Figure 3).






#16 deactivated 24 28.8
#16 activated 36 43.2
#19 deactivated * *
#19 deactivated 12 13.6
#20 no-operation 18 21.6
#20 no-operation 30 36
Table 2: Summary of the results of radioopaque marker transit study. In one
instance (*) the estimation was impossible as the animal chewed the markers.
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Figure 3: Markers disrupted by chewing on one occasion.
Chromic oxide ingestion study
The results of the chromic oxide ingestion transit studies are summarized in
Figure 4 to Figure 7. Traces of chromium are detected in the stool within the first
few hours and then the concentration declines. The concentration of chromium in the
stools rises once again after approximately 20-24 hours in all animals and remains
elevated at 30 hours. It also remained elevated at 50-55 hours in the two animals
studied (Figure 5, Figure 7).
Figure 4: Unoperated animal (#20). Chromic oxide (lg) study on two occasions.
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Figure 5: Unoperated animal (#20) Chromic oxide (lOg) study.
Figure 6: Unoperated animal (#19) Chromic oxide (lg) study.
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Time (hours)
Figure 7: Chromic oxide (lOg) study in animal with deactivated prosthesis (#16).
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Discussion
This study was performed in order to obtain an indication of the duration of
the colonic transit time in our experimental animals. The radiological method used
in this experiment was recommended as the accepted standard by the working party
5 2
on anorectal physiology measurement . The original report by Hinton et al involved
daily X-rays for a minimum of five days. They reported that, in 25 healthy subjects,
the first marker was passed within three days and that 80% of the markers had been
passed by the fifth day. Our project license did not allow unlimited administration of
general anaesthetics to the animals and since radiological evaluation could only be
performed under anaesthetic or heavy sedation, the simplified method of Metcalf was
preferred. The transit time in the unoperated animal was 21.6 and 36 hours and in
the animals with the deactivated sphincter 13.6 and 28.8 hours, increasing to 43.2
hours upon activation of the device for six hours. Using the same method, the mean
colonic transit time in healthy humans was reported to be 35 hours (S.E.=2.1) and
39 hours (S.E.=3)6. In contrast a much greater variability has been reported using
12 1
Hinton's method ' : duplicate measurements varied by as much as three days and
transit time varied between 22 and 125 hours in males and 46 to 128 hours in
females . Our results indicate that the transit time in the Yucatan minipig is
comparable to that of humans. A transit time of six days (144 hours) has been
reported for pigs . This, however, was measured immediately post colonic resection
and anastomosis and must be severely biased by the presence of post operative ileus
and the effects of the anaesthetic and cannot be comparable to normal. Transit time
does not appear to be markedly affected by the mere presence of this neosphincter,
but is reportedly prolonged by 100% in enterectomised dogs . In that study,
however, the "artificial sphincter" reported by the authors consisted of two severely
constricted non-relaxing myomecyomised segments of bowel.
Even though the above simplified radiological method can be used to
estimate segmental transit times in the human colon, this was not possible in
minipigs due to the differences in the colonic anatomy: the terminal ileum opens into
the caecum which leads into the spiral colon. The two are superimposed in the right
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and middle of the upper and lower abdomen. The spiral colon leads to a long rectum
which spans the whole of the abdomen in a cranio-caudal direction (see Chapter 7)
and there is no sigmoid colon. These colonic segments are superimposed making
radiological evaluation of the segmental distribution of the markers impossible.
The magnitude of the transit time measured by the marker method is
comparable to that measured by the chromic oxide ingestion/excretion method.
Chromic oxide is not absorbed in significant quantities in the bowel and its
appearance in the faeces marks the ingestion to anus time. The method for analysis
used has been validated against a chemical assay method, and the inclusion of
Calcium and Silicate in the standard solutions minimized extraneous interference4.
Traces of chromium are detected in the stool within the first few hours and
then the concentration declines. This early rise is possibly due to contamination of
the pen with the chromic powder. The concentration of chromium in the stools rises
once again after approximately 20-24 hours in all animals and remains elevated at 30
hours. It also remained elevated at 50-53.5 hours in the two animals that this
estimation was done (Figure 5, Figure 7).
In summary, the colonic transit time and mouth to anus time have been
measured by two methods in a small number of our experimental animals. The
transit time is comparable to that measured in healthy humans.
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A new implantable artificial anal sphincter in which an inflatable expander
compresses and flattens the bowel against a pillow has been developed and tested in
a porcine model. Sixteen animals were implanted and studied for periods of up to 20
weeks. Of the eleven animals where the artificial sphincter was regularly closed,
eight completed the study and were continent during 85% of the activation times.
There was no evidence of ischaemic injury.
Major complications were related only to the failure of the control pumps.
The study suggests that the neosphincter produces faecal continence without




An artificial anal sphincter1 (Chapter 3), which is designed to reproduce the
normal physiology of the ano-rectum by flattening and angulating the bowel without
causing crenation has been developed. The technical details pertaining to
implantation in an animal model have been evaluated (Chapter 4). We have shown
in the laboratory that by eliminating crenation, occlusion pressure was evenly
distributed without localised high pressure points under the device (Chapter 3).
Further, the design facilitates the creation of angulation of the bowel with a relatively
large area of distribution of the occlusion pressure, allowing the device to be set at
lower operating occlusion pressures than that required for circular designs yet still
achieve continence.
In this chapter, the results of a study where this neosphincter has been
implanted in a porcine model are presented.
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Materials and Methods
The prosthetic sphincter consists of an inflatable expander which compresses
the bowel against a gel-filled pillow (Figure 1).
Figure 1: The implantable Neosphincter Prototype
A pressure regulating balloon maintains basal pressure in the expander at a
value set between 65-120 cmH20. For defaecation to begin liquid is transferred from
the expander to the balloon by means of a pump. When the expander is empty, the
bowel is free to dilate which allows evacuation. Fluid then leaks back gradually to
occlude the bowel over a 5 minute period. The pump incorporates a manually
operated shut-off valve which allows the sphincter to remain open for prolonged
periods (e.g. post-operative tissue healing). The neosphincter has been tested in a
study of 16 female minipigs (weight 13.5-20 kg). Five of these animals were used as
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controls (Group A): three were implanted but not activated, one had a sham operation
and one had no surgery (Table 1). The remaining 11 animals (Group B) had
implanted and activated sphincters.
Number of animals Type of operation
Group A (control) 5 No activation
Group B 11 Implanted, activated
Table 1: Details of the groups of the experimental animals.
The anal sphincters of all animals who underwent surgery were divided at the
end of the implantation procedure.
Animals were observed for two to three weeks prior to surgery and bowel
habit noted. During this period all animals were vaccinated against Salmonella with
Bovivac (Hoechst Animal Health, Hoechst U.K. Ltd) 2 ml subcutaneously, two doses
two weeks apart. Each animal was anaesthetised as described in Chapter 4. The
peritoneal cavity was approached via a mid-line incision and the rectum was
mobilised. In the implanted animals, the expander was placed beneath the lower
rectum through a mesenteric window (Figure 2) and the pillow was positioned on the
anterior surface of the bowel (Figure 3). The expander's tie straps were then threaded
through the anchoring slots in the back of the pillow and the straps adjusted so that a
2.25 cm diameter cylindrical sizer could pass between the bowel wall and the
neosphincter. The straps were then secured with Prolene sutures, apart from the first
animal where vicryl was used. The pillow was sutured to the anterior abdominal
wall. The uterus and fallopian tubes were used to cover the device, in order to avoid
the development of intestinal adhesions.
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Figure 2: The expander is passed through a mesenteric window in the
mesorectum.
Figure 3: Appearance of the Neosphincter at the end of the implantation
procedure.
The expander was then inflated with a 12.5% solution of Hypaque in normal
saline until the intraluminal bowel pressure measured by a catheter tipped transducer
(Type CTU1 Gaeltec Ltd, Isle of Skye) reached between 45-60 cmH20 and the
corresponding expander pressure noted. The balloon was placed in the peritoneal
cavity and the control pump in the inguinal region through a subcutaneous tunnel.
The pump and reservoir were primed with Hypaque solution and connected to the
expander. The working pressure of the sphincter could be set to any level up to «
135 cmH20. The working pressure was set to the value found to give an intraluminal
pressure (or operating pressure) of between 45-60 cmH20 by adjusting the volume of
liquid in the system. Pump function was checked and the expander then left deflated
with the shut-off valve closed. All parts of the implant, the peritoneal cavity and the
wound layers were copiously lavaged with a mixture of Gentamicin 0.8 mg/ml and
Metronidazole 5 mg/ml. The wound was closed in layers with vicryl and interrupted
Prolene to skin. The resting anal pressure was then measured using the station
pullthrough technique. Finally, the anal sphincter of each animal was divided.
Antibiotic prophylaxis (Ampicillin long acting 25mg/kg per day) commenced at
induction and continued for one week after operation. Analgesia (O.Olmg/kg
Buprenorphine twelve hourly) was required for the first 24 hours post-op. The
animals received a balanced electrolyte solution of Lactade (Beecham Animal
Health) orally for the first 18 hours and resumed normal feeding thereafter. To avoid
the risk of faecal impaction, all animals received a regime of mild laxatives (Liquid
paraffin 15 ml once per day, Sterculia 98%, 5 ml twice per day). They were fed three
times a day (commercial pig diet pellets, Stewart and Larbert Ltd, Larbert) and had
free access to water. The sham operated animal underwent the same surgical
procedure without the implantation of the prosthesis and the area of the mesenteric
window was marked by non absorbable sutures.
After two weeks, to allow for tissue healing, each implanted animal was
given a general anaesthetic and the sphincter closed by releasing the shut-off valve.
12.5% Hypaque was instilled into the rectum and the effectiveness of holdback by
the sphincter demonstrated under X-Ray screening. Rectal angulation and the
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position of the sphincter were measured from radiographs taken during screening.
The resting anal pressure was measured once again using the station pullthrough
technique.
The animals were housed in separate pens and the 11 implanted animals
(group B) had their prosthetic sphincters activated for periods which gradually
increased from 2 to 6 hours per day over a ten day period to allow intestinal
adaptation. Pens were cleaned before each activation period and the animals were
observed during the occlusion time for evidence of faecal soiling.
Continence was assessed and graded as follows:
• Grade I: Fully continent of formed feces
• Grade II: Leakage solely within two hours of activation
• Grade III: Incontinent
If the sphincter was ineffective then sphincter pressure was increased by
injecting more Hypaque solution into the system through the septum in the pumps.
The animals in group B were variably terminated between 5 and 20 weeks post
implantation in order to study the progressive effect of sphincteric compression on
the bowel wall. All animals in group B had the sphincters continuously activated for
36 hours on at least three occasions one week prior to termination. Similarly, the
animals in group A were terminated at between 11 and 18 weeks. Arterial blood
pressure was measured by femoral artery puncture prior to termination.
At the time of termination, the implant was tested in-situ in four animals from
group B, by inflating the expander to increasing volumes and recording the system
pressure generated. The bowel surrounded by the prosthetic sphincter was excised
with a further bowel sample from a region 10 cm proximal to the sphincter site. In
seven animals, the colon was examined microscopically for necrosis and other host
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responses. Haematoxylin and Eosin sections were taken from seven of the eight
implanted and activated animals and the average mucosal thickness was estimated by
measurement from five different areas using a traveling microscope (magnification
x400). The bowel width and wall thickness was also measured macroscopically.
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Results
Of the 16 animals studied three were terminated within two weeks and did
not provide data regarding neosphincter function. One of these three had an early
implant infection; the remaining two developed colonic obstruction (one due to
control pump malfunction which caused the sphincter to remain closed, the second
due to a misaligned expander). There were, therefore, five animals in Group A and
eight animals in Group B available for long term study.
At two weeks, radiological evaluation of the device in each implanted animal
demonstrated holdback for fluids confirming activation (Figure 4). The mean angle
created by the device at that time was 61° (S.D.=20.93), while the mean distance of
the prosthesis from the anus was 18.5 cm (S.D.=4.22). The resting anal pressure fell
from 20.8 mmHg (S.D.=5.9) prior to division of the anal sphincter to 0.4 mmHg
(S.D.=1.4). This was statistically significant (p<0.001, T=15.8, d.f.=34). Arterial
blood pressure was 72/51.8 (10.9/8.5)mmHg (mean systolic/diastolic, S.D. in
brackets). Blood pressure was not significantly different when compared with that of
the animals used in the acute experiments (systolic: p>0.13, diastolic p>0.80,
Chapter 4).
The observation of bowel frequency undertaken before surgery showed that
the mean rate of defaecation was 8.6 times/24 hours (S.D.=3.26). In the sham
operated control animal this increased to a mean of 20.1 times/24 hours (S.D.=3.69)
after surgery. In the 3 implanted but non-activated controls the corresponding
defaecation frequency was 13.4 times/24 hours. The mean defaecation frequency of
all five control animals (group A) was 14.1 times/24 hours (S.D.=5.45), i.e.
equivalent to once every 1.7 hours. Details of the post operative continence in the 8
animals with activated sphincters after surgery (group B) are shown in Table 2. The
animals were completely continent of faeces during 75% of the activation times
(Table 2 continence score I). Soiling during the first 2 hours of the 6 hour occlusion
period occurred 9% of the time. The animals were incontinent during 15% of the
occlusion times.
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Figure 4: Radiological appearance of the artificial sphincter after instillation of
contrast material in the rectum (top). The neosphincter is activated and the
distal rectum cleared to demonstrate effective fluid holdback and bowel
angulation (bottom).
310
Active implant Bowel Operating Number of Number of occasions each continence
duration angulation occlusion activations score was observed during the
(weeks) pressure of 6 hours activation periods.
(cmH20) in lifetime CONTINENCE SCORE:
I II III
5 50° 51 5 5 0 0
7 65° 45 3 2 0 1
8 OO00 46 6 4 1 1 i
9 75° 46 15 10 1 4
10 OO 60 4 1 3 0
15 65° 43 38 33 2 3
18 OO L/1 O 41 52 33 5 14
20 OO 64 38 33 4 1
Total: 161 121 16 24 (14.9%)
(75.2%) (9.9%)
Table 2: Continence data for Group B animals with activated sphincter.
Continence score:
I. Continent of formed faeces
II. Leakage solely within two hours of activation
III. Incontinent.
During follow up of the 13 animals, there were six pump malfunctions: four
had leaking shut-off valves, one developed a blocked bypass resistor and one pump
casing developed leakage of fluid. The only problem associated with the active
sphincter, related to the use of vicryl for the expander anchoring sutures which
allowed the expander to dislodge from the pillow in one animal.
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At post mortem it was noted that a fibrous capsule had formed around each
prosthesis. The pressure-volume relationship was studied in detail in four sphincters
in-situ as shown in Figure 5. The compliance of the sphincter complex is represented
by the slope of each point of each curve (compliance C-AV/AP) in Figure 5 and is
reduced in all animals. There was no definite progressive loss of compliance with
time.
Figure 5: Expander Pressure versus Volume at implantation and at
post-mortem in four implanted and activated animals.
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Duration of active implant (weeks)
Figure 6: Mucosal thickness proximal to the sphincter (no fill) and
under the sphincter (diagonal fill) for seven implanted and
activated animals. Bars represent mean + Standard Deviation.
Histological examination of tissues underneath the prosthesis showed no
evidence of rectal ulceration. The average mucosal thickness in the control animals
was 445 pm (S.E.M =37.8). The mucosal thickness proximal to the sphincter in the
activated animals was 502.7 pm (S.E.M.=115.2) and at the sphincter site 522.8 pm
(S.E.M.=105). There was no significant difference between the mucosal thickness in
the seven sets of specimens taken proximal to the sphincter and those from under the
sphincter(p=0.49) (Figure 6). There was also no significant difference between the
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mucosal thickness of the controls and that of the mucosa proximal to (p=0.36) or at
the sphincter site (p=0.19) in the activated animals. All rectal layers were well
preserved apart from the loose areolar tissue of the submucosa (Figure 7). There was
a slight but significant dilatation of the rectum proximal to the sphincter and also
thickening of the bowel wall both in the proximal and distal rectum. These changes
where due to muscle and serosal thickening (see Appendix 5). Silicone deposits
were not identified in any of the specimens.
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Figure 7: Histological appearance of rectal wall at the level of the neosphincter,




The results of the present study confirm the efficacy of the neosphincter
design. The implant was at least 75% effective in achieving continence, while there
was no clinical or histological evidence of ischaemia in the colon beneath or adjacent
to the implant. This is in contrast to the mucosal atrophy which was observed when
2 3 •
a circular cuff design was implanted around bowel and stomach in dogs and in pig
colon4. Significant urethral atrophy was also observed under the AMS 800 cuff in
piglets (male more severe than females) within six to eight weeks of implantation5,
even though the device was never activated.
The mini-pig was chosen as the experimental model because the size,
• •67
structure and biomechanical properties of the intestine ' , and the dietary composition
• 8and consistency of fasces are similar to that of humans. Colonic transit time is also
similar to that of humans (Chapter 5). Since it has been observed that mini-pigs9 and
dogs in the laboratory setting readily obstruct with viscous stools, a gentle laxative
regime was used to avoid this possibility. Mini-pigs also have a more frequent
defecatory pattern than humans. Our control animals evacuated approximately every
two hours imposing a limit on the maximum occlusion time of six hours. This
maintained animal comfort but challenged the neosphincter to hold back the volume
of three motions. This would equate to an occlusion time of at least 24 hours in the
human. We have also shown that the sphincter does not cause ischasmic changes,
even when it was activated for 36 hours in the minipig. The duration of activation is
in accordance with other studies: a period of six hours was reported in a mongrel
dog model10, six to eight in beagles2'11 and three to eight in a porcine ileostomy
12
model . An occlusion period of 23 hours in pigs with a perineal colostomy caused
bowel erosion in almost 100% of animals4.
The prototype sphincters used in the present study were of a size suitable for
human implantation and as such were too large to place in the porcine pelvis. This
dictated that the occlusion site was on average 18 cm from the anus. Such placement
had the disadvantage of potential evacuation of feces from the lower rectum after
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neosphincter activation. For this reason we have separately documented animal
continence for the whole activation period and episodes of incontinence during the
first two hours after activation (see Table 2). Where some evacuation occurred
during the first two hours, but the animals were continent thereafter, it seems
probable that this resulted from emptying of the dead space. The two hour interval
was chosen to be just greater than the average defaecation frequency expected in the
control animals. Taking this into account, it appears that the device was successful in
achieving continence 85% of the activation time. Animals were unequivocally
incontinent for 15% of the activation times. Loss of fluid from the system accounted
for seven episodes of fecal incontinence in one animal (29% of the total episodes of
incontinence in all animals). This problem was rectified by injection of fluid into the
hydraulic system. The other major cause of incontinence was the separation of the
two components of the device (expander, pillow) due to re-absorption of the vicryl
sutures used to secure the straps in the first animals. This was corrected by using
non-absorbable sutures in the remaining animals.
13Silicone shedding was reported in 50% of children with the artificial urinary
sphincter after three years. No silicone particles have been observed histologically in
our study, but remains a possibility after long term implantation. Encapsulation has
been observed around all silicone implants including the circular urinary cuff
sphincter2'4'9'14. We found that encapsulation also occurred around our neosphincter
making the expander less compliant with the potential risk of impairing pressure
transmission. The surface of our neosphincter was textured, to minimize the effect of
capsule formation, as texturing promotes the development of a more compliant
capsule15. It is recognised that the elastic properties of these capsules change as they
mature and may account for the variation in compliance that we measured with time.
Certainly we observed no progressive loss of compliance with increasing
implantation time (Figure 5). The materials used for the present sphincter are of a
similar grade to those used in the urinary sphincter which had a lifespan of more than
ten years. It is reasonable to assume, therefore, that comparable compliance changes
and lifetimes should be expected for the present device.
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Complications encountered in the present study were predominantly due to
the unreliability of the pump. In particular, shut-off valve leakage led to prolonged
unplanned sphincter activation and was responsible for obstruction in three animals.
This pump, which was developed in our laboratory, is undergoing redesign before
implantation in humans. The engineering tolerances expected from these pumps will
be very high, and cycling apparatus has been designed to assess continuing reliability
after several tens of thousands cycles of activation (equivalent to approximately 50
years normal usage). It may be that the automatic re-occlusion feature used in the
urinary device will not be appropriate for the more prolonged act of defaecation. and
the new design includes an option of keeping the sphincter open until defaecation is
complete.
The key design feature of our sphincter is the inclusion of angulation with
flattening of the bowel which reduces the occlusion pressure necessary to control
formed stool. This is in accordance with our present understanding of the dynamics
of flow and has been confirmed in our laboratory studies16. As in the human
sphincter the device will be less effective in controlling liquid. Using the current
design, we were able to achieve continence at occlusion pressures of only 45-60
cmH20. The angulation in this study was created in the upper rectum some 18 cm
from the pelvic floor. In the human we expect to place the device at the level of the
upper anal canal above the pelvic floor, after rectal mobilisation. Assuming similar
angulation of the anorectal angle is achieved in the human, we would expect to
operate the system at an occlusion pressure of 65 cmH20. This is the lower level of
normality for basal anal canal pressures and a level at which we have shown there is
no risk to the blood supply of the human colon (Chapter 8). Transient rises in intra¬
abdominal pressure will produce transient rises in hydraulic system pressure; a
further benefit of the design.
In conclusion, this study has shown that our novel prosthetic anal sphincter
produces continence without tissue damage in the minipig model.
317
References
1 Carter KB, Finlay IG, Richardson W. Prosthetic Anal Sphincter. International
Patent 1992;WO 92/16162:1-24.
2 Sofia CA, Rush BF, Koziol J, Rolko JM, Seebode JJ. Experiences with an
Artificial Sphincter to Establish Continence in Dogs. American Surgeon
1988;54:390-394.
3 Nguyen DH, Ganesan GS, Sumfest JM, et al. The use of the AMS 800 artificial
urinary sphincter in combination with the gastric tube for continence in the canine
model. J Urol 1993;150:737-741.
4 Satava RM, King GE. An artificial anal sphincter. Phase 2: Implantable sphincter
with a perineal colostomy. J Surg Res 1989;46:207-211.
5 Mokhless I, Hassouna MM, Kiruluta GH, et al. The evolution of artificial sphincter
cuff in growing animals. J Urol 1988;140:632-636.
6 Dall FH, Jorgensen CS, Djurhuus JC, Gregersen H. Biomechanical wall properties
of the porcine rectum: A study using impedance planimetry. Dig Dis 1991 ;9:346-
352.
7 Dall FH, Jorgensen CS, Houe D, Gregersen H, Djurhuus JC. Biomechanical wall
properties of the human rectum. A study with impedance planimetry. Gut
1993;34:1581-1586.
8 Panepinto LM, Phillips RW, Wheeler LR, Will DH. The Yucatan miniature pig as
a laboratory animal. Laboratory Animal Science 1978;28(3):308-313.
9 Shoshany G, Pena A. Evaluation of a silastic anorectal sphincter placed by the
posterior sagittal approach in pigs. Int J Ped Surg Sci 1994;8:67-69.
10 Beahrs OH, Bess MA, Beart RW, Pemberton JH. Indwelling ileostomy valve
device. Am J Surg 1981 ;141:111
11 Chandler JG, Adams RB, Friedman CJ, Marcella KL, Gucrrant RL. Assessment
of an implantable ileostomy sphincter. Surgery 1985;98:72-80.
12 Rosen MA, Light JK. Spontaneous bladder rupture following augmentation
enterocystoplasty. J Urol 1991;146:1232-1234.
13 Reinberg Y, Manivel JC, Gonzalez R. Silicone shedding from artificial urinary
sphincter in children. J Urol 1993;150:694-696.
318
14 Delaney J, Broadie T, Timm GW, Bradley WE. A prosthetic sphincter for the
gastrointestinal tract. JSurg Res 1974;16:204-209.
15 Ersek RA. Molecular impact surface textured implants (MISTI) alter beneficially
breast capsule formation after 36 months. Journal ofLong-Term Effects ofMedical
Implants 1991 ;1(2): 155-169.
16 Hajivassiliou CA, Carter KB, Finlay IG. Anorectal angle enhances faecal
continence. Br JSurg 1996;83:53-56.
319
Chapter 7




Materials and Methods 323
Activation of the neosphincter 323
Demonstrating fluid holdback 324
Assessment of the hydraulic switch 324
Results 325
In-vitro study of the pump components 325
In-vivo radiological studies 328
Anatomical positioning and assessment of function of the neosphincter 328







There are several reports outlining the radiological evaluation of the several
17 i •models of the artificial urethral sphincter prosthesis " and also the AMS 800 during
its use as an artificial anal sphincter8"11.
The design, operation and implantation of the AASP 2000 artificial anal
sphincter has been described in previous chapters (Chapter 3, Chapter 6). As the
device is fully implantable, clinical assessment -especially in a less than fully
cooperative animal- could be at best difficult. Even under the best possible
circumstances clinical assessment would be inconclusive in a significant proportion
of malfunction episodes, and radiological assessment would, therefore, be necessary
to contribute to the further elucidation of each problem. As this system is filled with
radioopaque contrast material, it is particularly suited to radiological assessment.
The radiographic techniques used to evaluate patients with sphincters are not new,
and no special equipment is necessary. This chapter outlines the methods used to
assess a malfunctioning device and presents a logical algorithm to assist with the
diagnosis and management of these malfunctions.
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Materials and Methods
A short, in-vitro, study was performed to evaluate the appearance of the
components of the AMS and AASP control pumps (Figure 1, Figure 2, Figure 3).
The pumps were filled with Hypaque solution and X-Rayed on he bench with the
shutoff valve open (deactivated) and closed (activated).
The animals were routinely X-rayed two weeks after implantation to assess
and activate the device. They were also X-rayed whenever a complication arose.
This was performed under Halothane face mask anaesthesia (technique as described
in Chapter 6, but without endotracheal intubation). The project license allowed for
repeated sedation / anaesthesia for radiological assessment for therapeutic reasons.
Plain X-Rays were taken in the ventrodorsal (Figure 4) and lateral shoot-
through planes (Figure 5) with the animal lying in a radiolucent gutter. The distance
between the plate and the X-Ray head was kept constant throughout the duration of
the study to ensure that size measurements were compatible between investigations.
The activation and deactivation of the device and effective fluid holdback
were also assessed by a contrast enema.
Activation of the neosphincter
In most animals the device was left unprimed and was activated after two
weeks in order to eliminate the risk of inadvertent activation during the post¬
operative recovery phase. A dose of Amphipen (Appendix 6) was administered with
the pre-medication and another dose was given 24 hours later. Under a general
anaesthetic, the injection port of the pump was impaled under strict asepsis (Figure 6)
and a solution of Hypaque in saline (as described in Chapter 6) was instilled through
a three way tap. When filled with radioopaque fluid, the expander, tubing, balloon
reservoir and control pump are readily identifiable (Figure 4). This also allowed
simultaneous measurement of the hydraulic system pressure; the pressure was set to
the desired level (« 65 mmHg) by the infusion of the appropriate volume of fluid.
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Hydraulic system pressure measurements were made using a Baxter pressure
transducer (Uniflow DPT model).
Anal tone was measured during the anaesthetic sessions by the station
pullthrough technique with a catheter tipped microtransducer (Gaeltec CTU1, see
Chapter 1, Chapter 3, Chapter 6).
Demonstrating fluid holdback
A Foley catheter was inserted in the rectum and the balloon filled with 30 ml
Hypaque solution. 100-200 ml of Hypaque (diluted as above), was quickly instilled
into the rectum and an X-Ray was taken (Figure 7). Gentle traction on the catheter
ensured that the anal canal remained sealed. The neosphincter was then activated and
the distal rectum washed using copious amounts of saline in order to remove the
contrast material. Another X-Ray was taken in order to demonstrate effective fluid
holdback (Figure 8). The device was then deactivated and the animal allowed to
recover.
The anorectal angle and the distance of the neosphincter from the anal margin
was also determined from these radiographs. The latter was calculated after
correction for projection enlargement was applied.
Assessment of the hydraulic switch
The silicone casing of the switch was impaled percutaneously with a #25
needle (Figure 6) and the pressure inside the casing measured. Hypaque solution was
instilled to outline the switch and the tubing if necessary, e.g. if vacuum had
developed inside the casing (Chapter 3 and subsequent discussion).
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Results
In-vitro study of the pump components
The AMS pump was X-Rayed in two planes (Figure 1, Figure 2) to show its
components (Figure 1) and assess the shutoff valve travel (Figure 2).
The travel of the AMS pump shutoff valve (Figure 2) was three times that of
the AASP device (Figure 3). The inner voids of the former were also much neater
and of an overall greater diameter despite its smaller overall size.
Figure 1: Vertical (PA) view of the AMS pump showing the spring loaded ball
valve on the balloon side and its non-spring loaded counterpart on the sphincter
cuff side. The shutoff valve (radioopaque circle) is also shown.
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Figure 2: Lateral exposure of the AMS pump with the shutoff valve closed (top)
and open (bottom). Valve travel is approximately 9 mm on projection.
326
Figure 3: Lateral exposure of the AASP pump with the shutoff valve closed
(top) and open (bottom). Valve travel is approximately 2.5 mm on projection.
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In-vivo radiological studies
There were no complications attributable to the performance of these
investigations.
Anatomical positioning and assessment of function of the neosphincter
The position of the device, the normal appearances of its components and the
anatomy of the bowel on plain radiography and after contrast instillation are shown
in Figures 4 to 9. The components of the pump (shutoff valve, resistor, spring loaded
one way valves and injection port backing plate) are clearly seen. In Figure 7 and
Figure 8 the satisfactory performance of the neosphincter is confirmed by
demonstrating effective fluid holdback.
The internal components of the optional hydraulic switch are shown in Figure
9. As it can be seen, this switch consists simply of an encapsulated spring type hose
clip with a ratchet type catch. The contour of the switch can be palpated through the
very thin silicone casing and manual opening or closing can be effected as
appropriate.
The ventrodorsal view demonstrates the anatomy of the porcine distal large
intestine after contrast instillation (Figure 10). There is no sigmoid colon in the pig
(in fact there is no anorectal angulation either as this is only a feature of man and
orthognate apes), and the rectum is seen to extend to the splenic area. This was also
confirmed at laparotomy.
The AMS 800 pump was implanted in one animal (Figure 11). This device
has a very reliable shutoff valve, but it has no injection port and its casing is not self
sealing. As system pressure measurement was an essential part of the experimental
protocol, an injection reservoir was implanted in the circuit to provide percutaneous




Figure 4: Ventrodorsal view of the primed but deactivated device. The
intraperitoneal balloon is seen in the right mid abdomen, the control pump in
the left inguinal region and the (optional) shunt and series switches in the right
and left inguinal regions respectively. The contour of the empty expander is
seen, partly covered by the steel reinforcing plates of the pillow.
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Figure 5: Lateral shoot-through view of the activated device. The two segments
of the filled expander are seen just being separated from the pillow by the colon,
which is compressed by the activated expander.
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Figure 6: Crop view of the control pump with a #21 needle impaling the
injection port. The shutoff valve, resistor and spring loaded one way ball valves
are also shown.
Figure 7: Contrast outlines the bowel with the device deactivated.
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Figure 8: The Neosphincter is activated and the rectum cleared demonstrating
fluid holdback.
332
Figure 9: Lateral shoot through X-Ray of the unprimed, deactivated device.
The switch casing has been filled with contrast to show the outline of its
components.
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Figure 10: Ventrodorsal view with the distal bowel outlined with contrast. The
rectum is seen to span the whole length of the center of abdomen to the splenic
area. More proximally, it becomes the spiral colon anatomically (not shown).
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Figure 11: Radiological appearance of the AMS 800 pump which was
implanted in one animal. As this pump does not have an injection port, a





AMS 800 Control pump
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Figure 12: Diagrammatic representation of the implanted system incorporating
the AMS 800 control pump and an injection port.
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The hydraulic switch
Due to the unreliability of the shutoff valve and the resistor (Chapter 3,
Chapter 6 and Appendix 5), one or two hydraulic switches were implanted with the
system in an attempt to preempt and rectify the problems (Figure 13). Flowever, the
operation of the switch proved universally unsatisfactory. Following implantation,
the air inside the gas permeable, flexible casing was reabsorbed and the casing
collapsed and caused pressure on the switch itself (Chapter 3). This caused the
switch to be maintained in a partially or fully closed position (Figure 14) and could
not be operated manually. Contrast instillation into the casing via a 25 Gauge needle
confirmed this by demonstrating waisting and kinking of the tubing (Figure 15). The
appearance shown in Figure 15 is almost certainly worse in real life, as even the
minutest volume of contrast injected into the casing, would relieve the vacuum and
allow the switch to partially open. Further fluid injection into the casing relieved the





Parallel (or shunt) switch
• The series switch protects
against a leaking, unstable
deactivation valve.
• The parallel switch protects
against a blocked resistor.
Control pump incorporating
deactivation button, injection
port and automatic cuff refill
feature
Figure 13: Diagrammatic representation of the implanted system incorporating
the series and parallel switches.
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Figure 14: Radiological appearance of the malfunctioning switch shown in
close-up. Note the collapsed casing and the waisting of the tubing. This is
caused by air reabsorption from the casing (see text).
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Figure 15: Close-up view of the hydraulic switch after contrast instillation into
the casing. Waisting of the tubing is still present, even though the casing is
partially expanded to its normal shape.
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Figure 16: Further injection of fluid into the switch, relieved the vacuum and
allowed manual operation.
System leakage
In one animal the system could not be inflated by routine puncture and fluid
injection at the two week postoperative routine activation session. It was possible to
inject fluid into the balloon, but this did not equilibrate with the expander (Figure
17). The pump could not create suction. There was radiological evidence of fluid
leakage from the system (Figure 17, Figure 18). The contrast outlines the outside of
the tube ("tramlining" in Figure 17) and the balloon surface (Figure 18), by leakage
into and along presumed maturing fibrous tracts. This animal was therefore kept as
an implanted control and terminated electively after 12.5 weeks. At routine
postmortem the leakage was found to be from the pump casing.
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Figure 17: Contrast was injected in the system but leaked through the pump
casing. It outlines the surface of the tubes and causes the "tramlining" sign: two
radio-opaque lines separated by the radiolucent tubing (arrow).
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Figure 18: Crescent of contrast on the outside of the balloon of the animal




There were several episodes of colonic obstruction due to inadvertent
activation of the control pump. This was always diagnosed clinically by palpation of
the pump and resolved upon subsequent deactivation of the device. There were three
episodes of colonic obstruction the cause of which was diagnosed radiologically: two
were due to the impaction of hard stools and the third due to displacement of the
expander in relation to the pillow (Figures 19 to 21).
One animal became constipated for two days. Fascal loading was confirmed
by plain abdominal X-Ray. A Foley catheter was passed per-rectum and a soapy
water enema administered proximal to the neosphincter (Figure 19). There was good
return of faeces and the obstruction was relieved. No other similar problems occurred
in this animal.
Figure 19: One animal became loaded with faeces and received an enema. A
Foley catheter was passed proximal to the sphincter to administer the enema
with a good result.
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Another animal suffered obstruction because of ingestion of the sawdust that
was used to line the pen. This was also relieved successfully with an enema. Note
the crescentic appearance of the empty expander at plain X-Ray (Figure 20). This
was presumably due to stretching of the lumen at that point by the hard stool.
Figure 20: Lateral abdominal X-Ray of an animal with intestinal obstruction
due to sawdust ingestion. Note the crescentic shape of the empty expander
which is presumably due to stretching by the hard stool.
The last animal suffered obstruction because the expander element slipped in
relation to the pillow (Figure 21). The bowel angulation was exaggerated and, in
addition, the expander must have physically obstructed the flow of fecal material.
For this reason, this animal was terminated prematurely.
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Figure 21: Colonic obstruction due to displacement of the expander in relation
to the pillow.
Overall 25 plain radiographs and 24 contrast enemas were performed in 15
animals. The different types of investigations performed in the animals are
summarized in Table 1.
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ID. Routine Assessment for
Complication
Malfunction
AXR Contrast AXR Contrast Component Action/Other
#1 1 1
#2 1 1
#4 1 1 1 1 Slow resistor Nil
#5 1 1 Pump leak Control animal
#6 1 1 1 1 Switch activated Injection into
casing







#13 1 1 1 1 Resistor blocked Nil
#14 1 Constipation.
Enema












ID. Routine Assessment for
Complication
Malfunction
AXR Contrast AXR Contrast Component Action/Other
studies)
#19 2 2 Pump replaced
#20 1 1
Tota : 17 17 8 7 = 25 plain, 24 contrast X-Rays.
Table 1: Summary of radiological investigations.
A stepwise method for radiological assessment of this device based on our
above experience is presented Figure 22.
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Radiographic evaluation of this device postoperatively reveals functional
adequacy (or inadequacy) of the prosthesis and aids in delineating malfunction
aetiology. As the mechanical control and operation of this device is similar to that of
the AMS urinary sphincter, the complications and method of assessment described
above will be compared to those reported in the literature for the AMS device.
Pagani et al. present the first series of radiological assessment of the early
AMS models (AMS 742A/B/C). The guidelines on preoperative patient assessment
and preparation they report are not relevant to this anal sphincter. Tubing kink and
fluid leak from the system were the main complications they reported and this was
confirmed by subsequent studies involving the AMS 792 model3'4 but not for the
AMS 8004'6. We did not encounter any complications pertaining to kinked tubing
and this may be a reflection that, as with the AMS 800, kink resistant tubing was
used.
We observed that fluid loss from the system was due to leakage from the
pump casing due to a perforation. It was also shown that the self sealing mechanism
incorporated in the pump was unsatisfactory. Gradual leak (or "bleeding") from
silicone prostheses is well established and fluid loss from the AMS system is known
to occur gradually due to osmosis or contrast crystallization4. This complication was
not definitely established by our observations as the time of follow-up of the
experimental animals was much shorter than the patient series in which it was
reported. In addition, leakage from the injection port would always overshadow the
much slower leakage that occurs via osmosis across the silicone wall of the
prosthesis.
Intestinal obstruction was mainly due to pump malfunction (inadvertent
activation due to shutoff valve unreliability), which was usually diagnosed and dealt
with clinically (Chapter 3, Chapter 6, Appendix 5). There were, however, three cases
of colonic obstruction in which the diagnosis was made radiologically: one was due
to constipation, the other due to sawdust impaction and the third due to displacement
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of the cuff. The first two were treated by the administration of an enema under the
same anaesthetic, but the latter animal had to be terminated as the only other way this
could have been relieved would have been by revisional surgery as this was not
allowed by the experimental protocol for reasons of animal welfare. Obstructive
complications were also reported with the urinary device3'4, both as causes of acute
retention3'4 and chronic bladder outlet obstruction3 and were also reported by patients
with a modified version as an anal sphincter9'10.
In our experimental animal series, most complications that were analysed
radiologically related to the pump (see Chapter 3 and Chapter 6) or its ancillary
components (hydraulic switch). The thin silicone wall of the device allowed
diffusion of air into the tissues, eventually creating a vacuum which exerted a
collapsing force on the switch, causing it to close and become unusable. This
occurred relatively quickly (within two weeks). It was readily diagnosed
radiologically and treated, in the short term, by injecting approximately 1-2 ml of
contrast into the casing to neutralize the vacuum. This, however, did not confer a
long term solution as the fluid leaked out through the thin wall of the silicone casing
by diffusion and the problem recurred almost as fast as it developed in the first
instance.
Another complication encountered was inability to activate the pump
following activation of the shutoff valve. This operation depends on a critical
volume of fluid remaining inside the bulb prior to deactivation which will allow the
subsequent generation of a surge of pressure by pressing on the bulb, thus unseating
the shutoff valve. It was necessary to inject fluid into the bulb on several occasions
to achieve activation and this was done during the general anassthetic/radiology
sessions. Other experimental parameters (bowel angulation, distance between the
prosthesis and anal canal, bowel distention and anal tone/pullthrough pressure) were
also evaluated during these sessions.
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In one study where the modified AMS 800 device was used as an anal
sphincter9, it is suggested that its effectiveness may be contributed towards by the
maintenance of an acute anorectal angle.
The method of assessment of this device that has been presented does not
involve any new techniques or equipment. The radiographic examination is the
prime postoperative means of evaluating these prostheses as clinical feedback may be
difficult to interpret or impossible to collect and endoscopic instrumentation may
damage the rectum.
This new experimental Neosphincter may be implanted in humans as part of a
pilot study, once the shortfalls that have been identified in the design and its
construction have been corrected. This analysis would enable the professionals who
have gained an understanding of the normal operation of the sphincter and its
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The effect of the Neosphincter on colonic blood













A laser doppler flow scanner prototype was used to assess the blood flow
distribution in human colon intraoperatively in control patients and in patients with
inflammatory bowel disease. The biological zero flow value was found to be 46
relative perfusion units. Blood flow was significantly higher in inflamed colon
(332.8 PUs versus 286.4 PUs). The scanner demonstrated intestinal mural blood
perfusion and was able to define ischasmia demarcation lines prior to visible changes
ensuing.
The effects of progressive compression by the AASP 2000 artificial anal
Neosphincter were also studied in the two groups of patients. Progressive reduction
of blood flow was observed with increasing inflation pressures. Colonic blood flow
remained above 48% of its baseline value even at levels of system pressure beyond
the sphincters' planned maximum settings. It appears that the Neosphincter is not




Laser doppler flowmetry is a non-invasive technique which can be used to
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assess tissue blood flow " . The method for extracting blood flow information from
doppler spectra has previously been well demonstrated and the working principle of
this method has been described in detail4"7. Blood flow is inferred by measuring the
doppler frequency shift in light reflected from moving red blood cells in the tissue
being studied. However, the static contact probe used so far has disadvantages which
make measurements tedious and sometimes unreliable . The probe must abut onto
the tissue being studied and this influences the local blood flow9. Blood flow can
only be measured in an area of approximately 3 mm , i.e. the detection area of a
single light fiber source and detector. The technique is also susceptible to movement
artefact and the results depend on the orientation of the fiber9.
A new technique has been presented10, whereby a laser beam remotely scans
the biological area of interest (up to 0.5m ). This laser doppler flow scanner (LDS)
directs a laser beam on to the surface of the tissue by means of a motor and mirror
assembly. The reflected light contains doppler frequency and reflected light intensity
information from which blood flow can be calculated. The beam is moved along the
colon in a raster fashion and blood flow information from the reflected and doppler-
shifted light is continuously recorded and stored in a computer. A colour coded
image is constructed which shows the distribution of blood flow, expressed in
arbitrary perfusion units (PUs). This data can be presented as a two-dimensional
contour map, showing the blood flow distribution in the tissue of interest (Figure 1,
Figure 2).
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Figure 1: The laser doppler flow scanner was used to demonstrate increase
blood flow and its distribution in partial thickness scald (a.) and no blood flow
in full thickness burn (b.).
Northern Regional Medical Physics Departnent
LASER SCAN ANALYSIS
480
Figure 2: Sample trace of a scan of human colon blood supply distribution.
Colour coded bar numbers represent arbitrary Perfusion Units (PUs). The
Neosphincter is opaque to Laser light.
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We have used the prototype laser doppler scanner (LDS) to measure and
compare colonic blood flow distribution in 12 human volunteers undergoing
colectomy (6 controls, 6 with inflammatory bowel disease). The effects of
progressive compression by the AASP 2000 Neosphincter on colonic blood flow
distribution were also compared in the two patient groups.
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Patients and Methods
One patient was studied as part of a pilot study to assess the suitability of the
static probe laser doppler flow meter (PeriFlux PF2; for method of static laser
doppler measurements see Chapter 4). The setting of the Neosphincter was as
described below. The blood flow measurements were cumbersome mainly due to
movement artefacts and the extra anaesthesia time could not be justified both in
clinical and service terms. The baseline readings were also quite variable (Appendix
4). For these reasons this technique was not used again and a further set of patients
was assessed with the prototype flow scanner.
Twelve adult patients (eight males, four females, median age 49.8 years,
range 24.3-78.7 - Table 1) were enrolled in the study. Routine bowel preparation
with Picolax and Klean-prep solution was instigated pre-operatively. Six patients
had colectomy for inflammatory bowel disease (I.B.D.) and six had colectomy for
non-inflammatory conditions (rectal prolapse, carcinoma) and acted as controls.
Routine biochemical and hsematological investigations were obtained within 48
hours pre-operatively and on the first post-operative day.
Age Sex Diagnosis Age Sex Diagnosis
1 71 F Rectal prolapse 7 40.23 M U.C.
2 70 F Crohn's disease 8 75.2 F Carcinoma
3 78.7 M Carcinoma, U.C. 9 30 M U.C.
4 74.5 M Carcinoma 10 31.8 M Carcinoma
5 72.3 M Carcinoma 11 24.3 M Crohn's disease
6 46.4 F Carcinoma 12 49.8 M I.B.D.
Table 1: Details of the 12 patients studied with the laser doppler flow scanner.
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One patient had colectomy for carcinoma following long term ulcerative
colitis (U.C.) and was included in the inflammatory bowel disease group; another had
inflammatory bowel disease of indeterminate histological type (Table 1).
Another patient (Id. No 2) was also diabetic and one patient had previous
surgery (Id. No 5) and the only blood supply available to support the right colon was
the ileocecal artery. These two patients were excluded from the numerical analysis
of the blood flow data.
Anaesthesia was induced with thiopentone and maintained with a nitrous
oxide / oxygen / isoflurane mixture. Intra-operative cardio-respiratory parameters
were continuously monitored. After mid-line laparotomy the colon was routinely
mobilized and delivered through the wound. A segment of colon approximately 25
cm long was prepared for the experiments in the following way: the colon and its
blood supply were stapled and divided distally and the dissection in the mesentery
was continued until all the accessory feeding vessels were divided so that all blood
supply came from a proximal feeding vessel (end-artery). The AASP 2000
Neosphincter was then placed around the bowel so that it encircled the whole
circumference of the bowel including the end-artery (Figure 3). Upon inflation of the
Neosphincter, the blood supply to the colon under the expander would decrease and
this decrease would be reflected on the blood flow in the distal segment of the bowel
which could be scanned. In two patients the bowel was not divided distally but was
left in continuity having divided the distal blood supply (Figure 4) in order to
demonstrate mural blood flow (a bowel clamp could be applied to the distal colon to
mimic the conditions in the other 10 patients).
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^/sphincter
distal colon proximal colon
Figure 3: Experimental arrangement to study the blood supply distribution in
the colon. The distal colon depends on its blood supply on the end artery which
passes under the Neosphincter. Blood flow changes under the device should be
reflected on the distal segment of the colon which can be scanned.
end artery ^/sphincter
proximal colon
Figure 4: Experimental arrangement to study the presence of mural blood
supply in the colon. Upon release of the clamp, any blood flow in the distal
segment of the bowel could only be due to mural perfusion.
The straps of the expander were adjusted using the 22.5 mm specially
designed sizer which was identical to that used in the animal experiments (Chapter
6). The expander was then inflated with normal saline to achieve inflation pressures
of 30, 60 and 90 mmHg. The pressure applied by the sphincter on the bowel was
measured at each stage by the station pull-through technique using a Gaeltec CTU1
catheter tipped microtransducer. All measurements were repeated three times. Both
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the sphincter inflation pressure and pull-through pressure were continuously recorded
on a Gould two channel Chart Recorder (Model 8188-2202-09, Gould Ltd, 57, Rue
St. Sauveur, Ballainvillers, France).
Prior to using the LDS, the bowel was surrounded with operative theater
drapes and all nearby metal objects were covered, in accordance with local safety
protocols. The scanner was placed approximately lm above the patient and the
blood flow measurement performed without any contact with the patient or the sterile
operative field. Standard lighting conditions were maintained throughout the
measurements in all patients to prevent interference from bright ambient light
sources. The surface of the bowel was scanned using the LDS with the sphincter
uninflated, at each pressure setting and with the mesentery clamped in order to
establish a biological zero flow reading. At the same time the, intensity of reflected
light was measured and stored along with the doppler signal. These could be
analyzed separately. Each scan took approximately 1.5 minutes. The artificial
sphincter is opaque to laser light and can be easily identified on the scanned images
(Figure 2, Figure 5, Figure 6, Figure 8). Image processing software10 was used to
analyze selected areas of the colon proximal and distal to the sphincter on each scan.
Each area contained several hundred reading points (pixels) and the average flow
reading in perfusion units (PUs) for each area was calculated.
Statistical analysis
The unpaired t-test was used to compare the data.
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Safety considerations:
Safety guidelines for the use of the laser doppler flow scanner prototype were
drawn by the Department of Clinical Physics and Bioengineering, Royal Infirmary,
Glasgow. The following discussion outlines the relative risk of retinal exposure to
laser light and compares the static laser probe with the scanner.
Definition of terms:
Mean permitted energy on the retina (MPE):
0 75 -2
MPE=18xt Jm" where t: time of exposure
Radiant energy received by the eye averaged over the area of limiting aperture (H):
El=(Energy of laserxtexp) / AP
where texp=pupil diameter/scanner beam speed
and AP: area ofpupil
Also, laser power=2 mW Pupil diameter=7 mm
Case 1: fixed beam
For an exposure time of 0.25 s,
MPE=6.4 Jm"2 EN 13 Jm"2
i.e. protective glasses of transmission factor < 50% would be required.
Case 2: scanning beam
100 line scan takes 2% minutes, .". 1 line takes approx. 1.5 s.
At recommended laser distance of 1 m, scan width is 35 cm
.'. beam speed=0.23 ms"1 and texp=0.03 s
MPEscan=1-3 Jm"2 HScan=1.6 Jm"2
i.e. protective glasses of transmission factor < 80% would be required.
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Results
The pre-operative haemoglobin (Hb), haematocrit (Hct) and mean corpuscular
volume (MCV) were within the normal range and there was no significant difference
in these parameters post-operatively (Table 2). The scans were stored by a dedicated
computer and analyzed subsequently using specially designed software (Figure 2,
Figure 5). The blood flow was averaged over a selected area of the bowel proximal
and distal to the Neosphincter.
Pre-op (S.D.) Post-op (S.D.) P
Hb 11.9 (2.14) 11.5 (1.78) 0.40
Hct 0.37 (0.06) 0.35 (0.05) 0.14
MCV 81.1 (7.42) 81.3 (7.02) 0.61
Table 2: Pre- and post-operative levels of hematological parameters that are
known to affect blood rheological characteristics.
Figure 5: Laser Blood flow distribution scan before (a.) and after (b.) image
analysis and enhancement.
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In one patient the intensity scan showed that the colon was losing its
reflectance during mobilization (Figure 6a) and ischaemia was confirmed by the
doppler measurements (Figure 6b). A new demarcation/resection line had to be
adopted as suggested by the doppler scan.
Figure 7 demonstrates the existence of intestinal mural blood supply. The
distal segment of the colon is rendered ischaemic by the application of mesenteric
and intestinal cross clamps (Figure 7a). Upon release of the intestinal clamp, the
distal segment of the colon is perfused with blood from the wall of the proximal
segment up to a distance of at least 6 cm.
a. Intensity scan b. Blood flow scan
Figure 6: Demonstration of devitalized bowel during mobilization. Intensity
data from the scan shows that bowel has lost its reflectance (a., arrowhead).
Doppler scan clearly showed the perfusion demarcation line (b., arrow).
1
• « } Bf^h:isa|l;ircli""p
a. Intestinal and vascular clamps in-situ b. Intestinal clamp removed |
Figure 7: Demonstration of mural blood supply. The distal bowel is ischemic
after cross clamping its wall and the mesentery (a.). Upon release of the bowel
clamp the distal segment is perfused through the wall of the proximal colonic
segment (b.).
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Scans were performed with the expander uninflated and inflated to 30, 60 and
90 mmHg. A specimen series of scans during progressive inflation of the
Neosphincter is shown in Figure 8a-d. The operating occlusion pressures applied
onto the bowel (Ppunthrough) were approximately 0, 20, 38 and 58 mmHg respectively
as the transmission factor was approximately 0.63 mmHg occlusion pressure per
mmHg expander pressure (Figure 9).
There was no statistically significant differences in blood flow distribution in
the colon proximal to the Neosphincter with progressive inflation of the device for
each patient (Figure 10). The maximum decrease observed was from 275 PU
(SD=11.5) at 0 mmHg to 200 PU (SD=42.1) at 67.5 mmHg (filled triangles, Figure
10). This occurred in a patient where only a small portion of proximal bowel could
be brought into the scanning field. When the patient data was pooled together,
however, a statistically significant decrease of 13% was obtained (from 317.6 PUs to
275.4 PUs, S.E.M.=50.1 and 51.7 respectively, p<0.001).
The "biological zero" value (i.e. the doppler flow reading with all blood
supply clamped) was 46 PUs (S.E.M.=14.2) with no statistical difference between
the two groups of patients (p=0.88).
Blood flow distal to the Neosphincter appeared to decrease progressively with
increased sphincteric compression (Figure 9, Figure 11). When the raw flow values
for all the patients were used, the correlation is poor (r =0.14). Even if the two
patients with poor initial blood supply and diabetes are excluded the correlation is
i 2 2still weak (r =0.25). Stronger correlation (r =0.48) is observed when the blood flow
is expressed as a percentage of the baseline value (Figure 12). In these
circumstances, blood flow decreases by 0.34% per mmHg increase of expander
pressure or 0.54% per mmHg increase of operating occlusion pressure (both patient
groups pooled together).
The blood flow results in the two patient groups are compared in Figure 13
and Figure 14.
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Figure 9: Correlation of operating occlusion pressure on the bowel (PpUiithrough)
versus expander inflation pressure (PExpander) f°r the 12 patients.
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The blood flow values were not statistically different in the colon proximal or
distal to the deflated Neosphincter for the 10 patients as a whole group (322.5 PUs,
S.E.M =49.9 and 296.5 PUs, S.E.M.=35.5 respectively, p=0.19) or in the two groups
separately (p=0.24 for control group and p=0.34 for I.B.D. group).
The blood flow in the whole segment of the colon (proximal and distal to the
device) was significantly lower in the control group compared with the group with
I.B.D. (286.4 PUs, S.E.M.=30.3 PUs and 332.8, S.E.M.=44.8 respectively, p<0.01).
The blood flow in the different segments of the colon in the two groups without
sphincteric compression is summarized in Table 3.
Control (S.E.M.) I.B.D. (S.E.M.) P
Whole colon 286.4 (30.3) 332.8 (44.8) <0.01
Proximal segment 297.8 (24.5) 347.2 (59) 0.12
Distal segment 274.7 (33.6) 318.3 (22.6) <0.05





Figure 10: Blood flow distribution in the colon proximal to the Neosphincter
versus progressive compression (both patient groups).
Figure 11: Blood flow distribution in the colon distal to the Neosphincter versus
progressive compression (both patient groups).
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Figure 12: Blood flow distribution in the colon distal to the Neosphincter
expressed as % of baseline versus progressive compression.
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Figure 13: Blood flow distribution in the colon distal to the Neosphincter versus
progressive compression. Comparison between patients with inflammatory
bowel disease (filled symbols) and controls (open symbols). Data from the two
excluded patients are also shown (legends as in Figure 14).
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b. Blood flow versus P,Pullthrough
Figure 14: Blood flow distribution in the colon distal to the Neosphincter
expressed as % of baseline versus progressive compression. Comparison
between patients with inflammatory bowel disease and controls. Data from the
two excluded patients are also shown.
The data plotted in Figure 13 and Figure 14 indicate that inflamed colon is
less sensitive to the application of pressure. When the raw blood flow values are
plotted (Figure 13), the correlation is weak (see Table 4) and the spurious data from
the two excluded patients would further weaken the relationship. When the blood
flow values are expressed as a percentage of the baseline value (Figure 14) the
correlation becomes much stronger (Table 5). The blood flow changes in the patient
with the ischemic colon are now well within the confidence interval of the
population and could be included in the analysis. The only spurious results are those





(PU per mraHg PExpander)
Blood flow decrease
(PU per mmHg PPui,through)
Controls 0.37 -1.09 -1.74
I.B.D. 0.56 -0.69 -1.1
Ischemic 0.99 -0.27 -0.43
Diabetic 0.37 -0.33 -0.52





(% per mmHg PExpander)
Blood flow decrease
(% per mmHg PPuiithrough)
Controls 0.64 -0.41 -0.66
I.B.D. 0.72 -0.22 -0.35
Table 5: Blood flow decrease (% of baseline) in the two patient groups.
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Discussion
A review of laser doppler flowmetry with special reference to the
gastrointestinal tract:
Single fiber static laser doppler flowmetry has been used to assess
0 1 1 ?Q 8 91 ?? 30-3Q
gastrointestinal blood flow in animals ' " and humans ' ' '
18 37
The results correlate well with tissue oxygen tension ' but are unaffected by
hypoxia40. Blood flow measurements in the gastro-intestinal tract also correlate well
with isotope wash-out techniques (85Kr washout13, Hydrogen clearance19'24'25,27'41,
133 42 • 36
Xe washout in nasal mucosa ), fluorescein flowmetry , radioactive microsphere
•••16 18
distribution and electromagnetic flow probe measurements .
There are three main limitations of the technique of single fiber laser doppler
flowmetry:
1. Blood flow is measured in relative perfusion units and the geometry of the probe
influences the flux measurements29,43. The instrument, therefore, requires re-
calibration each time a set of experiments is performed15,19.
2. The measurements are made in a very small volume of tissue44 (typically 1 mm2),
therefore single readings are unrepresentative due to the variability in spatial
distribution of blood flow in most tissues.
3. The fiberoptic laser-guide and detector fiber sensor is susceptible to movement
artefact or changes in orientation21 and is required to exert pressure21,45 on the
21 • 21tissues to avoid optical dissociation , thus affecting local blood flow .
One way that some of these limitations and the inter-observer variations (12-
8 46
35%) reported ' can be partially overcome is to take multiple readings over a
relatively extended period of time29,46. In addition, several probe designs have been
developed.
A microprocessor controlled moving arm was developed in order to move the
laser probe to precise coordinates47. It does not, however, serve to solve the
methodological problems of the technique. An integrating probe containing seven
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separate detector units arranged circumferentially in one flat package has been
designed44. The blood flow value is averaged between the detectors. A standard
probe was placed in the center of the device and the two compared both in-vitro44 and
in-vivo44'4*: significant correlation between the two was reported44'48. A special
hybrid probe which incorporates a Hydrogen electrode in order to self calibrate the
instrument to absolute flow values has also been reported41. Perhaps a more useful
approach is that whereby a very small semiconductor unit which incorporates both
the laser emitter and detector is placed directly on the tissue49. This is still a "contact
measurement" method, however, which may perturb the local blood flow
distribution.
At zero blood flow conditions (e.g. with the tissue vasculature clamped) there
is a persistent laser flux reading5 or "biological zero" (BZ) value amounting to
approximately 15% of the baseline flow value. This phenomenon may be due to
Brownian motion of the red blood cells and small random movements of the tissues.
48
Laser light of a different wavelength may contribute to a reduction of this artefact .
This BZ value was relatively small in well perfused tissues (5-10% of baseline on a
warm toe) but much larger in relatively ischemic tissues50 (59-83% on a cold
malleolus).
There was an initial debate as to whether the blood flow measurements
obtained by the laser doppler instrument represented part or the full thickness of the
bowel wall. An early study suggested that the mucosal blood flow could be
measured separately from that of the serosa14, a fact that has not been confirmed by
subsequent studies in animals15'16'18'20'24 and humans20'30'31,34.
In a theoretical analysis of the factors that affect sampling depth Jakobsson
and Nilsson51 showed that thicker optical fibers had a deeper tissue penetration and
this was also dependent on the bio-optical characteristics of the tissue studied. Their
results also suggest that a single optical fiber (acting both as the laser emitter and
detector) had a shallower penetration depth than a multiple fiber arrangement
whereby one or more acted as the emitter and the other as the detector. Thicker optic
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fibers more widely spaced achieved an increased depth of measurement at the
expense of the linearity of measurements. These results were confirmed in an in-vivo
29animal study . Statistically, the larger probes (three fibers of diameter and center
separation >500 /mi) with transmural colonic penetration offer more reproducible
results in that reproducibility within ±10% can be achieved with three as opposed to
ten measurements required for the finer probes29.
2 10
The depth of penetration is approximately 1 mm in skin ' and 6 mm in
20human colon , probably representing a composite or an integral of the transmural
blood supply20'43.
Perhaps the most significant development in the field of laser doppler
flowmetry was the introduction of the laser doppler flow scanner10. It has a spatial
resolution of at least 3 mm and it offers a fast and reliable method to produce a blood
flow distribution map of a biological tissue of interest. It is a no-contact method with
obvious methodological and patient advantages (e.g. no compromise of sterility of
operative fields).
52 53
Two further reports on similar instruments have been subsequently made ' .
The prototype versions of both these instruments have been assessed in-vitro and also
on human skin. A smaller scanning surface (0.15 m ) and shallower measurement
52 • 133
depth (0.25 mm) have been reported . The measurements correlate well with Xe
53washout blood flow measurements .
In our experiments, an evolution prototype of the instrument reported by
Essex and Byrne10 was assessed. This instrument was able to evaluate blood supply
distribution and analyze it effectively. The statistical analysis functions incorporated
in the software allowed averaging, histogram equalization and standard deviation
measurements to be made on the raw data. There have been several studies to assess
colonic blood flow using single fiber laser flowmetry in cats20, dogs18'27'54 pigs46'55
30 33 37 38 56 57and humans ' ' ' ' ' . This is the first report of the measurement of colonic blood
flow distribution by the laser doppler flow scanner. The instrument can also be used
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33 • • 57
to assess various conditions (colostomy blood flow , effects of radiation and safe
57
levels of blood flow for the viability of colonic anastomosis ) more thoroughly.
Colonic ischaemia was demonstrated both by the intensity and the doppler
flux scans prior to visible changes ensuing (Figure 6). Upon completion of the
operative dissection, visible ischaemic changes were obvious and the resection line
was modified according to that previously indicated by the scanner. The time
consuming studies on discrete point blood flow measurements on ischemic intestine
11 23 24 27 28 32 35 • •in animals ' ' ' ' and humans ' could be expanded by applying the scanning
technique to large segments, even the total length, of the bowel.
We were also able to demonstrate the presence of mural blood supply along
the large intestine to a distance greater than the width of the bowel wall (Figure 7).
The blood flow values were not statistically different in the colon proximal or
distal to the uninflated Neosphincter for the 10 patients as a whole group or in the
two groups separately. The blood flow in the whole segment of the colon (proximal
and distal to the device) was significantly lower in the control group compared with
37
the group with I.B.D. and this is in accordance with a previously reported study .
The hyperemia associated with I.B.D. is well recognized and, whereas
demonstrating it endoscopically with the laser doppler fiber may represent an
• • 37
interesting research finding , the doppler scanner may be able to demonstrate
segmental I.B.D. activity in the whole length of the intestine intraoperatively.
The model presented in this study attempts to circumvent the problem posed
by the fact that the Neosphincter is opaque to laser light. Clearly it would be useful
to obtain an estimate of the effects of the Neosphincter on blood flow to assess its
safety for human long-term implantation. This model allows this estimate to be
obtained because the blood supply of the bowel depends on an end artery which
passes under the Neosphincter. Changes in blood flow under the device should be
reflected in the distal segment of the colon which could be scanned. The expander
inflation pressure can be directly correlated with the operating occlusion pressure as
measured by the pullthrough method because this device applies pressure on the
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bowel evenly, without causing crenation or localized areas of pressure gradients (see
Chapter 3, Chapter 4).
Upon inflation of the Neosphincter there was a small but significant decrease
in the blood flow measured in the colon proximal to the device (Figure 10). This
may be related to part of the bowel being angled and obscured under the expanding
sphincter. It may also be related to the fact that as the resistance to blood flow
increases by the inflation of the expander, this causes a decrease in the total possible
outflow past the device, thus also decreasing the inflow of blood to the colon.
Figure 9 shows that the setting of the sphincter around the bowel was
consistent in all the patients studied. Even though there was such a good correlation
between the expander pressure and the pull-through pressure, the latter more
faithfully represents the actual intra-luminal pressure in the bowel. The same settings
were also used in the survival animal experiments (Chapter 6).
The blood flow in the diabetic patient did not decrease significantly with
increasing sphincteric compression (Figure 14). The presence of calcified arterial
vasculature in diabetes of long standing is well recognized and this may explain the
above finding. The presence of poorly compliant vasculature in inflammatory bowel
disease may also explain the fact that inflamed bowel is less sensitive to the
application of pressure (Figure 13, Figure 14). Even though the compliance of the
vasculature in I.B.D. has not been measured to date, it is conceivable that the
inflammatory infiltrate and fibrosis surrounding the blood vessels may contribute to
the causation of this observed effect.
The BZ value of the laser doppler flow scanner (LDS) was similar in
magnitude to that of the static instrument5. As this parameter is a significant
proportion («15 %) of the resting laser doppler flux measurement, it was taken into
account when reporting the decrease of the colonic blood flow as a response to
sphincteric compression.
In non-inflamed bowel, inflation of the Neosphincter to 30, 60 and 90 mmHg
caused progressive decrease of the blood flow to 75%, 63% and 57% of its baseline
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value respectively. When the level of BZ is accounted for, the corrected levels of
blood flow are 64%, 54% and 48.5% respectively. A balloon plateau pressure of 70
mmHg is planned for the human implantation study and this should produce an
operating occlusion pressure of less than 45 mmHg. Blood flow should, therefore,
not be decreased to less than 50% of its baseline value by the device.
It is generally accepted that the intestine can tolerate chronic reduction of its
blood supply to approximately 50% of its baseline. Since blood supply of
approximately 30% of baseline is sufficient to allow healing of colonic
27
anastomoses and on the basis of the previously reported in-vitro and animal results
in this thesis, and also the fact that the AASP 2000 Neosphincter prototype does not
reduce the blood flow in colon to below 48% of its baseline value even at levels of
system pressure beyond its planned maximum settings, it appears that the
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Chapter 9
Protocol for long term Human implantation
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Design of Clinical Trial of AASP 2000 artificial anal sphincter
prosthesis
Clinical Investigators




Glasgow, G3 1 2ER.
Mr Constantinos Argyrou Hajivassiliou FRCS,
Department of Pediatric Surgery,
Royal Hospital for Sick Children,
Glasgow, G3 8SJ.
Investigation site:
Department of Coloproctology, Glasgow Royal Infirmary,
16, Alexandra Parade, Glasgow, G31 2ER.
Local Ethics Committee approval obtained on 22nd April 1996.
Description and intended purpose of the device:
Prosthetic implantable anal sphincter intended to correct faecal incontinence.
In summary, a new design of pump has been utilised, the tubing and connectors have
been made 'kink free' and a new design of sphincter is employed whereby a linear
pillow and expander are used to flatten the bowel rather than a circular cuff which
might cause crenation.
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Aims and objectives of clinical investigation:
Assessment of a prosthetic implantable anal sphincter in human subjects.
Design of study:
Based on the Helsinki convention
Number of patients involved: 12
Number of devices to be used: 12
Duration ofstudy:
Two years intensive follow-up, followed permanently less intensively.
Proposed Start Date: 01/07/96
Proposed Completion Date: 01/10/98
Implantation Period: 3 months
Control group:
The use of a control group for this study is not appropriate.
Criteria for subject selection, inclusion, exclusion and withdrawal:
Selection:
Subjects with severe faecal incontinence who have the manual dexterity and




Subjects shall be between 18 and 70 years, otherwise fit and healthy with no
intercurrent disease.
Exclusion:
Subjects who cannot operate the device or are unfit for the operative
procedure. There will be a preliminary instruction/consultation when the prospective
subjects will have to demonstrate that they can use and understand the function of the
device. If they fail this evaluation they will be excluded.
Withdrawal:
Subjects will be withdrawn at the discretion of the clinicians, if they have any
serious complication, or at the patients' request.
Subjects requiring deactivation of the device will not necessarily be
withdrawn from the investigation and will be followed up for the full duration. If
required, components may be removed/explanted and replaced when the
complications subside or are remedied. All such incidents shall be reported on case
report forms.
Provisions for recovery of the device:
All explanted devices or components shall be returned to Biosil for
investigation / testing.
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Data collection / Analysis / Statistics
Methods offollow up and assessment during the investigation:
Subjects will be managed routinely during the post-operative period. The
devices shall remain in the deactivated state for a period of four weeks. The device
will be activated under careful ward supervision and patients will remain in hospital
until device operation is satisfactorily. Before being discharged, the subjects will be
issued with clear instructions and be given a thorough assessment. This will include
a 24 hour contact telephone number for use if any complications arise, to ensure that
they are seen by physicians who are familiar with the prosthesis and aware of the
procedures. Once the subjects are discharged from hospital they will be reviewed as
described in Table 1. During these reviews, the functioning of the device will be
measured using ano-rectal physiology studies and / or radiological assessments on
approximately a monthly basis. After 3 months, the studies will reduce to every 3
months for a further 6 months. The approximate timings for the studies are marked
on the table with "S". All observations and medication administered shall be
recorded on the Case Report Form. This form shall also be used to record all adverse





1 1 week 9 6 months - S
2 3 weeks 10 8 months- S
3 1 month - S 11 10 months
4 6 weeks 12 1 year -S
5 2 months - S 13 1 year 3 months
6 10 weeks 14 1 year 6 months - S
7 3 months - S 15 1 year 9 months
8 4 months 16 2 years -S
Table 1: Approximate review schedule.
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Description ofprocedures to record and report severe adverse events and adverse
device effects:
The investigators shall record adverse events and adverse device effects in the
subject's case report form. The investigators shall inform without undue delay Biosil
about any severe adverse event and adverse device effect, and provisions made in
writing or by telephone or fax with written confirmation. In any emergency situation
the investigators shall exercise their judgement to safeguard the subject's interests. In
that case deviations from the clinical investigation plan shall not require the prior
approval of Biosil or the Ethics Committee. Such deviations shall not be considered
as a breach of agreement and shall be reported to Biosil.
Biosil will keep records of any adverse events and adverse device effects
reported to Biosil during the clinical investigation, as per the normal customer
complaints procedure contained within the corrective and preventative action
procedure. Biosil is responsible for informing in writing all clinical investigators
about the severe adverse events and adverse device effects. This information will be
transmitted within ten days. Biosil will consider jointly with the clinical
investigators all adverse events and adverse device effects and if required Biosil shall
report them to the appropriate authorities as per Biosil's medical device vigilance
procedure contained within the advisory note and recall procedure. The investigators
shall inform the Ethics Committee of any severe adverse device effect.
Description andjustification ofstatistical design:
There is no need for statistical method and analysis as the study is an all or
none, line study of 12 consecutive subjects.
The first patient is scheduled to be implanted on 21st August 1996.
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Conclusions
The need for an Artificial Anal Sphincter for a selected group of patients has
been established in the historical reviews in the introductory section.
The data presented in the first two chapters discount the importance of the
anorectal flutter valve theory for fecal continence and suggest that liquids are
retained in the rectum by anal occlusion pressure alone, whereas the retention of
semi-solid material is enhanced by anorectal angulation. The fecal substitute
specifically designed for these experiments may be clinically useful in dynamic
anorectal imaging investigations (videoproctography, isotope proctography).
The newly developed AASP 2000 Neosphincter which was described in this
thesis appears to be free from the ischasmic complications associated with
circumferential occlusive pressure on the bowel. It achieves this by applying the
occlusion pressure in an even way over a large area, without creating localised
pressure points. The creation of angulation also allows for the operating occlusion
pressure of the sphincter to be set at even lower levels (approximating the lower end
of the normal range of resting anal pressure in humans) and this increases the safety
margin of the device.
The study in the survival minipig model suggests that the neosphincter
produces fecal continence without intestinal ischasmia. The presence of the
deactivated neosphincter did not influence the colonic transit time in the minipig. At
present, reliability of the Neosphincter is limited only by the performance of the
pump.
The algorithm developed for the radiological assessment of the function and
complications of the implanted device should be useful in humans.
The disadvantages and limitations of the static, single probe laser doppler
blood flow meter have been largely overcome by the new laser doppler flow scanner
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prototype which was used to assess blood flow in inflamed and non-inflamed colon
in human volunteers.
Blood flow was significantly higher in inflamed colon. The scanner
demonstrated segmental hyperemia, and visually confirmed the existence of
intestinal mural blood perfusion. The scanner was also able to define ischasmia
demarcation lines prior to visible changes ensuing. This may assist in defining the
safe levels for bowel anastomosis and also demonstrate intestinal non-viability
intraoperatively.
The effects of progressive compression by the AASP 2000 artificial anal
Neosphincter were also studied in these patients. Progressive reduction of blood
flow was observed with increasing inflation pressures. Colonic blood flow remained
above 48% of its baseline value even at levels of system pressure beyond the
sphincters' planned maximum settings. It appears that the Neosphincter is not likely
to cause ischaemic injury to the human colon at the planned occlusion pressures.
A new control pump to operate the Neosphincter to overcome the problems
associated with the existing device was specifically designed.
Further technological concepts may be incorporated to afford even more
physiological features to the Neosphincter.
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In this chapter, some thoughts will be presented on how to improve the AASP
2000 system based on original ideas, previous experience and also possibilities on
the implementation of new technological concepts in the proposed designs.
Design of a new pump
The pump used for controlling the AASP 2000 (Figure 1) was based on the
AMS 800 device.
Figure I: Schematic diagram of the control pump. The fluid flow restrictor
(resistor) was made of a single narrow tube, whereas in the AMS 800 it was
made of a porous glass material which was less susceptible to blockage.
Figure 2: The shutoff valve. This simple "piston" type of valve was found to be
unreliable.
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Experience to date confirms the reliability problems of the shutoff valve
(Figure 2), one way ball valves and the easily blocked resistor. The "piston" type
valve was found to be unreliable (Chapter 3). AMS used a "waisted" design1 for this
component which conferred excellent reliability. The problems with the resistor
were almost certainly due to the use of a single lumen narrow pathway resistor in the
AASP design (Chapter 3) as opposed to a porous glass material with a high
12 *i
connectivity coefficient (Appendix 1) used by AMS ' . Other ergonomic and
manufacturing details also need to be addressed. In addition, the design features
suitable for controlling a urethral valve with automatic refilling/equilibration,
although they make the device convenient and simple to operate by the patients, may
not be ideal for controlling defecation due to the long period the valve has to remain
deactivated during defecation.
One solution would be to develop the existing design further and manually
shutting the shutoff valve at the initiation of defecation and activating it on
completion of evacuation. This would involve an extra two operations by the
patient. This is not a major problem, however, as the current guidelines from AMS
suggest that the device is maintained in its deactivated state during sleep. This would
make the device identical to the commercially available unit with likely patent
12
infringement ' . The necessity for a more controllable pump was recognized by
AMS who, at the time, were exploring the control of urinary as well as fecal
incontinence. Their attempts to develop an alternative device were aborted in the
early stages of its development3 in favour of the current AMS 800 pump.
In order to incorporate these design features, namely manually operated shunt
pathway in place of the resistor in addition to a shutoff valve, I designed a new
pump4 (Figure 3, Figure 4, Figure 5, ). The shunting channel would be de-activated
by the first pumping stroke of the bulb thus allowing the expander to be emptied
and remain empty during defecation. At the end of evacuation the shunt is pressed
and returns to the "open" position thus allowing fast equilibration of pressure
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rapidly closing the sphincter. This may be advantageous as slow equilibration may
also allow time for stool to be interposed between the expander and the pillow thus
leading to leakage. This design would entail one extra operation by the patient, that
of pressing the shunt valve at the end of evacuation. The engineering
implementation of the designs shown in Figure 3, Figure 4 and Figure 5 was
difficult, and the prototype under development corresponds to Figure 6.
Figure 3: Proposed Pump for the control of faecal incontinence. Design
incorporating Shunt Valve with pressure equilibrating channels, possibly
providing a "stabilizing hydrostatic pressure" effect.
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Figure 4: Proposed Pump for the control of faecal incontinence. Design with soft
















Modified Exhaust Valve Seat
Figure 5: Proposed Pump for the control of faecal incontinence. Design with
modified exhaust valve seat.
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shunt pathway
Figure 6: New control pump4 with manually controlled shunt pathway. The
device is shown with the shutoff valve open and the shunt pathway blocked.
The shunt valve operation of the device is as follows: in the "block" position,
the flow of fluid from the balloon to the expander side is checked. A pressure
increase in the bulb is directly transmitted to the bottom of the shunt via channel D
pushing it to the "shunt " position. The proposed designs in Figure 3 and Figure 4
depend on the faster transmission of the pressure wave through a wider channel (D)5
thus deactivating the shunt valve before this pressure wave is transmitted through the
narrow channel (d) and dissipated through the shunt.
The device shown in Figure 3 depicts a design attempting to incorporate a
"stabilizing pressure" applied to the shunt valve base through channel "b", akin to the
current design in use where this pressure is applied on the top surface of the shutoff
valve. Bench tests have proved that this does not confer any significant advantage to
the reliability of the valve as the "unseating pressure" with a 100 mmHg pressure
head is not significantly increased (Chapter 3). In addition, this channel has to be
less than 0.2 mm in diameter, otherwise the balloon check valve would be rendered
ineffective. In this design, channel "a" carries fluid to and from the expander side of
the system thus allowing for the upwards or downwards movement of the shunt
piston.
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Figure 4 shows a design without channels "a" and "b". The former is
replaced by the compliant dome which also allows for manual manipulation of the
shunt, whereas the latter is not required.
Figure 5 introduces a modification in the valve seat of the balloon check
valve: the valve is spring loaded and is normally closed as before, but by choosing a
more compliant spring and introducing another valve seat on the exhaust side of the
flow, the valve could allow fluid to be pumped normally by application of gentle
slow squeezes on the bulb, whereas it would close and allow for shunt deactivation if
the first stroke is sharp and quick. This design was considered to pose a very
difficult task of manual dexterity both for the patient and the attending clinician and
was not developed further.
Figure 6 and subsequent figures depict the theoretical operation of a design
incorporating a two compartment, three port poppet valve mechanism, to achieve
the desired shunting (see also Appendix 3). By placing this unit in series with the
shutoff valve, the operation should become more reliable as the critical choice of the,
now redundant, channels "d" and "D" is now obviated. The operation of the shutoff
valve is depicted simply by an open or closed channel to aid clarity (Figure 2).
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The operation would be quite simple: starting with a deactivated pump with a
closed shutoff valve (Figure 7a), the patient would press the bulb, thus closing the
expander side ball check valve and transferring the pressure wave to the bottom of
the shunt ball or poppet valve (Figure 7b) and eventually "popping" the latter to the
closed position (Figure 7c). This opens the shutoff valve during the same operation
as the pressure is now transmitted to the bottom of its piston, and allows pumping to
commence (Figure 7d).
Figure 7: Manual operation of the new pump at the start of defaecation.
When the expander is emptied, evacuation commences and it remains empty
until the patient has completed the act of defecation (Figure 7d). The patient then
presses the appropriate part of the case, which is easily deformed and identified by a
bump, and this action pops the ball or poppet valve down to the "shunt" position and
allows for rapid pressure equilibration and refdling of the expander (Figure 8a-d).
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Figure 8: Manual activation of shunt valve.
In the above designs, the shutoff valve can be placed at 90° to the shunt
valve, and this, in conjunction with a flat pump body design, would afford both space
saving and ease of discrimination between the two valves. The presence of a
separate shutoff valve is still desirable to ensure long term deactivation, e.g. during




These valves were designed and developed by Hakim and Hakim and
patented by Codman-Medos7 (Figure 9, Figure 10). These valves were originally
developed for the control of hydrocephalus shunting systems and are designed to
precisely regulate the opening pressure of the system by external programming of a
wireless servo motor.
Figure 9: View of the Hakim valve from above.
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Figure 10: Cross section of the Hakim valve to show its components and
operation (see text).
The ball valve and its seat Figure 10(1) are both made of synthetic ruby.
Pressure is applied on the superior aspect of the ruby ball by a stainless steel spring
element (2) the pressure characteristics of which are set by a telescopic fulcrum (3)
and calibrated during manufacture. A wireless externally programmable stepper
motor (4) incorporating a "spiral staircase" cam (5) on its superior aspect precisely
sets the tension on the spring depending on the angle of rotation of the cam.
This design offers the possibility of multiple permutations and combinations
that would be pertinent to an artificial sphincter control mechanism. The spring may
be replaced by a rigid plate, which would transform the pressure control valve to an
on/off switch. These could then be placed in series and/or in parallel with one
another to replace the shutoff valve and possibly to also act as selector switches for
the selection of one of several balloons (see next section: Balloon with multiple
plateau pressures).
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Balloon with multiple plateau pressures
One of the limitations of these designs is the inability to vary the operating
pressure of the sphincter, unless a new balloon is inserted by revisional surgery. The
animal experiments in this study were performed by setting the system pressure at a
point along the slope of the sigmoidal pressure-volume curve, thus allowing for the
option to inject fluid to raise the operating pressure if necessary. This, however, had
the disadvantages of losing the protective effect of a pressure plateau and also meant
that the operating pressure critically depended on a specific volume of fluid in the
system.
One way round the problem, assuming a plateau is still considered necessary,
would be to design a balloon with two or more plateaus so that pressure regulation
could be effected over a certain range of inflation volumes which when exceeded
would lead the system to a new higher plateau and so on. This idea is summarized in
Figure 11 to Figure 13.
Figure 11: Proposed balloon made from two components of different pressure-
volume characteristics to achieve a double plateau effect.
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Figure 11 and Figure 12 depict the same proposed design, whereby two or
more sections of the balloon are made of silicone of different thickness. The
expansion of each segment could be limited over a specific range of the plateau for
each one by internally placed expansion limiting elements (Figure 12). Upon
progressive inflation, the pressure would increase almost in a stepwise fashion. Of
course, the highest plateau should be set to a safe level which would not compromise
tissue perfusion.
Figure 12: Same design as previous figure, but with the inclusion of balloon
expansion limiting elements to set the range of volume for the pressure plateau











Figure 13: Multiple balloons with different plateaus could be connected
together and each one selected by a change-over hydraulic switch.
Multiple balloons could be connected together and each one selected in a
non-invasive manner if a reliable hydraulic switch was available (Figure 13).
Magnetically operated valves were assessed by AMS but were not developed
further.
An inductively activated and deactivated valve based on the shape memory
effect9 would appear interesting. The basic mechanism governing the properties of
shape memory alloys is a change in metal structure: a martensitic structure
transforms, at a pre-defined temperature, into an austenitic structure during heating
and reverts to the martensitic structure when the temperature is lowered again.
Through careful processing, it is possible to associate a specific shape with each of
the metal structures, and since structure is linked to temperature, this simply means
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that a switch from low to high temperature or vice versa will result in a change in
shape or, if this change in shape is prevented, in a force. The temperature range
during which this transformation occurs is relatively small and can be freely chosen
anywhere below 110°C. Such a biocompatible and corrosion resistant microactuator
made from a Nickel-Titanium alloy (measuring 1.8X40 mm, weight 0.5 grams,
activation time 0.1s, activation voltage 0.5-5V, load 1 Newton) is commercially
available.
The design of a programmable switch around an inductively coupled stepper
motor as described by Hakim should also be possible (see above).
408
Inductively coupled stimulation of the colon
Based on the current knowledge of fecal continence mechanisms which are
reviewed in the first section, there is little doubt that an intact sensory pathway is
essential for the maintenance of satisfactory control of defecation. Simply inserting
an artificial sphincter in a dysmotile colon would probably result in failure. The
simplest option would be to condition the patient or "train" the colon to contract at a
specific time each day, which would be convenient to the patient and deactivate the
sphincter at that time.
Another possibility could involve the surgical insertion of a pair of
stimulation electrodes into the bowel wall and stimulate these at will by inductive
coupling. These electrodes could also be incorporated into the wall of the expander
at the area of contact with the bowel during manufacture (Figure 14) and the
inductive receiver would be placed subcutaneously. In a preliminary study using a
signal generator (power 25 W, frequency 68 KHz), it was possible to induce a
voltage of 3.5 V in an untuned coil (inductance 1 mH) placed 2 cm away. If this
system is tuned and coded, then non-invasive colonic activation could be achieved











Figure 14: Proposed expander modification to incorporate a tuned receiver and
stimulating electrodes to allow transcutaneous bowel stimulation.
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